Argentina, Chaco...Argentina, Chaco (2008−2012) Average annual person−years by sex and age group...
Transcript of Argentina, Chaco...Argentina, Chaco (2008−2012) Average annual person−years by sex and age group...
146
Central and South America
Argentina, Chaco (2008−2012)Average annual person−years by sex and age group
54 200 0- 52 352
51 001 5- 49 185
57 077 10- 54 950
57 874 15- 55 743
52 102 20- 49 928
44 395 25- 43 583
38 020 30- 38 392
30 663 35- 31 602
28 025 40- 28 606
27 620 45- 27 834
25 134 50- 25 549
21 648 55- 21 431
16 247 60- 16 392
11 745 65- 13 476
8 819 70- 11 503
5 939 75- 8 586
4 442 80+ 7 166
Total534 951 536 278Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleTrachea, bronchus, and lung 31.9Prostate 26.4Colon 15.3Stomach 13.2Other and unspecified 12.7Kidney 9.8Oesophagus 8.9Non-melanoma skin cancer 6.8Pancreas 6.2Bladder 6.0Larynx 6.0Non-Hodgkin lymphoma 5.4Liver 4.4Rectum 4.1Brain and nervous system 4.0Testis 3.7Mouth 3.3Penis 2.5Gallbladder etc. 2.4Melanoma of skin 2.4
All sites 197.0
Breast 47.2Cervix uteri 26.4Other and unspecified 11.2Colon 11.2Trachea, bronchus, and lung 8.4Ovary 6.6Stomach 5.4Corpus uteri 5.1Pancreas 4.5Thyroid 4.5Kidney 4.0Non-melanoma skin cancer 4.0Non-Hodgkin lymphoma 3.9Brain and nervous system 3.5Gallbladder etc. 3.0Oesophagus 2.7Liver 2.5Rectum 2.4Uterus unspecified 2.1Bladder 1.8
All sites 179.1
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
SOURCE OF POPULATIONPopulation data retrieved from the National Institute of Statistics and Census (INDEC; https://www.indec.gob.ar). Methodology is passive.
Argentina, Chaco (2008−2012)Average annual person−years by sex and age group
54 200 0- 52 352
51 001 5- 49 185
57 077 10- 54 950
57 874 15- 55 743
52 102 20- 49 928
44 395 25- 43 583
38 020 30- 38 392
30 663 35- 31 602
28 025 40- 28 606
27 620 45- 27 834
25 134 50- 25 549
21 648 55- 21 431
16 247 60- 16 392
11 745 65- 13 476
8 819 70- 11 503
5 939 75- 8 586
4 442 80+ 7 166
Total534 951 536 278Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleTrachea, bronchus, and lung 31.9Prostate 26.4Colon 15.3Stomach 13.2Other and unspecified 12.7Kidney 9.8Oesophagus 8.9Non-melanoma skin cancer 6.8Pancreas 6.2Bladder 6.0Larynx 6.0Non-Hodgkin lymphoma 5.4Liver 4.4Rectum 4.1Brain and nervous system 4.0Testis 3.7Mouth 3.3Penis 2.5Gallbladder etc. 2.4Melanoma of skin 2.4
All sites 197.0
Breast 47.2Cervix uteri 26.4Other and unspecified 11.2Colon 11.2Trachea, bronchus, and lung 8.4Ovary 6.6Stomach 5.4Corpus uteri 5.1Pancreas 4.5Thyroid 4.5Kidney 4.0Non-melanoma skin cancer 4.0Non-Hodgkin lymphoma 3.9Brain and nervous system 3.5Gallbladder etc. 3.0Oesophagus 2.7Liver 2.5Rectum 2.4Uterus unspecified 2.1Bladder 1.8
All sites 179.1
Argentina, ChacoCONTRIBUTORSMaria Angelica DuarteClaudia RojasGuillermina Veronica TabaréGraciela Abriata
Argentina, Chaco (2008–2012)Average annual person–years by sex and age group
147
Central and South America
Argentina, Chaco (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
16 0.4 0.3 0.7 0.03 0.09 31 0.7 0.6 1.4 0.09 0.19 75 1.7 1.4 3.3 0.27 0.40 14 0.3 0.3 0.6 0.04 0.05 24 0.5 0.4 1.0 0.07 0.11 20 0.5 0.4 0.8 0.07 0.10 8 0.2 0.1 0.3 0.03 0.04 3 0.1 0.1 0.1 0.01 0.01
13 0.3 0.2 0.6 0.02 0.06 202 4.6 3.8 8.9 0.43 1.02 305 6.9 5.7 13.2 0.76 1.49 27 0.6 0.5 1.2 0.07 0.11
359 8.1 6.7 15.3 0.79 1.74 94 2.1 1.8 4.1 0.26 0.49 12 0.3 0.2 0.5 0.04 0.06
100 2.3 1.9 4.4 0.19 0.49 56 1.3 1.0 2.4 0.12 0.28
141 3.2 2.6 6.2 0.30 0.78 11 0.2 0.2 0.5 0.02 0.06
138 3.1 2.6 6.0 0.43 0.75 721 16.3 13.5 31.9 1.63 3.97 19 0.4 0.4 0.8 0.06 0.08 35 0.8 0.7 1.4 0.09 0.11 57 1.3 1.1 2.4 0.15 0.30
157 2.9 6.8 0.33 0.74 7 0.2 0.1 0.3 0.02 0.03
17 0.4 0.3 0.7 0.06 0.07 42 0.9 0.8 1.7 0.12 0.19 18 0.4 0.3 0.8 0.03 0.10
57 1.3 1.1 2.5 0.15 0.25 603 13.6 11.3 26.4 0.86 2.93 103 2.3 1.9 3.7 0.25 0.26 0 0.0 0.0 0.0 0.00 0.00
224 5.1 4.2 9.8 0.57 1.24 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.1 0.01 0.02
142 3.2 2.7 6.0 0.28 0.72 0 0.0 0.0 0.0 0.00 0.00
13 0.3 0.2 0.5 0.02 0.06 98 2.2 1.8 4.0 0.28 0.38 24 0.5 0.4 1.0 0.09 0.10 5 0.1 0.1 0.2 0.01 0.01 3 0.1 0.1 0.1 0.01 0.01
37 0.8 0.7 1.4 0.08 0.14 134 3.0 2.5 5.4 0.36 0.55 0 0.0 0.0 0.0 0.00 0.00
24 0.5 0.4 1.0 0.06 0.11 48 1.1 0.9 2.0 0.08 0.14 23 0.5 0.4 0.9 0.07 0.09 27 0.6 0.5 1.1 0.05 0.11 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
293 6.6 5.5 12.7 0.66 1.38 4583 85.7 197.0 10.44 22.43 4426 100.0 82.7 190.2 10.11 21.70
6 0.1 0.1 0.2 0.01 0.01 17 0.4 0.3 0.7 0.06 0.08 22 0.5 0.4 0.8 0.06 0.10 7 0.2 0.1 0.3 0.03 0.03 3 0.1 0.1 0.1 0.01 0.01 6 0.1 0.1 0.2 0.02 0.02 3 0.1 0.1 0.1 0.00 0.02 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.1 0.00 0.02
77 1.7 1.4 2.7 0.13 0.31 142 3.1 2.6 5.4 0.38 0.58 15 0.3 0.3 0.5 0.04 0.05
301 6.5 5.6 11.2 0.70 1.24 64 1.4 1.2 2.4 0.17 0.26 17 0.4 0.3 0.7 0.05 0.09 72 1.6 1.3 2.5 0.13 0.26 81 1.8 1.5 3.0 0.18 0.31
127 2.7 2.4 4.5 0.21 0.51 9 0.2 0.2 0.4 0.03 0.05
14 0.3 0.3 0.5 0.03 0.06 224 4.8 4.2 8.4 0.51 0.96 10 0.2 0.2 0.4 0.03 0.04 30 0.6 0.6 1.1 0.08 0.10 42 0.9 0.8 1.6 0.11 0.16
119 2.2 4.0 0.15 0.36 2 0.0 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
25 0.5 0.5 0.9 0.07 0.09 1212 26.2 22.6 47.2 3.43 5.27 32 0.7 0.6 1.1 0.06 0.11 13 0.3 0.2 0.5 0.04 0.06
684 14.8 12.8 26.4 2.13 2.66 124 2.7 2.3 5.1 0.44 0.63 60 1.3 1.1 2.1 0.11 0.21
174 3.8 3.2 6.6 0.47 0.70 2 0.0 0.0 0.1 0.01 0.01
48 1.0 0.9 1.6 0.11 0.11
105 2.3 2.0 4.0 0.27 0.43 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
52 1.1 1.0 1.8 0.09 0.19 1 0.0 0.0 0.0 0.00 0.00
12 0.3 0.2 0.4 0.02 0.04 90 1.9 1.7 3.5 0.25 0.32
118 2.6 2.2 4.5 0.33 0.43 4 0.1 0.1 0.2 0.01 0.01 5 0.1 0.1 0.2 0.00 0.01
30 0.6 0.6 1.1 0.07 0.09 99 2.1 1.8 3.9 0.24 0.43 0 0.0 0.0 0.0 0.00 0.00
22 0.5 0.4 0.9 0.05 0.12 41 0.9 0.8 1.6 0.09 0.10 35 0.8 0.7 1.3 0.08 0.12 25 0.5 0.5 0.9 0.04 0.08 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
320 6.9 6.0 11.2 0.53 1.15 4746 88.5 179.1 12.04 19.02 4627 100.0 86.3 175.1 11.89 18.66
† See note following population pyramid
Argentina, Chaco (2008–2012)
148
Central and South America
Argentina, Córdoba
Argentina, Córdoba (2008–2012)Average annual person–years by sex and age group
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
SOURCE OF POPULATION2004–2009 population: Directorate of Socio-demographic Statistics, based on the 2008 population census of the Province of Córdoba and the 2001 National Population, Households, and Housing Census (INDEC; https://www.indec.gob.ar). General Directorate of Statistics and Census of the Province of Córdoba. 2010–2015 population: Directorate of Socio-demographic Statistics, based on population estimates by sex, department, and calendar year 2010–2025, Demographic analysis series No. 38 and 2010 National Population, Households, and Housing Census. General Directorate of Statistics and Census of the Province of Córdoba.
CONTRIBUTORSMartín AlonsoRosalba FitaBeatriz Carballo Q.Graciela NicolásMarcela ÁlvarezOlga Toledo
Argentina, Córdoba (2008−2012)Average annual person−years by sex and age group
56 200 0- 53 208
54 248 5- 52 008
54 831 10- 53 062
58 690 15- 58 733
63 611 20- 65 926
60 464 25- 62 080
54 238 30- 55 326
44 890 35- 46 863
36 649 40- 39 811
34 268 45- 38 230
31 237 50- 36 139
28 892 55- 34 629
24 857 60- 30 950
18 922 65- 25 359
14 227 70- 20 379
10 548 75- 17 533
10 119 80+ 23 191
Total656 891 713 427Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 46.5Trachea, bronchus, and lung 26.7Colon 20.3Non-melanoma skin cancer 17.3Bladder 11.6Kidney 10.5Stomach 9.5Other and unspecified 9.3Non-Hodgkin lymphoma 8.6Pancreas 7.7Brain and nervous system 7.7Rectum 6.8Testis 6.1Liver 4.8Larynx 4.6Oesophagus 3.8Lymphoid leukaemia 3.2Gallbladder etc. 2.8Melanoma of skin 2.6Multiple myeloma 2.4
All sites 240.4
Breast 84.0Colon 12.9Non-melanoma skin cancer 12.6Cervix uteri 10.6Trachea, bronchus, and lung 9.1Ovary 8.9Thyroid 8.1Other and unspecified 7.5Corpus uteri 7.0Brain and nervous system 7.0Pancreas 5.9Non-Hodgkin lymphoma 5.8Kidney 5.2Stomach 3.8Gallbladder etc. 3.6Rectum 3.6Melanoma of skin 2.9Liver 2.5Lymphoid leukaemia 2.3Bladder 2.3
All sites 225.9
Argentina, Córdoba (2008−2012)Average annual person−years by sex and age group
56 200 0- 53 208
54 248 5- 52 008
54 831 10- 53 062
58 690 15- 58 733
63 611 20- 65 926
60 464 25- 62 080
54 238 30- 55 326
44 890 35- 46 863
36 649 40- 39 811
34 268 45- 38 230
31 237 50- 36 139
28 892 55- 34 629
24 857 60- 30 950
18 922 65- 25 359
14 227 70- 20 379
10 548 75- 17 533
10 119 80+ 23 191
Total656 891 713 427Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 46.5Trachea, bronchus, and lung 26.7Colon 20.3Non-melanoma skin cancer 17.3Bladder 11.6Kidney 10.5Stomach 9.5Other and unspecified 9.3Non-Hodgkin lymphoma 8.6Pancreas 7.7Brain and nervous system 7.7Rectum 6.8Testis 6.1Liver 4.8Larynx 4.6Oesophagus 3.8Lymphoid leukaemia 3.2Gallbladder etc. 2.8Melanoma of skin 2.6Multiple myeloma 2.4
All sites 240.4
Breast 84.0Colon 12.9Non-melanoma skin cancer 12.6Cervix uteri 10.6Trachea, bronchus, and lung 9.1Ovary 8.9Thyroid 8.1Other and unspecified 7.5Corpus uteri 7.0Brain and nervous system 7.0Pancreas 5.9Non-Hodgkin lymphoma 5.8Kidney 5.2Stomach 3.8Gallbladder etc. 3.6Rectum 3.6Melanoma of skin 2.9Liver 2.5Lymphoid leukaemia 2.3Bladder 2.3
All sites 225.9
149
Central and South America
Argentina, Córdoba (2008–2012) Argentina, Córdoba (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
3 0.0 0.0 0.1 0.01 0.01 62 0.8 0.9 1.8 0.12 0.21 50 0.6 0.8 1.4 0.11 0.15 37 0.5 0.6 1.0 0.06 0.12 15 0.2 0.2 0.4 0.02 0.05 16 0.2 0.2 0.5 0.03 0.07 7 0.1 0.1 0.2 0.02 0.03
17 0.2 0.3 0.5 0.03 0.05 4 0.0 0.1 0.1 0.01 0.02
147 1.8 2.2 3.8 0.14 0.45 345 4.3 5.3 9.5 0.45 1.16 34 0.4 0.5 0.9 0.07 0.09
743 9.2 11.3 20.3 1.08 2.38 242 3.0 3.7 6.8 0.36 0.87 26 0.3 0.4 0.7 0.04 0.07
179 2.2 2.7 4.8 0.24 0.54 103 1.3 1.6 2.8 0.12 0.36 287 3.5 4.4 7.7 0.36 0.97 10 0.1 0.2 0.3 0.03 0.03
158 2.0 2.4 4.6 0.30 0.59 951 11.8 14.5 26.7 1.47 3.48 38 0.5 0.6 1.1 0.06 0.11 54 0.7 0.8 1.6 0.10 0.13 92 1.1 1.4 2.6 0.16 0.28
651 9.9 17.3 0.90 1.91 20 0.2 0.3 0.6 0.03 0.07 75 0.9 1.1 2.1 0.17 0.19 55 0.7 0.8 1.6 0.08 0.15 42 0.5 0.6 1.2 0.04 0.14
30 0.4 0.5 0.9 0.07 0.10 1754 21.7 26.7 46.5 1.75 6.08 226 2.8 3.4 6.1 0.45 0.46 1 0.0 0.0 0.0 0.00 0.00
369 4.6 5.6 10.5 0.71 1.22 2 0.0 0.0 0.1 0.00 0.00 3 0.0 0.0 0.1 0.00 0.00
428 5.3 6.5 11.6 0.58 1.39 2 0.0 0.0 0.1 0.01 0.01
10 0.1 0.2 0.3 0.01 0.03 263 3.3 4.0 7.7 0.48 0.80 69 0.9 1.1 2.1 0.17 0.22 10 0.1 0.2 0.4 0.02 0.03 13 0.2 0.2 0.4 0.02 0.06 67 0.8 1.0 1.9 0.13 0.17
301 3.7 4.6 8.6 0.56 0.97 1 0.0 0.0 0.0 0.00 0.00
84 1.0 1.3 2.4 0.16 0.26 102 1.3 1.6 3.2 0.18 0.29 55 0.7 0.8 1.5 0.11 0.15 61 0.8 0.9 1.6 0.07 0.15 38 0.5 0.6 1.1 0.06 0.14 44 0.5 0.7 1.1 0.04 0.10
344 4.3 5.2 9.3 0.49 1.04 8740 133.1 240.4 12.71 28.36 8089 100.0 123.1 223.1 11.81 26.45
4 0.0 0.1 0.0 0.00 0.00 26 0.3 0.4 0.5 0.03 0.06 25 0.3 0.4 0.6 0.04 0.07 33 0.3 0.5 0.8 0.05 0.09 7 0.1 0.1 0.2 0.01 0.02 7 0.1 0.1 0.1 0.01 0.02 3 0.0 0.0 0.1 0.00 0.01 4 0.0 0.1 0.1 0.00 0.01 2 0.0 0.0 0.0 0.00 0.00
95 1.0 1.3 1.6 0.07 0.15 202 2.0 2.8 3.8 0.22 0.40 41 0.4 0.6 0.9 0.06 0.10
688 7.0 9.6 12.9 0.70 1.48 176 1.8 2.5 3.6 0.21 0.42 34 0.3 0.5 0.7 0.05 0.08
151 1.5 2.1 2.5 0.11 0.29 187 1.9 2.6 3.6 0.19 0.46 332 3.4 4.7 5.9 0.28 0.70 10 0.1 0.1 0.2 0.02 0.02 31 0.3 0.4 0.7 0.05 0.08
447 4.5 6.3 9.1 0.56 1.16 44 0.4 0.6 0.9 0.04 0.10 40 0.4 0.6 1.0 0.07 0.09
123 1.2 1.7 2.9 0.21 0.32 639 9.0 12.6 0.76 1.48 15 0.2 0.2 0.3 0.01 0.04 7 0.1 0.1 0.1 0.00 0.02
62 0.6 0.9 1.4 0.09 0.14 3750 37.9 52.6 84.0 5.94 9.80 43 0.4 0.6 0.8 0.04 0.09 23 0.2 0.3 0.5 0.03 0.05
430 4.4 6.0 10.6 0.84 1.12 315 3.2 4.4 7.0 0.50 0.91 61 0.6 0.9 1.2 0.09 0.13
393 4.0 5.5 8.9 0.62 1.03 10 0.1 0.1 0.2 0.02 0.02 6 0.1 0.1 0.2 0.01 0.01
239 2.4 3.4 5.2 0.36 0.59 1 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00
127 1.3 1.8 2.3 0.12 0.24 1 0.0 0.0 0.0 0.00 0.00
19 0.2 0.3 0.6 0.03 0.04 301 3.0 4.2 7.0 0.47 0.68 315 3.2 4.4 8.1 0.67 0.79 12 0.1 0.2 0.5 0.02 0.03 7 0.1 0.1 0.2 0.01 0.02
56 0.6 0.8 1.4 0.09 0.12 268 2.7 3.8 5.8 0.33 0.68 3 0.0 0.0 0.0 0.00 0.00
62 0.6 0.9 1.3 0.09 0.16 73 0.7 1.0 2.3 0.13 0.17 55 0.6 0.8 1.5 0.09 0.14 63 0.6 0.9 1.0 0.05 0.09 35 0.4 0.5 0.8 0.06 0.08 17 0.2 0.2 0.3 0.02 0.03
400 4.0 5.6 7.5 0.38 0.89 10522 147.5 225.9 14.87 25.71 9883 100.0 138.5 213.3 14.11 24.22
† See note following population pyramid
150
Central and South America
Argentina, Entre Riós Province (2008−2011)Average annual person−years by sex and age group
47 036 0- 44 277
47 707 5- 45 300
49 585 10- 48 032
48 167 15- 46 788
43 117 20- 42 377
39 766 25- 39 809
38 600 30- 39 190
34 440 35- 34 907
30 152 40- 30 917
28 505 45- 29 783
26 087 50- 27 875
23 833 55- 25 307
20 201 60- 22 362
15 832 65- 18 818
11 616 70- 15 590
7 967 75- 12 795
7 430 80+ 16 836
Total520 041 540 963Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 53.9Prostate 45.5Trachea, bronchus, and lung 32.4Colon 27.2Other and unspecified 13.3Stomach 12.7Bladder 11.9Kidney 11.2Rectum 9.3Pancreas 8.8Oesophagus 7.1Larynx 6.2Testis 5.0Brain and nervous system 4.8Non-Hodgkin lymphoma 4.5Melanoma of skin 4.0Liver 3.8Mouth 3.1Gallbladder etc. 2.4Tongue 2.2
All sites 292.0
Breast 62.5Non-melanoma skin cancer 38.3Colon 20.7Cervix uteri 15.1Trachea, bronchus, and lung 10.0Thyroid 9.3Ovary 8.1Other and unspecified 7.5Pancreas 6.1Kidney 5.9Corpus uteri 5.7Stomach 5.3Rectum 5.1Non-Hodgkin lymphoma 3.8Melanoma of skin 3.4Brain and nervous system 3.4Bladder 2.8Oesophagus 2.7Uterus unspecified 2.3Gallbladder etc. 1.8
All sites 235.9
Argentina, Entre Ríos Province (2008–2011)Average annual person–years by sex and age groupArgentina, Entre Riós Province (2008−2011)
Average annual person−years by sex and age group
47 036 0- 44 277
47 707 5- 45 300
49 585 10- 48 032
48 167 15- 46 788
43 117 20- 42 377
39 766 25- 39 809
38 600 30- 39 190
34 440 35- 34 907
30 152 40- 30 917
28 505 45- 29 783
26 087 50- 27 875
23 833 55- 25 307
20 201 60- 22 362
15 832 65- 18 818
11 616 70- 15 590
7 967 75- 12 795
7 430 80+ 16 836
Total520 041 540 963Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 53.9Prostate 45.5Trachea, bronchus, and lung 32.4Colon 27.2Other and unspecified 13.3Stomach 12.7Bladder 11.9Kidney 11.2Rectum 9.3Pancreas 8.8Oesophagus 7.1Larynx 6.2Testis 5.0Brain and nervous system 4.8Non-Hodgkin lymphoma 4.5Melanoma of skin 4.0Liver 3.8Mouth 3.1Gallbladder etc. 2.4Tongue 2.2
All sites 292.0
Breast 62.5Non-melanoma skin cancer 38.3Colon 20.7Cervix uteri 15.1Trachea, bronchus, and lung 10.0Thyroid 9.3Ovary 8.1Other and unspecified 7.5Pancreas 6.1Kidney 5.9Corpus uteri 5.7Stomach 5.3Rectum 5.1Non-Hodgkin lymphoma 3.8Melanoma of skin 3.4Brain and nervous system 3.4Bladder 2.8Oesophagus 2.7Uterus unspecified 2.3Gallbladder etc. 1.8
All sites 235.9
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
SOURCE OF POPULATIONNational Institute of Statistics and Census (INDEC; https://www.indec.gob.ar); population estimates for 2009 (mid-term 2008–2010).
CONTRIBUTORSPatricia GiaccianiEnrique FernándezMiguel Angel PrinceCarmen GonzálezDiego GarcilazoLily HerreraJulio BechelliHéctor Arocena
Argentina, Entre Ríos Province
151
Central and South America
Argentina, Entre Ríos Province (2008–2011) Argentina, Entre Riós Province (2008−2011)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
27 0.5 0.6 1.2 0.09 0.12 50 0.9 1.2 2.2 0.15 0.31 68 1.2 1.6 3.1 0.22 0.40 21 0.4 0.5 0.9 0.06 0.10 22 0.4 0.5 1.0 0.09 0.12 10 0.2 0.2 0.4 0.02 0.06 6 0.1 0.1 0.3 0.02 0.02 3 0.1 0.1 0.1 0.01 0.02
21 0.4 0.5 0.9 0.07 0.11 163 2.9 3.9 7.1 0.42 0.90 290 5.2 7.0 12.7 0.66 1.60 21 0.4 0.5 1.0 0.05 0.14
644 11.6 15.5 27.2 1.31 3.29 216 3.9 5.2 9.3 0.49 1.13 18 0.3 0.4 0.8 0.05 0.11 88 1.6 2.1 3.8 0.23 0.44 57 1.0 1.4 2.4 0.15 0.25
205 3.7 4.9 8.8 0.57 1.02 9 0.2 0.2 0.4 0.01 0.04
141 2.5 3.4 6.2 0.37 0.83 746 13.5 17.9 32.4 1.98 4.05 25 0.5 0.6 1.1 0.07 0.15 16 0.3 0.4 0.7 0.04 0.08 90 1.6 2.2 4.0 0.23 0.45
1271 30.6 53.9 2.83 5.95 2 0.0 0.0 0.1 0.01 0.01 2 0.0 0.0 0.1 0.01 0.01
33 0.6 0.8 1.4 0.09 0.12 16 0.3 0.4 0.7 0.04 0.07
34 0.6 0.8 1.5 0.10 0.17 1123 20.3 27.0 45.5 1.35 5.38 108 1.9 2.6 5.0 0.36 0.40 2 0.0 0.0 0.1 0.01 0.01
250 4.5 6.0 11.2 0.72 1.40 3 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
284 5.1 6.8 11.9 0.46 1.46 1 0.0 0.0 0.0 0.00 0.01 5 0.1 0.1 0.3 0.01 0.01
101 1.8 2.4 4.8 0.32 0.46 42 0.8 1.0 1.9 0.13 0.21 8 0.1 0.2 0.5 0.02 0.03 0 0.0 0.0 0.0 0.00 0.00
28 0.5 0.7 1.3 0.09 0.11 104 1.9 2.5 4.5 0.27 0.50 0 0.0 0.0 0.0 0.00 0.00
23 0.4 0.6 1.0 0.06 0.11 41 0.7 1.0 1.9 0.08 0.19 21 0.4 0.5 1.0 0.06 0.11 39 0.7 0.9 1.8 0.09 0.20 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
312 5.6 7.5 13.3 0.66 1.58 6810 163.7 292.0 15.13 34.28 5539 100.0 133.1 238.1 12.30 28.33
5 0.1 0.1 0.1 0.01 0.02 16 0.3 0.4 0.6 0.05 0.06 17 0.3 0.4 0.5 0.02 0.06 9 0.2 0.2 0.4 0.02 0.04 2 0.0 0.0 0.1 0.01 0.01 3 0.1 0.1 0.1 0.01 0.02 2 0.0 0.0 0.0 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.01
88 1.6 2.0 2.7 0.15 0.32 172 3.1 4.0 5.3 0.27 0.62 17 0.3 0.4 0.5 0.03 0.06
638 11.5 14.7 20.7 1.07 2.47 151 2.7 3.5 5.1 0.31 0.60 30 0.5 0.7 1.2 0.09 0.17 41 0.7 0.9 1.0 0.03 0.08 61 1.1 1.4 1.8 0.07 0.24
199 3.6 4.6 6.1 0.31 0.71 2 0.0 0.0 0.1 0.00 0.00
18 0.3 0.4 0.6 0.05 0.07 288 5.2 6.7 10.0 0.66 1.22 15 0.3 0.3 0.5 0.04 0.06 13 0.2 0.3 0.5 0.04 0.04 93 1.7 2.1 3.4 0.23 0.38
1184 27.4 38.3 2.20 4.24 4 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
32 0.6 0.7 1.1 0.08 0.11 1691 30.5 39.1 62.5 4.41 7.08 35 0.6 0.8 1.0 0.03 0.14 22 0.4 0.5 0.8 0.06 0.09
357 6.4 8.2 15.1 1.20 1.55 162 2.9 3.7 5.7 0.39 0.71 63 1.1 1.5 2.3 0.19 0.28
214 3.9 4.9 8.1 0.62 0.89 9 0.2 0.2 0.3 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00
163 2.9 3.8 5.9 0.32 0.72 2 0.0 0.0 0.1 0.01 0.01 1 0.0 0.0 0.1 0.00 0.00
91 1.6 2.1 2.8 0.13 0.37 0 0.0 0.0 0.0 0.00 0.00 4 0.1 0.1 0.2 0.01 0.01
79 1.4 1.8 3.4 0.24 0.35 216 3.9 5.0 9.3 0.76 0.91 1 0.0 0.0 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
23 0.4 0.5 0.9 0.06 0.07 109 2.0 2.5 3.8 0.23 0.43 0 0.0 0.0 0.0 0.00 0.00
27 0.5 0.6 1.0 0.06 0.15 28 0.5 0.6 1.3 0.08 0.10 23 0.4 0.5 0.9 0.05 0.09 56 1.0 1.3 1.7 0.09 0.18 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
257 4.6 5.9 7.5 0.35 0.82 6734 155.6 235.9 15.07 26.59 5550 100.0 128.2 197.6 12.87 22.35
† See note following population pyramid
152
Central and South America
Argentina, MendozaCONTRIBUTORSMaría Cristina DiumenjoWalter Daniel LaspadaEmiliano ZaniSilvia Beatriz MarchevskyDalinda María AgostiniCarlos Alejandro Vazquez RizzettoRicardo ZulianJuana OrtizRuben CerchiaiAna Laura Pogonza
Argentina, Mendoza (2008−2012)Average annual person−years by sex and age group
78 046 0- 74 963
75 027 5- 72 809
79 947 10- 77 505
81 127 15- 79 127
74 399 20- 73 368
69 608 25- 69 651
61 012 30- 62 992
51 847 35- 55 032
45 710 40- 49 309
43 558 45- 47 618
41 199 50- 45 087
38 407 55- 43 073
31 502 60- 36 124
24 621 65- 29 514
18 839 70- 23 545
14 666 75- 19 962
10 683 80- 16 748
5 640 85+ 9 893
Total845 838 886 320Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 42.6Trachea, bronchus, and lung 24.2Non-melanoma skin cancer 20.0Colon 18.1Stomach 12.7Kidney 10.4Bladder 9.9Other and unspecified 9.6Rectum 7.7Non-Hodgkin lymphoma 7.5Pancreas 7.4Testis 7.3Brain and nervous system 6.2Oesophagus 5.3Liver 5.2Larynx 4.0Melanoma of skin 3.0Myeloid leukaemia 3.0Multiple myeloma 2.8Gallbladder etc. 2.7
All sites 234.2
Breast 73.8Non-melanoma skin cancer 13.7Colon 13.5Cervix uteri 13.0Ovary 9.5Corpus uteri 8.8Trachea, bronchus, and lung 7.6Other and unspecified 7.0Thyroid 6.6Pancreas 6.5Non-Hodgkin lymphoma 5.4Stomach 5.0Kidney 4.8Rectum 4.7Gallbladder etc. 4.2Brain and nervous system 4.1Uterus unspecified 3.1Myeloid leukaemia 2.7Liver 2.5Melanoma of skin 2.4
All sites 222.0
Argentina, Mendoza (2008−2012)Average annual person−years by sex and age group
78 046 0- 74 963
75 027 5- 72 809
79 947 10- 77 505
81 127 15- 79 127
74 399 20- 73 368
69 608 25- 69 651
61 012 30- 62 992
51 847 35- 55 032
45 710 40- 49 309
43 558 45- 47 618
41 199 50- 45 087
38 407 55- 43 073
31 502 60- 36 124
24 621 65- 29 514
18 839 70- 23 545
14 666 75- 19 962
10 683 80- 16 748
5 640 85+ 9 893
Total845 838 886 320Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 42.6Trachea, bronchus, and lung 24.2Non-melanoma skin cancer 20.0Colon 18.1Stomach 12.7Kidney 10.4Bladder 9.9Other and unspecified 9.6Rectum 7.7Non-Hodgkin lymphoma 7.5Pancreas 7.4Testis 7.3Brain and nervous system 6.2Oesophagus 5.3Liver 5.2Larynx 4.0Melanoma of skin 3.0Myeloid leukaemia 3.0Multiple myeloma 2.8Gallbladder etc. 2.7
All sites 234.2
Breast 73.8Non-melanoma skin cancer 13.7Colon 13.5Cervix uteri 13.0Ovary 9.5Corpus uteri 8.8Trachea, bronchus, and lung 7.6Other and unspecified 7.0Thyroid 6.6Pancreas 6.5Non-Hodgkin lymphoma 5.4Stomach 5.0Kidney 4.8Rectum 4.7Gallbladder etc. 4.2Brain and nervous system 4.1Uterus unspecified 3.1Myeloid leukaemia 2.7Liver 2.5Melanoma of skin 2.4
All sites 222.0
Argentina, Mendoza (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONIn Argentina, a population census is carried out every 10 years by the National Institute of Statistics and Census (INDEC; https://www.indec.gob.ar). Each province has an office that represents the National Institute; in Mendoza, it is the Directorate of Statistics and Economic Research of Mendoza.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
153
Central and South America
Argentina, Mendoza (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
3 0.0 0.0 0.1 0.00 0.01 38 0.4 0.4 0.8 0.06 0.10 32 0.3 0.4 0.7 0.05 0.09 40 0.4 0.5 0.8 0.05 0.09 18 0.2 0.2 0.4 0.03 0.05 4 0.0 0.0 0.1 0.01 0.01
19 0.2 0.2 0.4 0.04 0.05 6 0.1 0.1 0.1 0.00 0.01 6 0.1 0.1 0.1 0.01 0.01
263 2.5 3.1 5.3 0.26 0.63 630 6.0 7.4 12.7 0.69 1.49 38 0.4 0.4 0.8 0.05 0.11
893 8.6 10.6 18.1 0.87 2.20 379 3.6 4.5 7.7 0.40 0.92 31 0.3 0.4 0.7 0.05 0.09
262 2.5 3.1 5.2 0.26 0.62 134 1.3 1.6 2.7 0.12 0.34 375 3.6 4.4 7.4 0.36 0.95 16 0.2 0.2 0.4 0.03 0.05
188 1.8 2.2 4.0 0.25 0.54 1158 11.1 13.7 24.2 1.29 3.12 33 0.3 0.4 0.7 0.05 0.07 57 0.5 0.7 1.3 0.08 0.11
141 1.4 1.7 3.0 0.18 0.37 1019 12.0 20.0 0.95 2.21 23 0.2 0.3 0.5 0.02 0.06 31 0.3 0.4 0.7 0.05 0.06
101 1.0 1.2 2.3 0.15 0.23 44 0.4 0.5 0.9 0.04 0.12
75 0.7 0.9 1.5 0.09 0.17 2216 21.2 26.2 42.6 1.58 5.20 322 3.1 3.8 7.3 0.54 0.57 6 0.1 0.1 0.1 0.01 0.01
475 4.6 5.6 10.4 0.74 1.26 10 0.1 0.1 0.3 0.02 0.03 5 0.0 0.1 0.1 0.01 0.02
486 4.7 5.7 9.9 0.46 1.24 5 0.0 0.1 0.1 0.00 0.01
11 0.1 0.1 0.3 0.02 0.02 273 2.6 3.2 6.2 0.40 0.64 62 0.6 0.7 1.4 0.12 0.14 13 0.1 0.2 0.4 0.02 0.02 14 0.1 0.2 0.3 0.02 0.03 96 0.9 1.1 2.1 0.15 0.18
343 3.3 4.1 7.5 0.48 0.80 12 0.1 0.1 0.3 0.01 0.03
137 1.3 1.6 2.8 0.15 0.33 103 1.0 1.2 2.4 0.14 0.20 138 1.3 1.6 3.0 0.18 0.32 45 0.4 0.5 0.9 0.04 0.09 77 0.7 0.9 1.6 0.10 0.17 56 0.5 0.7 1.1 0.05 0.13
486 4.7 5.7 9.6 0.44 1.14 11448 135.3 234.2 12.15 27.45 10429 100.0 123.3 214.2 11.20 25.25
2 0.0 0.0 0.0 0.00 0.01 30 0.3 0.3 0.4 0.02 0.05 38 0.3 0.4 0.6 0.03 0.06 30 0.3 0.3 0.6 0.05 0.07 3 0.0 0.0 0.1 0.01 0.01 2 0.0 0.0 0.0 0.00 0.00 8 0.1 0.1 0.2 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00 5 0.0 0.1 0.1 0.01 0.01
132 1.1 1.5 1.9 0.07 0.22 309 2.7 3.5 5.0 0.28 0.58 44 0.4 0.5 0.7 0.04 0.07
849 7.3 9.6 13.5 0.72 1.55 268 2.3 3.0 4.7 0.26 0.58 43 0.4 0.5 0.8 0.05 0.10
162 1.4 1.8 2.5 0.13 0.26 248 2.1 2.8 4.2 0.24 0.53 431 3.7 4.9 6.5 0.29 0.76 12 0.1 0.1 0.2 0.01 0.02 25 0.2 0.3 0.4 0.03 0.05
464 4.0 5.2 7.6 0.45 0.91 29 0.3 0.3 0.5 0.03 0.06 40 0.3 0.5 0.9 0.07 0.07
127 1.1 1.4 2.4 0.16 0.29 867 9.8 13.7 0.73 1.48 14 0.1 0.2 0.3 0.01 0.03 5 0.0 0.1 0.1 0.01 0.01
95 0.8 1.1 1.9 0.12 0.18 3953 34.1 44.6 73.8 5.17 8.53 69 0.6 0.8 1.1 0.06 0.13 31 0.3 0.3 0.5 0.04 0.05
630 5.4 7.1 13.0 1.06 1.34 478 4.1 5.4 8.8 0.61 1.11 175 1.5 2.0 3.1 0.20 0.33 490 4.2 5.5 9.5 0.68 1.06 19 0.2 0.2 0.3 0.03 0.04 10 0.1 0.1 0.2 0.02 0.02
271 2.3 3.1 4.8 0.31 0.56 2 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
149 1.3 1.7 2.4 0.12 0.27 2 0.0 0.0 0.0 0.00 0.00
16 0.1 0.2 0.4 0.02 0.03 219 1.9 2.5 4.1 0.26 0.46 311 2.7 3.5 6.6 0.54 0.65 16 0.1 0.2 0.4 0.02 0.03 7 0.1 0.1 0.1 0.01 0.01
81 0.7 0.9 1.7 0.12 0.16 289 2.5 3.3 5.4 0.32 0.62 8 0.1 0.1 0.2 0.00 0.03
101 0.9 1.1 1.7 0.10 0.22 97 0.8 1.1 2.1 0.13 0.16
137 1.2 1.5 2.7 0.17 0.27 49 0.4 0.6 0.8 0.04 0.06 55 0.5 0.6 1.0 0.06 0.11 41 0.4 0.5 0.7 0.04 0.06
461 4.0 5.2 7.0 0.35 0.77 12450 140.5 222.0 14.27 25.07 11583 100.0 130.7 208.3 13.54 23.59
† See note following population pyramid
Argentina, Mendoza (2008–2012)
154
Central and South America
CONTRIBUTORSSusana Graciela IbañezVerónica BaroMariela BertorelloJuan José CeliZunilda DuarteFabiana GandolfiAna LuengoCarolina ManfrediJuan MarcialVerónica del Pino
Argentina, Tierra del Fuego (2008−2012)Average annual person−years by sex and age group
6 265 0- 5 877
6 690 5- 6 356
6 177 10- 5 939
6 009 15- 5 746
5 718 20- 5 334
5 861 25- 5 613
5 951 30- 5 685
5 032 35- 4 899
4 384 40- 4 322
4 548 45- 4 343
3 888 50- 3 463
2 689 55- 2 447
1 742 60- 1 631
1 024 65- 1 046
631 70- 713
358 75- 480
167 80- 317
101 85+ 215
Total67 235 64 426Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleTrachea, bronchus, and lung 23.6Colon 19.2Prostate 18.5Other and unspecified 15.8Stomach 14.2Kidney 11.8Bladder 11.0Non-melanoma skin cancer 10.7Rectum 7.4Testis 7.3Non-Hodgkin lymphoma 5.9Liver 5.2Melanoma of skin 3.7Gallbladder etc. 3.4Oesophagus 3.3Pancreas 2.9Hodgkin lymphoma 2.3Mouth 2.2Larynx 1.9Myeloid leukaemia 1.8
All sites 183.4
Breast 51.2Colon 11.4Trachea, bronchus, and lung 9.4Cervix uteri 8.9Ovary 7.6Non-melanoma skin cancer 7.6Corpus uteri 6.9Thyroid 5.4Other and unspecified 5.2Stomach 4.4Rectum 3.9Gallbladder etc. 3.5Bladder 3.1Liver 3.0Non-Hodgkin lymphoma 2.8Brain and nervous system 2.6Pancreas 2.5Hodgkin lymphoma 2.3Melanoma of skin 2.2Kidney 1.9
All sites 156.5
Argentina, Tierra del Fuego (2008−2012)Average annual person−years by sex and age group
6 265 0- 5 877
6 690 5- 6 356
6 177 10- 5 939
6 009 15- 5 746
5 718 20- 5 334
5 861 25- 5 613
5 951 30- 5 685
5 032 35- 4 899
4 384 40- 4 322
4 548 45- 4 343
3 888 50- 3 463
2 689 55- 2 447
1 742 60- 1 631
1 024 65- 1 046
631 70- 713
358 75- 480
167 80- 317
101 85+ 215
Total67 235 64 426Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleTrachea, bronchus, and lung 23.6Colon 19.2Prostate 18.5Other and unspecified 15.8Stomach 14.2Kidney 11.8Bladder 11.0Non-melanoma skin cancer 10.7Rectum 7.4Testis 7.3Non-Hodgkin lymphoma 5.9Liver 5.2Melanoma of skin 3.7Gallbladder etc. 3.4Oesophagus 3.3Pancreas 2.9Hodgkin lymphoma 2.3Mouth 2.2Larynx 1.9Myeloid leukaemia 1.8
All sites 183.4
Breast 51.2Colon 11.4Trachea, bronchus, and lung 9.4Cervix uteri 8.9Ovary 7.6Non-melanoma skin cancer 7.6Corpus uteri 6.9Thyroid 5.4Other and unspecified 5.2Stomach 4.4Rectum 3.9Gallbladder etc. 3.5Bladder 3.1Liver 3.0Non-Hodgkin lymphoma 2.8Brain and nervous system 2.6Pancreas 2.5Hodgkin lymphoma 2.3Melanoma of skin 2.2Kidney 1.9
All sites 156.5
SOURCE OF POPULATIONNational Institute of Statistics and Census (INDEC; https://www.indec.gob.ar); population projections based on the 2010 National Population, Households, and Housing Census.
Argentina, Tierra del Fuego (2008–2012)Average annual person–years by sex and age group
Argentina, Tierra del Fuego
155
Central and South America
Argentina, Tierra del Fuego (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.1 0.5 0.06 0.06 6 1.5 0.9 2.2 0.26 0.26 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.1 0.5 0.06 0.06 1 0.2 0.1 0.6 0.00 0.16 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 6 1.5 0.9 3.3 0.05 0.30
35 8.7 5.2 14.2 0.71 1.47 0 0.0 0.0 0.0 0.00 0.00
42 10.4 6.2 19.2 0.63 2.56 16 4.0 2.4 7.4 0.32 1.09 0 0.0 0.0 0.0 0.00 0.00
11 2.7 1.6 5.2 0.24 0.72 7 1.7 1.0 3.4 0.10 0.46 7 1.7 1.0 2.9 0.13 0.22 0 0.0 0.0 0.0 0.00 0.00 5 1.2 0.7 1.9 0.23 0.23
53 13.1 7.9 23.6 1.19 3.54 2 0.5 0.3 1.1 0.06 0.06 1 0.2 0.1 0.3 0.02 0.02
10 2.5 1.5 3.7 0.16 0.52 25 3.7 10.7 0.50 1.17 1 0.2 0.1 0.6 0.00 0.10 2 0.5 0.3 0.5 0.04 0.04 1 0.2 0.1 0.6 0.00 0.16 2 0.5 0.3 1.2 0.00 0.26
1 0.2 0.1 0.2 0.02 0.02 37 9.2 5.5 18.5 0.65 2.45 28 6.9 4.2 7.3 0.54 0.54 0 0.0 0.0 0.0 0.00 0.00
30 7.4 4.5 11.8 0.61 1.32 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
23 5.7 3.4 11.0 0.42 1.13 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 5 1.2 0.7 1.5 0.15 0.15 4 1.0 0.6 1.5 0.10 0.10 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.1 0.2 0.02 0.02 9 2.2 1.3 2.3 0.17 0.17
12 3.0 1.8 5.9 0.12 0.79 0 0.0 0.0 0.0 0.00 0.00 2 0.5 0.3 0.7 0.08 0.08 3 0.7 0.4 0.8 0.08 0.08 4 1.0 0.6 1.8 0.04 0.04 2 0.5 0.3 0.6 0.04 0.04 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
33 8.2 4.9 15.8 0.44 1.50 429 63.8 183.4 8.24 21.86 404 100.0 60.1 172.7 7.74 20.69
0 0.0 0.0 0.0 0.00 0.00 2 0.5 0.3 0.6 0.06 0.06 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 2 0.5 0.3 0.8 0.00 0.00
13 3.1 2.0 4.4 0.30 0.30 1 0.2 0.2 0.4 0.00 0.00
28 6.8 4.3 11.4 0.49 1.44 9 2.2 1.4 3.9 0.22 0.45 0 0.0 0.0 0.0 0.00 0.00 6 1.4 0.9 3.0 0.03 0.50 8 1.9 1.2 3.5 0.07 0.35 6 1.4 0.9 2.5 0.02 0.25 1 0.2 0.2 0.3 0.03 0.03 1 0.2 0.2 0.6 0.00 0.14
23 5.6 3.6 9.4 0.40 1.25 1 0.2 0.2 0.4 0.00 0.00 2 0.5 0.3 0.6 0.06 0.06 7 1.7 1.1 2.2 0.20 0.20
19 2.9 7.6 0.35 1.01 1 0.2 0.2 0.3 0.03 0.03 1 0.2 0.2 0.3 0.02 0.02 5 1.2 0.8 1.6 0.11 0.11
153 37.0 23.7 51.2 4.17 5.31 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.5 0.06 0.06
27 6.5 4.2 8.9 0.59 1.06 18 4.3 2.8 6.9 0.53 0.76 2 0.5 0.3 0.8 0.08 0.08
19 4.6 2.9 7.6 0.46 1.07 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
5 1.2 0.8 1.9 0.15 0.24 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 7 1.7 1.1 3.1 0.06 0.44 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 7 1.7 1.1 2.6 0.15 0.38
19 4.6 2.9 5.4 0.42 0.51 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 8 1.9 1.2 2.3 0.17 0.17 9 2.2 1.4 2.8 0.24 0.24 0 0.0 0.0 0.0 0.00 0.00 2 0.5 0.3 0.8 0.10 0.10 2 0.5 0.3 0.6 0.03 0.03 2 0.5 0.3 0.9 0.02 0.16 1 0.2 0.2 0.5 0.06 0.06 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.6 0.00 0.10
13 3.1 2.0 5.2 0.24 0.34 433 67.2 156.5 9.95 17.36 414 100.0 64.3 149.0 9.60 16.35
Argentina, Tierra del Fuego (2008–2012)
156
Central and South America
Brazil, AracajuCONTRIBUTORSCarlos Anselmo LimaJosé Erinaldo Lôbo de OliveiraElma Santana de OliveiraMaria das Graças Prata FrançaSueli Pina VieiraAnaleide de Figueiredo RezendeSuzana Maria de CarvalhoCecilia FerreiraOneide Souza Leite
Brazil, Aracaju (2008−2012)Average annual person−years by sex and age group
21 411 0- 20 716
21 763 5- 21 420
23 372 10- 23 168
23 842 15- 24 945
27 151 20- 29 581
27 134 25- 31 009
23 444 30- 27 862
19 515 35- 23 514
17 570 40- 21 643
15 328 45- 19 088
12 507 50- 15 544
9 665 55- 12 694
7 262 60- 9 694
4 774 65- 6 855
3 239 70- 5 202
1 928 75- 3 713
1 298 80- 2 660
955 85+ 2 384
Total262 158 301 692Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 122.0Prostate 121.4Trachea, bronchus, and lung 19.5Stomach 12.3Colon 9.8Bladder 9.4Larynx 8.9Non-Hodgkin lymphoma 7.8Liver 7.1Rectum 7.0Thyroid 6.9Kidney 6.5Brain and nervous system 5.8Oesophagus 5.4Pancreas 4.6Melanoma of skin 4.3Other and unspecified 4.2Tongue 3.8Mouth 3.6Lip 2.6
All sites 404.1
Non-melanoma skin cancer 90.1Breast 58.8Thyroid 33.3Cervix uteri 13.1Colon 9.3Trachea, bronchus, and lung 8.8Corpus uteri 8.3Ovary 6.7Rectum 6.7Stomach 6.3Non-Hodgkin lymphoma 5.1Melanoma of skin 4.4Pancreas 4.2Other and unspecified 4.0Kidney 3.7Brain and nervous system 3.6Gallbladder etc. 2.9Bladder 2.7Liver 2.6Multiple myeloma 1.9
All sites 298.1
Brazil, Aracaju (2008−2012)Average annual person−years by sex and age group
21 411 0- 20 716
21 763 5- 21 420
23 372 10- 23 168
23 842 15- 24 945
27 151 20- 29 581
27 134 25- 31 009
23 444 30- 27 862
19 515 35- 23 514
17 570 40- 21 643
15 328 45- 19 088
12 507 50- 15 544
9 665 55- 12 694
7 262 60- 9 694
4 774 65- 6 855
3 239 70- 5 202
1 928 75- 3 713
1 298 80- 2 660
955 85+ 2 384
Total262 158 301 692Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 122.0Prostate 121.4Trachea, bronchus, and lung 19.5Stomach 12.3Colon 9.8Bladder 9.4Larynx 8.9Non-Hodgkin lymphoma 7.8Liver 7.1Rectum 7.0Thyroid 6.9Kidney 6.5Brain and nervous system 5.8Oesophagus 5.4Pancreas 4.6Melanoma of skin 4.3Other and unspecified 4.2Tongue 3.8Mouth 3.6Lip 2.6
All sites 404.1
Non-melanoma skin cancer 90.1Breast 58.8Thyroid 33.3Cervix uteri 13.1Colon 9.3Trachea, bronchus, and lung 8.8Corpus uteri 8.3Ovary 6.7Rectum 6.7Stomach 6.3Non-Hodgkin lymphoma 5.1Melanoma of skin 4.4Pancreas 4.2Other and unspecified 4.0Kidney 3.7Brain and nervous system 3.6Gallbladder etc. 2.9Bladder 2.7Liver 2.6Multiple myeloma 1.9
All sites 298.1
Brazil, Aracaju (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2000 census (Brazilian Institute of Geography and Statistics; Ministry of Planning, Budget, and Management, Rio de Janeiro; http://www.ibge.gov.br), allowing for births, deaths, and migration into and out of the registration area.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
157
Central and South America
Brazil, Aracaju (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
27 0.9 1.0 2.6 0.16 0.30 40 1.4 1.5 3.8 0.27 0.50 38 1.3 1.4 3.6 0.26 0.37 9 0.3 0.3 0.8 0.02 0.05
18 0.6 0.7 1.7 0.11 0.17 9 0.3 0.3 0.9 0.05 0.08
15 0.5 0.6 1.4 0.09 0.18 11 0.4 0.4 1.0 0.10 0.12 11 0.4 0.4 1.1 0.08 0.16 56 2.0 2.1 5.4 0.31 0.63
127 4.4 4.8 12.3 0.71 1.44 17 0.6 0.6 1.5 0.08 0.16
102 3.6 3.9 9.8 0.47 0.99 73 2.6 2.8 7.0 0.34 0.88 4 0.1 0.2 0.3 0.04 0.04
71 2.5 2.7 7.1 0.42 0.82 19 0.7 0.7 1.8 0.12 0.21 44 1.5 1.7 4.6 0.22 0.58 4 0.1 0.2 0.3 0.02 0.04
93 3.3 3.5 8.9 0.58 1.03 191 6.7 7.3 19.5 0.95 2.56 3 0.1 0.1 0.3 0.02 0.02
10 0.3 0.4 0.7 0.05 0.08 44 1.5 1.7 4.3 0.26 0.48
1277 48.7 122.0 6.55 13.79 1 0.0 0.0 0.1 0.01 0.01
12 0.4 0.5 0.9 0.05 0.05 16 0.6 0.6 1.5 0.06 0.17 3 0.1 0.1 0.3 0.01 0.04
19 0.7 0.7 1.8 0.07 0.15 1151 40.3 43.9 121.4 5.39 15.66 21 0.7 0.8 1.3 0.10 0.10 0 0.0 0.0 0.0 0.00 0.00
67 2.3 2.6 6.5 0.34 0.85 2 0.1 0.1 0.2 0.00 0.06 0 0.0 0.0 0.0 0.00 0.00
93 3.3 3.5 9.4 0.28 1.01 0 0.0 0.0 0.0 0.00 0.00
10 0.3 0.4 0.9 0.05 0.09 68 2.4 2.6 5.8 0.38 0.57 91 3.2 3.5 6.9 0.54 0.73 3 0.1 0.1 0.3 0.01 0.04 1 0.0 0.0 0.1 0.01 0.01
28 1.0 1.1 2.0 0.12 0.14 87 3.0 3.3 7.8 0.44 0.85 4 0.1 0.2 0.4 0.02 0.04
26 0.9 1.0 2.4 0.18 0.30 23 0.8 0.9 2.2 0.12 0.23 27 0.9 1.0 2.5 0.14 0.23 6 0.2 0.2 0.5 0.02 0.04 8 0.3 0.3 0.8 0.02 0.08
11 0.4 0.4 1.0 0.06 0.10
44 1.5 1.7 4.2 0.19 0.44 4135 157.7 404.1 20.92 47.63 2858 100.0 109.0 282.0 14.36 33.84
16 0.5 0.5 1.1 0.05 0.15 7 0.2 0.2 0.5 0.04 0.06
18 0.5 0.6 1.1 0.05 0.14 8 0.2 0.3 0.5 0.04 0.06 3 0.1 0.1 0.2 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 7 0.2 0.2 0.4 0.02 0.04 1 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.1 0.00 0.00
19 0.6 0.6 1.2 0.08 0.13 101 3.1 3.3 6.3 0.39 0.68 19 0.6 0.6 1.2 0.04 0.14
153 4.7 5.1 9.3 0.50 0.98 105 3.2 3.5 6.7 0.43 0.72 21 0.6 0.7 1.3 0.07 0.13 43 1.3 1.4 2.6 0.17 0.25 46 1.4 1.5 2.9 0.18 0.30 67 2.0 2.2 4.2 0.13 0.50 5 0.2 0.2 0.3 0.02 0.02 9 0.3 0.3 0.6 0.06 0.08
135 4.1 4.5 8.8 0.48 1.08 5 0.2 0.2 0.4 0.02 0.05
12 0.4 0.4 0.7 0.04 0.06 69 2.1 2.3 4.4 0.26 0.53
1445 47.9 90.1 5.13 9.86 1 0.0 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
24 0.7 0.8 1.6 0.09 0.16 915 27.8 30.3 58.8 4.23 6.87 12 0.4 0.4 0.7 0.00 0.07 5 0.2 0.2 0.3 0.01 0.01
210 6.4 7.0 13.1 0.84 1.51 119 3.6 3.9 8.3 0.52 1.20 12 0.4 0.4 0.6 0.02 0.06
105 3.2 3.5 6.7 0.49 0.74 5 0.2 0.2 0.3 0.02 0.02 9 0.3 0.3 0.5 0.04 0.04
55 1.7 1.8 3.7 0.29 0.39 5 0.2 0.2 0.3 0.01 0.02 2 0.1 0.1 0.1 0.00 0.00
42 1.3 1.4 2.7 0.12 0.33 1 0.0 0.0 0.1 0.01 0.01
11 0.3 0.4 0.6 0.03 0.07 54 1.6 1.8 3.6 0.22 0.35
549 16.7 18.2 33.3 2.68 3.41 4 0.1 0.1 0.3 0.02 0.02 4 0.1 0.1 0.2 0.01 0.03
24 0.7 0.8 1.4 0.09 0.09 81 2.5 2.7 5.1 0.29 0.59 2 0.1 0.1 0.1 0.01 0.01
28 0.9 0.9 1.9 0.10 0.26 14 0.4 0.5 1.1 0.06 0.08 22 0.7 0.7 1.4 0.11 0.11 8 0.2 0.3 0.5 0.04 0.04 5 0.2 0.2 0.4 0.02 0.07
18 0.5 0.6 1.1 0.05 0.10
68 2.1 2.3 4.0 0.19 0.39 4731 156.8 298.1 18.84 33.02 3286 100.0 108.9 208.0 13.71 23.16
§Includes 8 cases of unknown age §Includes 4 cases of unknown age
† See note following population pyramid
Brazil, Aracaju (2008–2012)
158
Central and South America
Brazil, CuritibaCONTRIBUTORSCyntia Asturian LaporteCintia da Costa MarquesKenia Maria Brero Del PinoMaria Rita Ostrovski MartinsVivian de Fatima Blanchet BlumVera Regina Pilotto Abelardino da Silva
Brazil, Curitiba (2008−2011)Average annual person−years by sex and age group
56 413 0- 54 598
63 610 5- 61 523
69 540 10- 67 524
73 882 15- 72 592
80 357 20- 80 979
84 370 25- 87 268
78 867 30- 82 981
68 089 35- 73 894
63 009 40- 70 564
56 671 45- 67 317
47 705 50- 58 066
38 371 55- 47 531
28 133 60- 36 173
19 092 65- 26 008
13 727 70- 20 074
9 001 75- 14 957
5 249 80- 10 000
3 310 85+ 7 497
Total859 396 939 546Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 57.5Non-melanoma skin cancer 36.9Trachea, bronchus, and lung 19.5Stomach 14.2Colon 13.2Rectum 10.8Bladder 9.1Oesophagus 9.0Non-Hodgkin lymphoma 8.3Other and unspecified 7.8Brain and nervous system 6.4Kidney 6.1Liver 6.1Melanoma of skin 6.1Larynx 5.8Pancreas 5.8Testis 4.0Tongue 3.5Myeloid leukaemia 3.5Mouth 3.4
All sites 266.8
Breast 56.5Non-melanoma skin cancer 27.3Cervix uteri 10.7Colon 10.5Trachea, bronchus, and lung 9.7Rectum 7.6Ovary 7.1Corpus uteri 6.9Thyroid 6.7Stomach 6.7Other and unspecified 5.8Non-Hodgkin lymphoma 5.1Brain and nervous system 4.9Pancreas 4.6Melanoma of skin 4.1Kidney 3.1Bladder 3.0Myeloid leukaemia 2.9Liver 2.8Gallbladder etc. 2.3
All sites 208.4
Brazil, Curitiba (2008−2011)Average annual person−years by sex and age group
56 413 0- 54 598
63 610 5- 61 523
69 540 10- 67 524
73 882 15- 72 592
80 357 20- 80 979
84 370 25- 87 268
78 867 30- 82 981
68 089 35- 73 894
63 009 40- 70 564
56 671 45- 67 317
47 705 50- 58 066
38 371 55- 47 531
28 133 60- 36 173
19 092 65- 26 008
13 727 70- 20 074
9 001 75- 14 957
5 249 80- 10 000
3 310 85+ 7 497
Total859 396 939 546Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 57.5Non-melanoma skin cancer 36.9Trachea, bronchus, and lung 19.5Stomach 14.2Colon 13.2Rectum 10.8Bladder 9.1Oesophagus 9.0Non-Hodgkin lymphoma 8.3Other and unspecified 7.8Brain and nervous system 6.4Kidney 6.1Liver 6.1Melanoma of skin 6.1Larynx 5.8Pancreas 5.8Testis 4.0Tongue 3.5Myeloid leukaemia 3.5Mouth 3.4
All sites 266.8
Breast 56.5Non-melanoma skin cancer 27.3Cervix uteri 10.7Colon 10.5Trachea, bronchus, and lung 9.7Rectum 7.6Ovary 7.1Corpus uteri 6.9Thyroid 6.7Stomach 6.7Other and unspecified 5.8Non-Hodgkin lymphoma 5.1Brain and nervous system 4.9Pancreas 4.6Melanoma of skin 4.1Kidney 3.1Bladder 3.0Myeloid leukaemia 2.9Liver 2.8Gallbladder etc. 2.3
All sites 208.4
Brazil, Curitiba (2008–2011)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2010 census (Brazilian Institute of Geography and Statistics; Ministry of Planning, Budget, and Management, Rio de Janeiro; http://www.ibge.gov.br), allowing for births and deaths, but it was not possible to estimate migration into and out of the registration area.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
159
Central and South America
Brazil, Curitiba (2008–2011) Brazil, Curitiba (2008−2011)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
34 0.5 0.5 1.1 0.06 0.13 120 1.6 1.7 3.5 0.25 0.42 115 1.5 1.7 3.4 0.22 0.38 25 0.3 0.4 0.8 0.03 0.06 31 0.4 0.5 0.9 0.08 0.10 62 0.8 0.9 1.8 0.13 0.19 19 0.3 0.3 0.5 0.05 0.05 68 0.9 1.0 2.1 0.15 0.23 3 0.0 0.0 0.1 0.01 0.01
291 3.9 4.2 9.0 0.59 1.13 454 6.1 6.6 14.2 0.73 1.70 25 0.3 0.4 0.8 0.05 0.09
422 5.7 6.1 13.2 0.65 1.62 364 4.9 5.3 10.8 0.67 1.25 12 0.2 0.2 0.3 0.03 0.04
200 2.7 2.9 6.1 0.34 0.72 58 0.8 0.8 1.9 0.08 0.26
184 2.5 2.7 5.8 0.25 0.68 15 0.2 0.2 0.5 0.03 0.04
188 2.5 2.7 5.8 0.35 0.75 615 8.3 8.9 19.5 0.90 2.27 16 0.2 0.2 0.5 0.02 0.05 48 0.6 0.7 1.4 0.08 0.11
214 2.9 3.1 6.1 0.36 0.65 1204 17.5 36.9 1.80 4.17
6 0.1 0.1 0.2 0.01 0.04 18 0.2 0.3 0.5 0.03 0.04 82 1.1 1.2 2.4 0.15 0.26 14 0.2 0.2 0.4 0.02 0.06
26 0.4 0.4 0.8 0.04 0.08 1745 23.5 25.4 57.5 2.19 7.58 170 2.3 2.5 4.0 0.29 0.30 4 0.1 0.1 0.1 0.01 0.01
190 2.6 2.8 6.1 0.35 0.71 5 0.1 0.1 0.2 0.01 0.02 2 0.0 0.0 0.1 0.00 0.00
285 3.8 4.1 9.1 0.33 1.05 2 0.0 0.0 0.1 0.00 0.01
11 0.1 0.2 0.4 0.02 0.04 215 2.9 3.1 6.4 0.41 0.63 74 1.0 1.1 2.0 0.15 0.20 13 0.2 0.2 0.5 0.03 0.04 10 0.1 0.1 0.3 0.02 0.02 79 1.1 1.1 2.1 0.13 0.15
286 3.9 4.2 8.3 0.51 0.85 4 0.1 0.1 0.1 0.00 0.01
93 1.3 1.4 2.9 0.14 0.33 94 1.3 1.4 3.2 0.17 0.26
116 1.6 1.7 3.5 0.23 0.34 28 0.4 0.4 0.9 0.03 0.07 7 0.1 0.1 0.2 0.01 0.02 6 0.1 0.1 0.2 0.00 0.02
252 3.4 3.7 7.8 0.40 0.93 8624 125.4 266.8 13.59 31.19 7420 100.0 107.9 229.9 11.79 27.02
15 0.2 0.2 0.3 0.01 0.03 36 0.4 0.5 0.8 0.05 0.09 36 0.4 0.5 0.8 0.04 0.09 23 0.3 0.3 0.5 0.02 0.06 11 0.1 0.1 0.3 0.02 0.03 10 0.1 0.1 0.2 0.01 0.03 8 0.1 0.1 0.2 0.01 0.02
10 0.1 0.1 0.2 0.01 0.03 0 0.0 0.0 0.0 0.00 0.00
98 1.2 1.3 2.2 0.12 0.27 310 3.8 4.1 6.7 0.32 0.77 22 0.3 0.3 0.5 0.03 0.06
491 6.1 6.5 10.5 0.60 1.16 347 4.3 4.6 7.6 0.46 0.86 30 0.4 0.4 0.6 0.04 0.06
128 1.6 1.7 2.8 0.12 0.34 105 1.3 1.4 2.3 0.11 0.26 215 2.6 2.9 4.6 0.21 0.54 7 0.1 0.1 0.1 0.00 0.02
28 0.3 0.4 0.7 0.04 0.08 441 5.4 5.9 9.7 0.47 1.19 15 0.2 0.2 0.3 0.02 0.02 46 0.6 0.6 1.2 0.07 0.09
191 2.4 2.5 4.1 0.31 0.43 1283 17.1 27.3 1.34 3.00
2 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
59 0.7 0.8 1.5 0.10 0.14 2528 31.2 33.6 56.5 4.03 6.41 43 0.5 0.6 0.8 0.03 0.08 8 0.1 0.1 0.2 0.01 0.01
490 6.0 6.5 10.7 0.77 1.13 296 3.6 3.9 6.9 0.39 0.93 32 0.4 0.4 0.7 0.04 0.07
317 3.9 4.2 7.1 0.47 0.82 7 0.1 0.1 0.1 0.01 0.01 4 0.0 0.1 0.1 0.00 0.01
128 1.6 1.7 3.1 0.19 0.34 1 0.0 0.0 0.0 0.00 0.00 3 0.0 0.0 0.1 0.00 0.00
142 1.7 1.9 3.0 0.12 0.34 1 0.0 0.0 0.0 0.00 0.00
15 0.2 0.2 0.4 0.01 0.04 202 2.5 2.7 4.9 0.32 0.48 306 3.8 4.1 6.7 0.52 0.66 16 0.2 0.2 0.6 0.03 0.03 1 0.0 0.0 0.0 0.00 0.00
71 0.9 0.9 1.7 0.11 0.14 226 2.8 3.0 5.1 0.29 0.56 4 0.0 0.1 0.1 0.00 0.00
89 1.1 1.2 2.0 0.11 0.25 63 0.8 0.8 2.0 0.10 0.15
118 1.5 1.6 2.9 0.15 0.28 31 0.4 0.4 0.7 0.03 0.07 5 0.1 0.1 0.1 0.01 0.01 6 0.1 0.1 0.1 0.00 0.01
278 3.4 3.7 5.8 0.26 0.59 9398 125.0 208.4 12.55 23.12 8115 100.0 108.0 181.2 11.21 20.13§Includes 1 case of unknown age
† See note following population pyramid
160
Central and South America
Brazil, FlorianópolisCONTRIBUTORSClaudia Valeria CorraiolaJian de AndradeMaria Fernanda Regueira BredaIsrael Peres da SilveiraLizana Arend HenriquePatricia Nalovaiko da SilveiraAdriana Maria da Silva RubiniSenen Dyba Hauff
Brazil, Florianópolis (2008−2010)Average annual person−years by sex and age group
12 011 0- 11 406
13 744 5- 13 226
14 898 10- 14 492
16 476 15- 16 121
19 253 20- 18 910
20 716 25- 21 094
18 393 30- 18 987
15 317 35- 16 108
13 979 40- 15 541
13 655 45- 15 607
11 543 50- 13 403
9 437 55- 11 257
7 066 60- 8 390
4 620 65- 5 751
3 293 70- 4 470
2 076 75- 3 225
1 216 80- 2 160
803 85+ 1 940
Total198 496 212 088Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 235.7Prostate 92.5Trachea, bronchus, and lung 36.2Bladder 26.2Colon 24.1Stomach 19.2Thyroid 16.7Rectum 16.5Non-Hodgkin lymphoma 15.0Melanoma of skin 13.6Kidney 13.4Liver 10.6Oesophagus 7.7Larynx 7.5Pancreas 7.0Brain and nervous system 6.9Lymphoid leukaemia 6.5Other and unspecified 5.8Myeloid leukaemia 5.6Mouth 4.5
All sites 616.6
Non-melanoma skin cancer 164.3Breast 86.6Thyroid 66.7Colon 18.3Trachea, bronchus, and lung 17.2Cervix uteri 15.6Melanoma of skin 12.8Stomach 11.5Non-Hodgkin lymphoma 9.9Rectum 9.8Ovary 9.1Kidney 8.2Corpus uteri 7.1Other and unspecified 6.2Bladder 5.8Brain and nervous system 5.5Lymphoid leukaemia 4.6Pancreas 4.5Multiple myeloma 4.2Gallbladder etc. 2.9
All sites 502.9
Brazil, Florianópolis (2008−2010)Average annual person−years by sex and age group
12 011 0- 11 406
13 744 5- 13 226
14 898 10- 14 492
16 476 15- 16 121
19 253 20- 18 910
20 716 25- 21 094
18 393 30- 18 987
15 317 35- 16 108
13 979 40- 15 541
13 655 45- 15 607
11 543 50- 13 403
9 437 55- 11 257
7 066 60- 8 390
4 620 65- 5 751
3 293 70- 4 470
2 076 75- 3 225
1 216 80- 2 160
803 85+ 1 940
Total198 496 212 088Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 235.7Prostate 92.5Trachea, bronchus, and lung 36.2Bladder 26.2Colon 24.1Stomach 19.2Thyroid 16.7Rectum 16.5Non-Hodgkin lymphoma 15.0Melanoma of skin 13.6Kidney 13.4Liver 10.6Oesophagus 7.7Larynx 7.5Pancreas 7.0Brain and nervous system 6.9Lymphoid leukaemia 6.5Other and unspecified 5.8Myeloid leukaemia 5.6Mouth 4.5
All sites 616.6
Non-melanoma skin cancer 164.3Breast 86.6Thyroid 66.7Colon 18.3Trachea, bronchus, and lung 17.2Cervix uteri 15.6Melanoma of skin 12.8Stomach 11.5Non-Hodgkin lymphoma 9.9Rectum 9.8Ovary 9.1Kidney 8.2Corpus uteri 7.1Other and unspecified 6.2Bladder 5.8Brain and nervous system 5.5Lymphoid leukaemia 4.6Pancreas 4.5Multiple myeloma 4.2Gallbladder etc. 2.9
All sites 502.9
Brazil, Florianópolis (2008–2010)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation data provided by the Brazilian Institute of Geography and Statistics (IBGE; http://www.ibge.gov.br) based on the 2010 census, which visited every home in Brazil (191 000 officers visited 67.6 million homes in 5565 municipalities).
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
161
Central and South America
Brazil, Florianópolis (2008−2010)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
7 0.3 0.6 1.2 0.03 0.12 24 1.1 2.0 4.0 0.27 0.48 26 1.2 2.2 4.5 0.22 0.70 7 0.3 0.6 1.2 0.04 0.15 5 0.2 0.4 0.8 0.07 0.07
18 0.8 1.5 3.1 0.23 0.42 13 0.6 1.1 2.1 0.14 0.28 15 0.7 1.3 2.6 0.15 0.25 3 0.1 0.3 0.6 0.00 0.09
45 2.0 3.8 7.7 0.49 0.93 112 5.1 9.4 19.2 1.00 2.21 12 0.5 1.0 1.9 0.07 0.15
140 6.3 11.8 24.1 1.13 2.94 99 4.5 8.3 16.5 0.87 1.96 7 0.3 0.6 1.3 0.07 0.17
61 2.8 5.1 10.6 0.52 1.35 9 0.4 0.8 1.6 0.10 0.13
41 1.8 3.4 7.0 0.32 0.80 6 0.3 0.5 0.9 0.06 0.09
43 1.9 3.6 7.5 0.39 1.01 207 9.3 17.4 36.2 1.57 4.47 12 0.5 1.0 1.9 0.07 0.27 9 0.4 0.8 1.3 0.08 0.13
84 3.8 7.1 13.6 0.91 1.50 1392 116.9 235.7 11.96 28.15
4 0.2 0.3 0.7 0.02 0.09 12 0.5 1.0 1.6 0.13 0.13 14 0.6 1.2 2.3 0.11 0.22 1 0.0 0.1 0.1 0.01 0.01
11 0.5 0.9 1.9 0.06 0.16 510 23.0 42.8 92.5 3.53 12.11 26 1.2 2.2 3.3 0.23 0.23 3 0.1 0.3 0.6 0.01 0.10
77 3.5 6.5 13.4 0.72 1.60 2 0.1 0.2 0.3 0.00 0.00 1 0.0 0.1 0.2 0.00 0.00
146 6.6 12.3 26.2 0.92 3.08 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.3 0.9 0.07 0.07
41 1.8 3.4 6.9 0.49 0.76 109 4.9 9.2 16.7 1.31 1.80 2 0.1 0.2 0.7 0.03 0.03 1 0.0 0.1 0.1 0.01 0.01
16 0.7 1.3 2.4 0.15 0.20 94 4.2 7.9 15.0 0.88 1.58 1 0.0 0.1 0.2 0.00 0.04
24 1.1 2.0 3.8 0.26 0.38 34 1.5 2.9 6.5 0.29 0.59 33 1.5 2.8 5.6 0.28 0.63 3 0.1 0.3 0.6 0.02 0.02 4 0.2 0.3 0.7 0.04 0.09 5 0.2 0.4 1.0 0.02 0.15
34 1.5 2.9 5.8 0.26 0.61 3609 303.0 616.6 30.62 73.53 2217 100.0 186.1 380.9 18.66 45.37
2 0.1 0.2 0.3 0.02 0.05 12 0.5 0.9 1.5 0.11 0.15 12 0.5 0.9 1.5 0.09 0.19 8 0.3 0.6 0.9 0.06 0.09 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.3 0.5 0.06 0.06 6 0.2 0.5 0.8 0.05 0.08 1 0.0 0.1 0.2 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00
20 0.8 1.6 2.3 0.18 0.18 92 3.5 7.2 11.5 0.64 1.24 16 0.6 1.3 1.9 0.13 0.16
143 5.5 11.2 18.3 0.87 2.31 76 2.9 6.0 9.8 0.61 1.12 11 0.4 0.9 1.5 0.08 0.14 18 0.7 1.4 2.2 0.10 0.21 23 0.9 1.8 2.9 0.19 0.36 36 1.4 2.8 4.5 0.15 0.49 0 0.0 0.0 0.0 0.00 0.00
11 0.4 0.9 1.4 0.08 0.18 129 5.0 10.1 17.2 1.02 2.20 9 0.3 0.7 1.3 0.06 0.15 7 0.3 0.6 0.9 0.06 0.06
99 3.8 7.8 12.8 0.96 1.27 1290 101.4 164.3 10.04 18.59
1 0.0 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
21 0.8 1.7 2.8 0.22 0.25 665 25.6 52.3 86.6 6.37 9.69 10 0.4 0.8 1.4 0.07 0.22 6 0.2 0.5 0.7 0.06 0.06
123 4.7 9.7 15.6 1.15 1.62 55 2.1 4.3 7.1 0.48 0.77 4 0.2 0.3 0.6 0.02 0.09
71 2.7 5.6 9.1 0.66 1.00 4 0.2 0.3 0.5 0.06 0.06 1 0.0 0.1 0.1 0.01 0.01
54 2.1 4.2 8.2 0.46 0.91 1 0.0 0.1 0.2 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00
45 1.7 3.5 5.8 0.26 0.65 1 0.0 0.1 0.1 0.00 0.00 4 0.2 0.3 0.5 0.05 0.05
41 1.6 3.2 5.5 0.34 0.54 511 19.7 40.2 66.7 5.65 6.96 5 0.2 0.4 0.6 0.05 0.09 0 0.0 0.0 0.0 0.00 0.00
17 0.7 1.3 2.2 0.17 0.20 78 3.0 6.1 9.9 0.58 1.07 1 0.0 0.1 0.1 0.01 0.01
31 1.2 2.4 4.2 0.24 0.54 27 1.0 2.1 4.6 0.23 0.42 22 0.8 1.7 2.8 0.17 0.24 3 0.1 0.2 0.4 0.01 0.04 9 0.3 0.7 1.2 0.10 0.13 3 0.1 0.2 0.3 0.01 0.01
49 1.9 3.9 6.2 0.41 0.65 3888 305.5 502.9 33.46 55.60 2598 100.0 204.2 338.6 23.42 37.01
§Includes 7 cases of unknown age §Includes 7 cases of unknown age
† See note following population pyramid
Brazil, Florianópolis (2008–2010)
162
Central and South America
Brazil, GoiâniaCONTRIBUTORSJose Carlos de OliveiraMaria Paula CuradoCarleane BandeiraMatinair S. MineiroElcivone Cirineu SouzaLarissa Pria de OliveiraDeleon Lopes da CostaGlaucia PassosGabriel Cirineu daSilva
Brazil, Goiânia (2008−2012)Average annual person−years by sex and age group
44 275 0- 42 723
46 790 5- 45 472
50 405 10- 50 017
54 613 15- 55 597
62 216 20- 65 364
64 430 25- 69 638
58 722 30- 63 922
48 328 35- 53 857
43 058 40- 49 921
38 158 45- 45 570
31 732 50- 38 724
24 691 55- 30 939
18 235 60- 23 226
12 566 65- 16 274
9 067 70- 12 530
5 569 75- 8 502
5 664 80+ 9 462
Total618 519 681 738Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Low rates of leukaemia.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 183.4Prostate 122.3Trachea, bronchus, and lung 21.3Colon 15.2Stomach 15.1Bladder 12.1Other and unspecified 11.6Rectum 10.2Non-Hodgkin lymphoma 7.7Kidney 7.2Brain and nervous system 6.9Oesophagus 6.0Larynx 6.0Liver 5.4Melanoma of skin 5.1Pancreas 5.0Mouth 3.8Multiple myeloma 3.8Tongue 3.0Thyroid 3.0
All sites 485.1
Non-melanoma skin cancer 159.5Breast 51.4Cervix uteri 14.5Thyroid 13.2Trachea, bronchus, and lung 12.1Colon 12.0Other and unspecified 8.1Rectum 7.9Ovary 6.5Corpus uteri 6.1Stomach 6.1Brain and nervous system 5.3Non-Hodgkin lymphoma 5.2Melanoma of skin 4.6Kidney 4.3Bladder 3.7Pancreas 3.6Gallbladder etc. 2.7Multiple myeloma 2.5Liver 2.3
All sites 353.6
Brazil, Goiânia (2008−2012)Average annual person−years by sex and age group
44 275 0- 42 723
46 790 5- 45 472
50 405 10- 50 017
54 613 15- 55 597
62 216 20- 65 364
64 430 25- 69 638
58 722 30- 63 922
48 328 35- 53 857
43 058 40- 49 921
38 158 45- 45 570
31 732 50- 38 724
24 691 55- 30 939
18 235 60- 23 226
12 566 65- 16 274
9 067 70- 12 530
5 569 75- 8 502
5 664 80+ 9 462
Total618 519 681 738Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Low rates of leukaemia.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 183.4Prostate 122.3Trachea, bronchus, and lung 21.3Colon 15.2Stomach 15.1Bladder 12.1Other and unspecified 11.6Rectum 10.2Non-Hodgkin lymphoma 7.7Kidney 7.2Brain and nervous system 6.9Oesophagus 6.0Larynx 6.0Liver 5.4Melanoma of skin 5.1Pancreas 5.0Mouth 3.8Multiple myeloma 3.8Tongue 3.0Thyroid 3.0
All sites 485.1
Non-melanoma skin cancer 159.5Breast 51.4Cervix uteri 14.5Thyroid 13.2Trachea, bronchus, and lung 12.1Colon 12.0Other and unspecified 8.1Rectum 7.9Ovary 6.5Corpus uteri 6.1Stomach 6.1Brain and nervous system 5.3Non-Hodgkin lymphoma 5.2Melanoma of skin 4.6Kidney 4.3Bladder 3.7Pancreas 3.6Gallbladder etc. 2.7Multiple myeloma 2.5Liver 2.3
All sites 353.6
Brazil, Goiânia (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONEstimates by the Brazilian Institute of Geography and Statistics (IBGE). The methodology of the estimates is described on the website (http://www.ibge.gov.br).
NOTES ON THE DATA*Low rates of leukaemia. †C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
163
Central and South America
*Brazil, Goiânia (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
26 0.3 0.4 0.9 0.05 0.10 84 1.1 1.4 3.0 0.22 0.34
105 1.3 1.7 3.8 0.27 0.43 24 0.3 0.4 0.8 0.07 0.10 33 0.4 0.5 1.1 0.11 0.12 60 0.8 1.0 2.1 0.15 0.25 30 0.4 0.5 1.0 0.09 0.11 41 0.5 0.7 1.5 0.09 0.19 8 0.1 0.1 0.3 0.03 0.04
163 2.1 2.6 6.0 0.38 0.71 392 5.0 6.3 15.1 0.64 1.91 21 0.3 0.3 0.8 0.04 0.07
411 5.2 6.6 15.2 0.78 1.76 276 3.5 4.5 10.2 0.57 1.19 12 0.2 0.2 0.5 0.01 0.05
140 1.8 2.3 5.4 0.27 0.66 49 0.6 0.8 1.8 0.09 0.22
128 1.6 2.1 5.0 0.24 0.64 17 0.2 0.3 0.6 0.03 0.06
159 2.0 2.6 6.0 0.40 0.73 543 6.9 8.8 21.3 0.99 2.73 17 0.2 0.3 0.6 0.03 0.05 45 0.6 0.7 1.5 0.08 0.15
135 1.7 2.2 5.1 0.26 0.61 4882 78.9 183.4 8.19 20.07
1 0.0 0.0 0.0 0.00 0.00 37 0.5 0.6 1.1 0.06 0.09 61 0.8 1.0 2.1 0.14 0.19 28 0.4 0.5 0.9 0.06 0.11
61 0.8 1.0 2.1 0.12 0.18 3039 38.5 49.1 122.3 4.78 16.10 57 0.7 0.9 1.6 0.11 0.12 1 0.0 0.0 0.0 0.00 0.01
194 2.5 3.1 7.2 0.45 0.90 7 0.1 0.1 0.3 0.01 0.04 0 0.0 0.0 0.0 0.00 0.00
308 3.9 5.0 12.1 0.43 1.45 4 0.1 0.1 0.2 0.01 0.02
26 0.3 0.4 0.9 0.06 0.07 190 2.4 3.1 6.9 0.39 0.76 98 1.2 1.6 3.0 0.21 0.29 9 0.1 0.1 0.3 0.02 0.03
10 0.1 0.2 0.3 0.02 0.03 54 0.7 0.9 1.6 0.11 0.15
218 2.8 3.5 7.7 0.43 0.81 8 0.1 0.1 0.3 0.02 0.02
98 1.2 1.6 3.8 0.18 0.44 50 0.6 0.8 2.0 0.12 0.14 44 0.6 0.7 1.7 0.08 0.15 12 0.2 0.2 0.4 0.03 0.03 6 0.1 0.1 0.2 0.01 0.01
40 0.5 0.6 1.5 0.08 0.17
310 3.9 5.0 11.6 0.55 1.30 12772 206.5 485.1 22.56 56.93 7890 100.0 127.6 301.7 14.36 36.86
11 0.2 0.2 0.3 0.00 0.04 27 0.4 0.4 0.7 0.04 0.08 45 0.6 0.7 1.2 0.06 0.14 17 0.2 0.2 0.5 0.03 0.04 7 0.1 0.1 0.2 0.01 0.03
14 0.2 0.2 0.4 0.02 0.03 16 0.2 0.2 0.4 0.03 0.03 4 0.1 0.1 0.1 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00
44 0.6 0.6 1.3 0.08 0.17 223 3.2 3.3 6.1 0.35 0.68 30 0.4 0.4 0.9 0.04 0.12
432 6.1 6.3 12.0 0.67 1.39 288 4.1 4.2 7.9 0.47 0.87 41 0.6 0.6 1.1 0.07 0.12 81 1.1 1.2 2.3 0.12 0.27 93 1.3 1.4 2.7 0.13 0.33
128 1.8 1.9 3.6 0.20 0.44 8 0.1 0.1 0.2 0.02 0.02
42 0.6 0.6 1.2 0.08 0.15 427 6.1 6.3 12.1 0.57 1.49 8 0.1 0.1 0.2 0.02 0.02
39 0.6 0.6 1.2 0.07 0.10 174 2.5 2.6 4.6 0.29 0.49
5786 84.9 159.5 7.43 17.86 1 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00
67 1.0 1.0 1.9 0.10 0.20 1876 26.6 27.5 51.4 3.66 5.89 29 0.4 0.4 0.8 0.05 0.08 22 0.3 0.3 0.6 0.04 0.06
555 7.9 8.1 14.5 1.00 1.57 217 3.1 3.2 6.1 0.40 0.71 28 0.4 0.4 0.8 0.05 0.10
238 3.4 3.5 6.5 0.39 0.71 3 0.0 0.0 0.1 0.00 0.01 3 0.0 0.0 0.1 0.01 0.01
144 2.0 2.1 4.3 0.22 0.55 5 0.1 0.1 0.1 0.00 0.02 2 0.0 0.0 0.1 0.00 0.01
137 1.9 2.0 3.7 0.15 0.39 1 0.0 0.0 0.0 0.00 0.00
18 0.3 0.3 0.6 0.03 0.04 182 2.6 2.7 5.3 0.32 0.52 516 7.3 7.6 13.2 1.04 1.32 12 0.2 0.2 0.5 0.03 0.03 4 0.1 0.1 0.1 0.00 0.02
64 0.9 0.9 1.7 0.11 0.14 190 2.7 2.8 5.2 0.30 0.58 15 0.2 0.2 0.5 0.02 0.06 87 1.2 1.3 2.5 0.15 0.29 29 0.4 0.4 1.0 0.05 0.07 53 0.8 0.8 1.5 0.10 0.13 12 0.2 0.2 0.3 0.02 0.03 6 0.1 0.1 0.2 0.00 0.03
42 0.6 0.6 1.1 0.05 0.14
293 4.2 4.3 8.1 0.42 0.83 12838 188.3 353.6 19.53 39.46 7052 100.0 103.4 194.1 12.10 21.60
§Includes 13 cases of unknown age §Includes 10 cases of unknown age
†*See note following population pyramid
*Brazil, Goiânia (2008–2012)
164
Central and South America
Brazil, JaúCONTRIBUTORSDonaldo Botelho VenezianoClaudia Luciana de Araujo VenezianoKatiane Patrícia Ferreira Souto
Brazil, Jaú (2008−2012)Average annual person−years by sex and age group
4 339 0- 4 075
4 660 5- 4 440
4 923 10- 4 757
5 062 15- 4 999
5 673 20- 5 577
6 040 25- 6 046
5 646 30- 5 535
4 960 35- 5 016
4 631 40- 4 909
4 562 45- 4 826
4 121 50- 4 415
3 308 55- 3 576
2 440 60- 2 675
1 671 65- 2 091
1 398 70- 1 762
999 75- 1 467
649 80- 1 017
378 85+ 649
Total65 460 67 832Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 157.5Prostate 52.1Trachea, bronchus, and lung 21.5Colon 16.8Bladder 14.7Other and unspecified 14.5Rectum 14.2Stomach 13.6Oesophagus 11.4Larynx 10.6Mouth 7.6Kidney 7.6Non-Hodgkin lymphoma 7.3Pancreas 6.4Melanoma of skin 6.3Tongue 5.9Testis 4.4Brain and nervous system 4.1Multiple myeloma 3.5Thyroid 3.3
All sites 420.0
Non-melanoma skin cancer 143.4Breast 44.0Colon 13.0Thyroid 12.0Rectum 10.6Corpus uteri 9.6Cervix uteri 9.0Other and unspecified 7.9Trachea, bronchus, and lung 7.2Ovary 7.0Stomach 5.6Non-Hodgkin lymphoma 5.4Melanoma of skin 4.6Brain and nervous system 4.5Pancreas 4.2Myeloid leukaemia 2.8Lymphoid leukaemia 2.6Kidney 2.4Bladder 2.2Multiple myeloma 2.0
All sites 318.9
Brazil, Jaú (2008−2012)Average annual person−years by sex and age group
4 339 0- 4 075
4 660 5- 4 440
4 923 10- 4 757
5 062 15- 4 999
5 673 20- 5 577
6 040 25- 6 046
5 646 30- 5 535
4 960 35- 5 016
4 631 40- 4 909
4 562 45- 4 826
4 121 50- 4 415
3 308 55- 3 576
2 440 60- 2 675
1 671 65- 2 091
1 398 70- 1 762
999 75- 1 467
649 80- 1 017
378 85+ 649
Total65 460 67 832Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 157.5Prostate 52.1Trachea, bronchus, and lung 21.5Colon 16.8Bladder 14.7Other and unspecified 14.5Rectum 14.2Stomach 13.6Oesophagus 11.4Larynx 10.6Mouth 7.6Kidney 7.6Non-Hodgkin lymphoma 7.3Pancreas 6.4Melanoma of skin 6.3Tongue 5.9Testis 4.4Brain and nervous system 4.1Multiple myeloma 3.5Thyroid 3.3
All sites 420.0
Non-melanoma skin cancer 143.4Breast 44.0Colon 13.0Thyroid 12.0Rectum 10.6Corpus uteri 9.6Cervix uteri 9.0Other and unspecified 7.9Trachea, bronchus, and lung 7.2Ovary 7.0Stomach 5.6Non-Hodgkin lymphoma 5.4Melanoma of skin 4.6Brain and nervous system 4.5Pancreas 4.2Myeloid leukaemia 2.8Lymphoid leukaemia 2.6Kidney 2.4Bladder 2.2Multiple myeloma 2.0
All sites 318.9
Brazil, Jaú (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2000 and 2010 censuses (Brazilian Institute of Geography and Statistics; Ministry of Planning, Budget, and Management, Rio de Janeiro; http://www.ibge.gov.br), allowing for births and deaths, but it was not possible to estimate migration into and out of the registration area.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
165
Central and South America
Brazil, Jaú (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
8 0.8 1.2 2.0 0.23 0.23 20 2.1 3.1 5.9 0.52 0.71 28 2.9 4.3 7.6 0.51 0.88 6 0.6 0.9 1.6 0.06 0.12 6 0.6 0.9 1.7 0.15 0.21
10 1.0 1.5 2.9 0.26 0.38 3 0.3 0.5 0.7 0.02 0.02
11 1.1 1.7 2.8 0.24 0.31 2 0.2 0.3 0.5 0.05 0.05
40 4.2 6.1 11.4 1.04 1.35 51 5.3 7.8 13.6 0.61 1.79 0 0.0 0.0 0.0 0.00 0.00
63 6.6 9.6 16.8 0.79 2.30 52 5.4 7.9 14.2 0.91 1.71 3 0.3 0.5 0.8 0.06 0.13 9 0.9 1.4 2.3 0.16 0.30 7 0.7 1.1 1.9 0.07 0.20
25 2.6 3.8 6.4 0.30 0.78 2 0.2 0.3 0.5 0.05 0.05
39 4.1 6.0 10.6 0.75 1.27 81 8.4 12.4 21.5 1.06 2.51 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.2 0.3 0.02 0.02
24 2.5 3.7 6.3 0.39 0.72 610 93.2 157.5 7.61 17.82 0 0.0 0.0 0.0 0.00 0.00 2 0.2 0.3 0.4 0.02 0.02 7 0.7 1.1 1.9 0.04 0.32 3 0.3 0.5 0.8 0.00 0.14
5 0.5 0.8 1.3 0.05 0.12 181 18.9 27.7 52.1 2.28 7.63 16 1.7 2.4 4.4 0.33 0.33 0 0.0 0.0 0.0 0.00 0.00
28 2.9 4.3 7.6 0.46 0.92 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
53 5.5 8.1 14.7 0.64 1.92 0 0.0 0.0 0.0 0.00 0.00 3 0.3 0.5 0.6 0.02 0.02
16 1.7 2.4 4.1 0.15 0.29 13 1.4 2.0 3.3 0.26 0.32 1 0.1 0.2 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 9 0.9 1.4 3.1 0.20 0.20
25 2.6 3.8 7.3 0.39 0.78 0 0.0 0.0 0.0 0.00 0.00
13 1.4 2.0 3.5 0.06 0.54 10 1.0 1.5 2.4 0.10 0.16 11 1.1 1.7 2.9 0.11 0.32 1 0.1 0.2 0.2 0.03 0.03 7 0.7 1.1 1.7 0.14 0.21
10 1.0 1.5 3.1 0.05 0.45
54 5.6 8.2 14.5 0.85 1.56 1569 239.7 420.0 22.09 50.17 959 100.0 146.5 262.6 14.47 32.35
2 0.3 0.3 0.4 0.02 0.02 5 0.6 0.7 1.1 0.04 0.21 5 0.6 0.7 0.9 0.04 0.09 3 0.4 0.4 0.6 0.04 0.04 1 0.1 0.1 0.2 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.2 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.2 0.00 0.06
27 3.4 4.0 5.6 0.36 0.47 1 0.1 0.1 0.2 0.02 0.02
65 8.2 9.6 13.0 0.74 1.22 50 6.3 7.4 10.6 0.59 1.15 3 0.4 0.4 0.6 0.02 0.08 4 0.5 0.6 0.9 0.06 0.10 9 1.1 1.3 1.9 0.11 0.23
21 2.6 3.1 4.2 0.08 0.51 1 0.1 0.1 0.2 0.02 0.02 2 0.3 0.3 0.4 0.00 0.05
31 3.9 4.6 7.2 0.56 0.88 0 0.0 0.0 0.0 0.00 0.00 3 0.4 0.4 0.7 0.04 0.04
21 2.6 3.1 4.6 0.27 0.44 686 101.1 143.4 7.63 16.24 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 5 0.6 0.7 1.0 0.05 0.11
198 24.9 29.2 44.0 3.21 4.66 9 1.1 1.3 1.7 0.08 0.18 2 0.3 0.3 0.5 0.02 0.07
40 5.0 5.9 9.0 0.50 1.04 42 5.3 6.2 9.6 0.49 1.28 1 0.1 0.1 0.3 0.04 0.04
32 4.0 4.7 7.0 0.53 0.70 1 0.1 0.1 0.2 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00
11 1.4 1.6 2.4 0.13 0.28 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
12 1.5 1.8 2.2 0.05 0.26 1 0.1 0.1 0.2 0.02 0.02 2 0.3 0.3 0.5 0.05 0.05
18 2.3 2.7 4.5 0.29 0.44 51 6.4 7.5 12.0 1.00 1.11 1 0.1 0.1 0.4 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 5 0.6 0.7 1.6 0.10 0.10
24 3.0 3.5 5.4 0.30 0.58 2 0.3 0.3 0.5 0.03 0.08 9 1.1 1.3 2.0 0.13 0.24 7 0.9 1.0 2.6 0.12 0.22
13 1.6 1.9 2.8 0.12 0.28 1 0.1 0.1 0.5 0.02 0.02 6 0.8 0.9 1.2 0.11 0.11 5 0.6 0.7 1.4 0.09 0.19
42 5.3 6.2 7.9 0.28 0.70 1482 218.5 318.9 18.47 34.68 796 100.0 117.4 175.5 10.84 18.45
† See note following population pyramid
Brazil, Jaú (2008–2012)
166
Central and South America
Brazil, Poços de CaldasCONTRIBUTORSAntonio Angelo RochaSoraia Ribeiro dos Santos ChisteJuliana Loro FerreiraWilmara Martins Araujo PaceteCristiano Lima
Brazil, Poços de Caldas (2008−2011)Average annual person−years by sex and age group
4 937 0- 4 784
5 287 5- 5 129
5 750 10- 5 621
6 021 15- 5 789
6 558 20- 6 447
6 853 25- 6 793
6 272 30- 6 481
5 444 35- 5 833
5 075 40- 5 538
4 813 45- 5 384
4 424 50- 5 035
3 837 55- 4 369
2 947 60- 3 273
2 058 65- 2 443
1 565 70- 1 946
1 039 75- 1 422
668 80- 964
377 85+ 759
Total73 925 78 010Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 128.7Prostate 104.0Stomach 18.9Trachea, bronchus, and lung 15.2Bladder 14.5Colon 11.7Rectum 8.1Oesophagus 7.3Non-Hodgkin lymphoma 6.4Melanoma of skin 5.4Tongue 5.2Larynx 5.1Multiple myeloma 5.1Liver 5.0Brain and nervous system 4.8Mouth 4.4Testis 4.4Pancreas 3.9Other and unspecified 3.9Lymphoid leukaemia 3.5
All sites 387.7
Non-melanoma skin cancer 113.0Breast 53.3Trachea, bronchus, and lung 10.3Colon 9.3Stomach 8.1Rectum 7.9Corpus uteri 7.9Non-Hodgkin lymphoma 7.3Melanoma of skin 7.3Cervix uteri 6.8Thyroid 6.4Ovary 4.8Brain and nervous system 4.5Pancreas 3.9Other and unspecified 3.9Bladder 3.3Multiple myeloma 3.0Kidney 2.0Myeloid leukaemia 2.0Gallbladder etc. 1.9
All sites 285.4
Brazil, Poços de Caldas (2008−2011)Average annual person−years by sex and age group
4 937 0- 4 784
5 287 5- 5 129
5 750 10- 5 621
6 021 15- 5 789
6 558 20- 6 447
6 853 25- 6 793
6 272 30- 6 481
5 444 35- 5 833
5 075 40- 5 538
4 813 45- 5 384
4 424 50- 5 035
3 837 55- 4 369
2 947 60- 3 273
2 058 65- 2 443
1 565 70- 1 946
1 039 75- 1 422
668 80- 964
377 85+ 759
Total73 925 78 010Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 128.7Prostate 104.0Stomach 18.9Trachea, bronchus, and lung 15.2Bladder 14.5Colon 11.7Rectum 8.1Oesophagus 7.3Non-Hodgkin lymphoma 6.4Melanoma of skin 5.4Tongue 5.2Larynx 5.1Multiple myeloma 5.1Liver 5.0Brain and nervous system 4.8Mouth 4.4Testis 4.4Pancreas 3.9Other and unspecified 3.9Lymphoid leukaemia 3.5
All sites 387.7
Non-melanoma skin cancer 113.0Breast 53.3Trachea, bronchus, and lung 10.3Colon 9.3Stomach 8.1Rectum 7.9Corpus uteri 7.9Non-Hodgkin lymphoma 7.3Melanoma of skin 7.3Cervix uteri 6.8Thyroid 6.4Ovary 4.8Brain and nervous system 4.5Pancreas 3.9Other and unspecified 3.9Bladder 3.3Multiple myeloma 3.0Kidney 2.0Myeloid leukaemia 2.0Gallbladder etc. 1.9
All sites 285.4
Brazil, Poços de Caldas (2008–2011)Average annual person–years by sex and age group
SOURCE OF POPULATIONProvided by the Brazilian Institute of Geography and Statistics (IBGE; http://www.ibge.gov.br).
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
167
Central and South America
Brazil, Poços de Caldas (2008−2011)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.1 0.2 0.3 0.03 0.03 18 2.1 3.0 5.2 0.35 0.65 15 1.7 2.5 4.4 0.29 0.56 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.2 0.3 0.03 0.03 2 0.2 0.3 0.6 0.03 0.11 0 0.0 0.0 0.0 0.00 0.00 7 0.8 1.2 2.0 0.20 0.20 2 0.2 0.3 0.6 0.02 0.10
24 2.8 4.1 7.3 0.47 0.88 63 7.3 10.7 18.9 0.98 2.13 7 0.8 1.2 2.1 0.09 0.22
38 4.4 6.4 11.7 0.38 1.74 27 3.1 4.6 8.1 0.46 1.08 2 0.2 0.3 0.6 0.05 0.05
15 1.7 2.5 5.0 0.33 0.61 4 0.5 0.7 1.3 0.03 0.25
13 1.5 2.2 3.9 0.27 0.42 1 0.1 0.2 0.3 0.03 0.03
17 2.0 2.9 5.1 0.34 0.69 49 5.7 8.3 15.2 0.38 2.31 0 0.0 0.0 0.0 0.00 0.00 2 0.2 0.3 0.6 0.04 0.04
20 2.3 3.4 5.4 0.37 0.53 442 74.7 128.7 6.40 14.06 2 0.2 0.3 0.6 0.07 0.07 0 0.0 0.0 0.0 0.00 0.00 7 0.8 1.2 2.2 0.13 0.27 1 0.1 0.2 0.3 0.00 0.00
1 0.1 0.2 0.3 0.04 0.04 348 40.2 58.8 104.0 4.50 13.54 15 1.7 2.5 4.4 0.34 0.34 0 0.0 0.0 0.0 0.00 0.00
11 1.3 1.9 3.2 0.16 0.36 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.2 0.3 0.04 0.04
50 5.8 8.5 14.5 0.77 1.47 1 0.1 0.2 0.3 0.04 0.04 1 0.1 0.2 0.3 0.04 0.04
17 2.0 2.9 4.8 0.36 0.42 5 0.6 0.8 1.4 0.15 0.15 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 4 0.5 0.7 1.2 0.06 0.06
22 2.5 3.7 6.4 0.15 0.69 0 0.0 0.0 0.0 0.00 0.00
16 1.8 2.7 5.1 0.27 0.67 10 1.2 1.7 3.5 0.22 0.35 8 0.9 1.4 2.5 0.19 0.27 2 0.2 0.3 0.6 0.02 0.02 2 0.2 0.3 0.4 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
13 1.5 2.2 3.9 0.12 0.44 1307 221.0 387.7 19.29 46.01 865 100.0 146.3 259.0 12.88 31.95
1 0.1 0.2 0.1 0.00 0.00 5 0.7 0.8 1.3 0.14 0.14 5 0.7 0.8 1.3 0.02 0.14 3 0.4 0.5 0.8 0.05 0.10 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 2 0.3 0.3 0.5 0.05 0.05 0 0.0 0.0 0.0 0.00 0.00 5 0.7 0.8 1.1 0.11 0.11
35 5.1 5.6 8.1 0.43 0.79 8 1.2 1.3 1.9 0.10 0.22
38 5.5 6.1 9.3 0.69 1.04 34 4.9 5.4 7.9 0.39 0.90 3 0.4 0.5 0.8 0.05 0.10 1 0.1 0.2 0.3 0.02 0.02 9 1.3 1.4 1.9 0.10 0.23
16 2.3 2.6 3.9 0.20 0.56 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
42 6.1 6.7 10.3 0.62 1.26 0 0.0 0.0 0.0 0.00 0.00 3 0.4 0.5 0.9 0.07 0.07
30 4.3 4.8 7.3 0.49 0.78 487 78.0 113.0 5.57 12.44 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 4 0.6 0.6 1.0 0.07 0.14
207 30.0 33.2 53.3 3.86 6.31 7 1.0 1.1 1.8 0.12 0.24 0 0.0 0.0 0.0 0.00 0.00
26 3.8 4.2 6.8 0.52 0.74 31 4.5 5.0 7.9 0.42 1.11 2 0.3 0.3 0.5 0.00 0.05
19 2.7 3.0 4.8 0.34 0.52 1 0.1 0.2 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00
7 1.0 1.1 2.0 0.14 0.20 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
15 2.2 2.4 3.3 0.13 0.42 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
16 2.3 2.6 4.5 0.32 0.42 25 3.6 4.0 6.4 0.57 0.63 3 0.4 0.5 1.2 0.09 0.09 0 0.0 0.0 0.0 0.00 0.00 4 0.6 0.6 1.4 0.10 0.10
30 4.3 4.8 7.3 0.54 0.71 1 0.1 0.2 0.2 0.02 0.02
14 2.0 2.2 3.0 0.09 0.32 2 0.3 0.3 0.5 0.04 0.04 8 1.2 1.3 2.0 0.11 0.17 2 0.3 0.3 0.4 0.02 0.02 7 1.0 1.1 1.7 0.06 0.24 3 0.4 0.5 0.6 0.04 0.04
17 2.5 2.7 3.9 0.26 0.51 1178 188.8 285.4 16.99 32.02 691 100.0 110.7 172.4 11.42 19.58
† See note following population pyramid
Brazil, Poços de Caldas (2008–2011)
168
Central and South America
Chile, Region of AntofagastaCONTRIBUTORSJuan Carlos Galaz AlamosJessica Andrea Moya CortesClelia VallebuonaCarla CartesNatalia VergaraNora DiazRodolfo PinoFernando SotoMarion Contreras
Chile, Region of Antofagasta (2008−2010)Average annual person−years by sex and age group
23 381 0- 22 516
22 361 5- 21 189
23 955 10- 22 912
24 286 15- 23 418
25 986 20- 22 596
25 259 25- 21 454
24 587 30- 21 460
24 317 35- 20 227
23 128 40- 18 896
21 668 45- 18 497
18 621 50- 16 085
13 967 55- 12 299
9 675 60- 9 263
6 285 65- 6 871
4 131 70- 5 150
2 717 75- 3 891
2 184 80+ 4 139
Total296 508 270 863Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*Low MV% and high DCO%.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 67.2Trachea, bronchus, and lung 45.3Prostate 39.3Stomach 21.2Bladder 20.2Colon 12.9Kidney 11.4Other and unspecified 8.4Testis 6.9Rectum 5.2Liver 5.0Non-Hodgkin lymphoma 4.7Gallbladder etc. 4.4Pancreas 4.2Oesophagus 3.6Larynx 3.3Brain and nervous system 2.8Thyroid 2.6Other thoracic organs 2.1Melanoma of skin 2.1
All sites 290.0
Non-melanoma skin cancer 46.5Breast 31.7Trachea, bronchus, and lung 18.2Cervix uteri 13.2Thyroid 11.1Gallbladder etc. 9.6Colon 8.8Bladder 8.0Stomach 7.8Kidney 6.9Other and unspecified 6.5Corpus uteri 6.0Ovary 5.6Pancreas 5.5Non-Hodgkin lymphoma 4.6Liver 3.2Rectum 2.6Melanoma of skin 2.5Brain and nervous system 2.5Lymphoid leukaemia 2.0
All sites 220.0
Chile, Region of Antofagasta (2008−2010)Average annual person−years by sex and age group
23 381 0- 22 516
22 361 5- 21 189
23 955 10- 22 912
24 286 15- 23 418
25 986 20- 22 596
25 259 25- 21 454
24 587 30- 21 460
24 317 35- 20 227
23 128 40- 18 896
21 668 45- 18 497
18 621 50- 16 085
13 967 55- 12 299
9 675 60- 9 263
6 285 65- 6 871
4 131 70- 5 150
2 717 75- 3 891
2 184 80+ 4 139
Total296 508 270 863Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*Low MV% and high DCO%.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 67.2Trachea, bronchus, and lung 45.3Prostate 39.3Stomach 21.2Bladder 20.2Colon 12.9Kidney 11.4Other and unspecified 8.4Testis 6.9Rectum 5.2Liver 5.0Non-Hodgkin lymphoma 4.7Gallbladder etc. 4.4Pancreas 4.2Oesophagus 3.6Larynx 3.3Brain and nervous system 2.8Thyroid 2.6Other thoracic organs 2.1Melanoma of skin 2.1
All sites 290.0
Non-melanoma skin cancer 46.5Breast 31.7Trachea, bronchus, and lung 18.2Cervix uteri 13.2Thyroid 11.1Gallbladder etc. 9.6Colon 8.8Bladder 8.0Stomach 7.8Kidney 6.9Other and unspecified 6.5Corpus uteri 6.0Ovary 5.6Pancreas 5.5Non-Hodgkin lymphoma 4.6Liver 3.2Rectum 2.6Melanoma of skin 2.5Brain and nervous system 2.5Lymphoid leukaemia 2.0
All sites 220.0
Chile, Region of Antofagasta (2008–2010)Average annual person–years by sex and age group
SOURCE OF POPULATIONNational Institute of Statistics (2014). Updated population 2002–2012 and population projections 2013–2020, Chile.
NOTES ON THE DATA*Low MV%. High DCO%.
169
Central and South America
*Chile, Region of Antofagasta (2008−2010)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.1 0.1 0.2 0.00 0.04 4 0.2 0.2 0.4 0.03 0.03 7 0.4 0.4 0.9 0.06 0.06 6 0.4 0.3 0.7 0.03 0.07 3 0.2 0.2 0.4 0.02 0.07 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.2 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.2 0.01 0.01
28 1.6 1.6 3.6 0.12 0.35 160 9.3 9.0 21.2 0.76 2.58 12 0.7 0.7 1.5 0.10 0.15 96 5.6 5.4 12.9 0.42 1.67 41 2.4 2.3 5.2 0.28 0.64 3 0.2 0.2 0.4 0.03 0.06
37 2.2 2.1 5.0 0.19 0.53 33 1.9 1.9 4.4 0.15 0.53 34 2.0 1.9 4.2 0.23 0.53 5 0.3 0.3 0.5 0.04 0.08
26 1.5 1.5 3.3 0.23 0.38 332 19.4 18.7 45.3 1.67 5.45 20 1.2 1.1 2.1 0.17 0.20 3 0.2 0.2 0.3 0.02 0.02
18 1.1 1.0 2.1 0.09 0.17 522 29.3 67.2 2.91 7.87 4 0.2 0.2 0.5 0.06 0.06 0 0.0 0.0 0.0 0.00 0.00
12 0.7 0.7 1.4 0.11 0.11 0 0.0 0.0 0.0 0.00 0.00
11 0.6 0.6 1.4 0.06 0.16 281 16.4 15.8 39.3 1.12 4.72 70 4.1 3.9 6.9 0.48 0.51 2 0.1 0.1 0.3 0.01 0.04
86 5.0 4.8 11.4 0.47 1.45 5 0.3 0.3 0.6 0.03 0.03
11 0.6 0.6 1.3 0.07 0.12 154 9.0 8.7 20.2 0.98 2.37 10 0.6 0.6 1.2 0.06 0.20 1 0.1 0.1 0.1 0.00 0.00
23 1.3 1.3 2.8 0.14 0.26 24 1.4 1.3 2.6 0.18 0.25 1 0.1 0.1 0.2 0.01 0.01 2 0.1 0.1 0.2 0.01 0.04 4 0.2 0.2 0.5 0.03 0.03
40 2.3 2.2 4.7 0.26 0.49 1 0.1 0.1 0.1 0.01 0.01 4 0.2 0.2 0.4 0.05 0.05 9 0.5 0.5 1.4 0.05 0.08
15 0.9 0.8 1.7 0.11 0.15 1 0.1 0.1 0.2 0.00 0.03 1 0.1 0.1 0.2 0.01 0.01 1 0.1 0.1 0.1 0.02 0.02
66 3.9 3.7 8.4 0.36 0.89 2234 125.6 290.0 12.24 33.53 1712 100.0 96.2 222.8 9.33 25.66
0 0.0 0.0 0.0 0.00 0.00 5 0.3 0.3 0.5 0.05 0.05 5 0.3 0.3 0.6 0.03 0.05 4 0.3 0.2 0.4 0.01 0.04 1 0.1 0.1 0.1 0.00 0.02 1 0.1 0.1 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
14 0.9 0.9 1.4 0.04 0.15 69 4.5 4.2 7.8 0.32 1.03 4 0.3 0.2 0.4 0.03 0.07
82 5.3 5.0 8.8 0.47 0.87 24 1.6 1.5 2.6 0.14 0.30 6 0.4 0.4 0.6 0.04 0.04
29 1.9 1.8 3.2 0.11 0.37 86 5.6 5.3 9.6 0.48 1.09 49 3.2 3.0 5.5 0.27 0.68 2 0.1 0.1 0.2 0.02 0.02 3 0.2 0.2 0.4 0.00 0.08
163 10.6 10.0 18.2 0.85 2.14 14 0.9 0.9 1.5 0.12 0.15 10 0.6 0.6 1.2 0.04 0.10 22 1.4 1.4 2.5 0.20 0.25
430 26.5 46.5 2.46 4.86 1 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
10 0.6 0.6 1.1 0.05 0.11 278 18.0 17.1 31.7 2.22 3.77 6 0.4 0.4 0.6 0.03 0.06 6 0.4 0.4 0.7 0.05 0.11
121 7.8 7.4 13.2 0.95 1.32 51 3.3 3.1 6.0 0.40 0.76 12 0.8 0.7 1.3 0.11 0.11 49 3.2 3.0 5.6 0.40 0.62 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
61 4.0 3.8 6.9 0.37 0.80 3 0.2 0.2 0.3 0.03 0.03 5 0.3 0.3 0.6 0.03 0.08
72 4.7 4.4 8.0 0.35 0.82 2 0.1 0.1 0.2 0.01 0.01 4 0.3 0.2 0.5 0.01 0.03
21 1.4 1.3 2.5 0.18 0.26 101 6.5 6.2 11.1 0.93 1.04 1 0.1 0.1 0.1 0.00 0.02 0 0.0 0.0 0.0 0.00 0.00 8 0.5 0.5 1.0 0.07 0.12
37 2.4 2.3 4.6 0.28 0.64 0 0.0 0.0 0.0 0.00 0.00 8 0.5 0.5 0.9 0.07 0.11
14 0.9 0.9 2.0 0.10 0.10 10 0.6 0.6 1.2 0.06 0.08 2 0.1 0.1 0.3 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 5 0.3 0.3 0.5 0.05 0.05
60 3.9 3.7 6.5 0.26 0.67 1972 121.3 220.0 12.72 24.11 1542 100.0 94.9 173.5 10.26 19.25
*See note following population pyramid
*Chile, Region of Antofagasta (2008–2010)
170
Central and South America
Chile, Bío Bío ProvinceCONTRIBUTORSMaría Elena UmañaClelia Vallebuona StagnoNora Díaz SanzanaRodolfo Pino AravenaMarion Contreras AranguizFernando Soto Valenzuela
Chile, Bío Bío Province (2008−2012)Average annual person−years by sex and age group
14 055 0- 13 796
14 597 5- 14 257
16 022 10- 15 560
16 639 15- 16 173
15 623 20- 15 672
13 909 25- 14 497
12 990 30- 13 399
13 281 35- 13 289
14 082 40- 13 827
13 414 45- 13 086
11 689 50- 11 490
9 955 55- 9 515
8 200 60- 8 014
6 306 65- 6 714
4 730 70- 5 004
3 079 75- 3 718
3 123 80+ 4 455
Total191 694 192 466Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 51.9Stomach 41.4Non-melanoma skin cancer 13.7Trachea, bronchus, and lung 9.9Testis 9.8Colon 9.6Gallbladder etc. 9.4Kidney 7.7Oesophagus 6.6Rectum 5.9Other and unspecified 5.9Pancreas 5.5Lymphoid leukaemia 5.4Non-Hodgkin lymphoma 4.7Brain and nervous system 4.3Myeloid leukaemia 3.7Liver 3.2Multiple myeloma 3.0Bladder 2.9Melanoma of skin 2.5
All sites 222.9
Breast 32.7Gallbladder etc. 22.4Stomach 14.8Cervix uteri 14.6Non-melanoma skin cancer 11.6Colon 9.7Corpus uteri 7.0Trachea, bronchus, and lung 6.9Ovary 6.5Thyroid 6.1Kidney 5.7Other and unspecified 5.4Rectum 5.4Pancreas 5.1Oesophagus 4.0Brain and nervous system 3.5Non-Hodgkin lymphoma 3.1Lymphoid leukaemia 3.1Melanoma of skin 3.0Liver 2.8
All sites 189.0
Chile, Bío Bío Province (2008−2012)Average annual person−years by sex and age group
14 055 0- 13 796
14 597 5- 14 257
16 022 10- 15 560
16 639 15- 16 173
15 623 20- 15 672
13 909 25- 14 497
12 990 30- 13 399
13 281 35- 13 289
14 082 40- 13 827
13 414 45- 13 086
11 689 50- 11 490
9 955 55- 9 515
8 200 60- 8 014
6 306 65- 6 714
4 730 70- 5 004
3 079 75- 3 718
3 123 80+ 4 455
Total191 694 192 466Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 51.9Stomach 41.4Non-melanoma skin cancer 13.7Trachea, bronchus, and lung 9.9Testis 9.8Colon 9.6Gallbladder etc. 9.4Kidney 7.7Oesophagus 6.6Rectum 5.9Other and unspecified 5.9Pancreas 5.5Lymphoid leukaemia 5.4Non-Hodgkin lymphoma 4.7Brain and nervous system 4.3Myeloid leukaemia 3.7Liver 3.2Multiple myeloma 3.0Bladder 2.9Melanoma of skin 2.5
All sites 222.9
Breast 32.7Gallbladder etc. 22.4Stomach 14.8Cervix uteri 14.6Non-melanoma skin cancer 11.6Colon 9.7Corpus uteri 7.0Trachea, bronchus, and lung 6.9Ovary 6.5Thyroid 6.1Kidney 5.7Other and unspecified 5.4Rectum 5.4Pancreas 5.1Oesophagus 4.0Brain and nervous system 3.5Non-Hodgkin lymphoma 3.1Lymphoid leukaemia 3.1Melanoma of skin 3.0Liver 2.8
All sites 189.0
Chile, Bío Bío Province (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation estimates based on the 2002 census using data from the National Institute of Statistics (2014). Population updates 2002–2012 and population projections 2013–2020, Chile.
171
Central and South America
Chile, Bío Bío Province (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.0 0.1 0.1 0.01 0.01 5 0.2 0.3 0.5 0.02 0.04 2 0.1 0.1 0.2 0.02 0.02 4 0.2 0.2 0.4 0.03 0.05 2 0.1 0.1 0.2 0.01 0.01 2 0.1 0.1 0.2 0.02 0.02 1 0.0 0.1 0.1 0.01 0.01 4 0.2 0.2 0.3 0.01 0.01 3 0.1 0.2 0.2 0.01 0.01
88 3.5 4.6 6.6 0.08 0.63 507 20.0 26.4 41.4 1.82 4.88 9 0.4 0.5 0.8 0.06 0.10
117 4.6 6.1 9.6 0.36 1.17 74 2.9 3.9 5.9 0.20 0.72 4 0.2 0.2 0.3 0.01 0.05
38 1.5 2.0 3.2 0.15 0.33 115 4.5 6.0 9.4 0.38 1.09 68 2.7 3.5 5.5 0.20 0.64 5 0.2 0.3 0.5 0.03 0.05 8 0.3 0.4 0.7 0.01 0.12
122 4.8 6.4 9.9 0.46 1.17 10 0.4 0.5 0.9 0.03 0.11 9 0.4 0.5 0.8 0.05 0.07
29 1.1 1.5 2.5 0.14 0.30 175 9.1 13.7 0.45 1.36 5 0.2 0.3 0.4 0.00 0.06 3 0.1 0.2 0.3 0.01 0.03
23 0.9 1.2 2.1 0.16 0.18 2 0.1 0.1 0.1 0.00 0.02
7 0.3 0.4 0.5 0.01 0.03 661 26.1 34.5 51.9 1.36 6.10 100 3.9 5.2 9.8 0.71 0.71 2 0.1 0.1 0.2 0.01 0.03
93 3.7 4.9 7.7 0.45 0.86 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.1 0.1 0.01 0.01
37 1.5 1.9 2.9 0.10 0.28 1 0.0 0.1 0.1 0.01 0.01 4 0.2 0.2 0.4 0.02 0.02
45 1.8 2.3 4.3 0.26 0.37 9 0.4 0.5 0.8 0.04 0.06 3 0.1 0.2 0.3 0.01 0.04 4 0.2 0.2 0.3 0.01 0.04 8 0.3 0.4 0.9 0.04 0.08
54 2.1 2.8 4.7 0.25 0.49 11 0.4 0.6 0.8 0.04 0.08 35 1.4 1.8 3.0 0.18 0.36 51 2.0 2.7 5.4 0.23 0.47 41 1.6 2.1 3.7 0.20 0.37 8 0.3 0.4 0.7 0.04 0.08
15 0.6 0.8 1.2 0.05 0.07 7 0.3 0.4 0.7 0.03 0.06
76 3.0 4.0 5.9 0.13 0.60 2708 141.3 222.9 8.95 24.47 2533 100.0 132.1 209.2 8.51 23.11
0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.1 0.1 0.01 0.01 1 0.0 0.1 0.1 0.01 0.01 5 0.2 0.3 0.4 0.04 0.04 2 0.1 0.1 0.1 0.00 0.00 1 0.0 0.1 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
58 2.5 3.0 4.0 0.12 0.49 207 9.1 10.8 14.8 0.67 1.67 10 0.4 0.5 0.9 0.06 0.12
139 6.1 7.2 9.7 0.39 1.07 69 3.0 3.6 5.4 0.28 0.66 4 0.2 0.2 0.3 0.01 0.05
41 1.8 2.1 2.8 0.08 0.33 298 13.1 15.5 22.4 1.10 2.73 74 3.2 3.8 5.1 0.24 0.55 4 0.2 0.2 0.3 0.03 0.03 3 0.1 0.2 0.2 0.00 0.03
98 4.3 5.1 6.9 0.32 0.75 7 0.3 0.4 0.5 0.02 0.06 8 0.4 0.4 0.7 0.05 0.08
38 1.7 2.0 3.0 0.21 0.30 167 8.7 11.6 0.44 1.17 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.1 0.1 0.01 0.01
22 1.0 1.1 2.0 0.14 0.20 399 17.5 20.7 32.7 2.24 3.66 9 0.4 0.5 0.6 0.02 0.05 9 0.4 0.5 0.7 0.05 0.07
173 7.6 9.0 14.6 1.11 1.48 84 3.7 4.4 7.0 0.45 0.85 3 0.1 0.2 0.2 0.01 0.02
78 3.4 4.1 6.5 0.39 0.77 2 0.1 0.1 0.1 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
71 3.1 3.7 5.7 0.29 0.72 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
24 1.1 1.2 1.5 0.04 0.15 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.2 0.5 0.02 0.02
45 2.0 2.3 3.5 0.17 0.38 67 2.9 3.5 6.1 0.50 0.61 1 0.0 0.1 0.1 0.00 0.01 3 0.1 0.2 0.2 0.01 0.01 6 0.3 0.3 0.5 0.02 0.04
39 1.7 2.0 3.1 0.20 0.32 7 0.3 0.4 0.5 0.03 0.07
30 1.3 1.6 2.3 0.10 0.31 29 1.3 1.5 3.1 0.16 0.26 14 0.6 0.7 1.3 0.08 0.15 2 0.1 0.1 0.1 0.01 0.01 9 0.4 0.5 0.7 0.03 0.07 6 0.3 0.3 0.4 0.01 0.03
78 3.4 4.1 5.4 0.22 0.56 2450 127.3 189.0 10.38 20.99 2283 100.0 118.6 177.3 9.94 19.82
Chile, Bío Bío Province (2008–2012)
172
Central and South America
Chile, ConcepciónCONTRIBUTORSCarla Espinoza VallejosJocelyn Sanhueza MonsalveAna Maria MoragaMiriam Piniza JaraDaniela Guiñez CabezasClelia VallebuonaNora DiazNatalia VergaraCarla CartesRodolfo Pino
Chile, Concepción (2008−2010)Average annual person−years by sex and age group
33 664 0- 31 803
35 293 5- 34 060
40 258 10- 38 915
47 836 15- 45 841
48 605 20- 47 417
38 352 25- 38 670
32 942 30- 34 443
35 132 35- 37 811
37 345 40- 40 095
35 900 45- 38 180
29 997 50- 32 678
23 144 55- 26 036
17 750 60- 20 780
13 561 65- 16 681
9 767 70- 13 253
6 192 75- 9 522
5 439 80+ 10 991
Total491 177 517 176Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 53.3Stomach 33.2Non-melanoma skin cancer 24.3Trachea, bronchus, and lung 12.3Colon 12.2Testis 9.5Kidney 8.8Gallbladder etc. 7.8Other and unspecified 7.7Non-Hodgkin lymphoma 6.3Oesophagus 5.7Liver 5.5Bladder 4.7Brain and nervous system 4.5Rectum 4.3Pancreas 4.1Lymphoid leukaemia 3.2Multiple myeloma 3.0Melanoma of skin 3.0Myeloid leukaemia 2.1
All sites 232.6
Breast 40.9Non-melanoma skin cancer 19.3Cervix uteri 14.4Stomach 14.0Gallbladder etc. 13.4Colon 10.7Thyroid 7.5Ovary 6.9Other and unspecified 6.6Trachea, bronchus, and lung 6.3Corpus uteri 5.7Brain and nervous system 4.5Non-Hodgkin lymphoma 4.5Kidney 4.4Pancreas 4.3Melanoma of skin 3.6Liver 3.5Rectum 3.1Lymphoid leukaemia 2.9Myeloid leukaemia 2.7
All sites 197.5
Chile, Concepción (2008−2010)Average annual person−years by sex and age group
33 664 0- 31 803
35 293 5- 34 060
40 258 10- 38 915
47 836 15- 45 841
48 605 20- 47 417
38 352 25- 38 670
32 942 30- 34 443
35 132 35- 37 811
37 345 40- 40 095
35 900 45- 38 180
29 997 50- 32 678
23 144 55- 26 036
17 750 60- 20 780
13 561 65- 16 681
9 767 70- 13 253
6 192 75- 9 522
5 439 80+ 10 991
Total491 177 517 176Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 53.3Stomach 33.2Non-melanoma skin cancer 24.3Trachea, bronchus, and lung 12.3Colon 12.2Testis 9.5Kidney 8.8Gallbladder etc. 7.8Other and unspecified 7.7Non-Hodgkin lymphoma 6.3Oesophagus 5.7Liver 5.5Bladder 4.7Brain and nervous system 4.5Rectum 4.3Pancreas 4.1Lymphoid leukaemia 3.2Multiple myeloma 3.0Melanoma of skin 3.0Myeloid leukaemia 2.1
All sites 232.6
Breast 40.9Non-melanoma skin cancer 19.3Cervix uteri 14.4Stomach 14.0Gallbladder etc. 13.4Colon 10.7Thyroid 7.5Ovary 6.9Other and unspecified 6.6Trachea, bronchus, and lung 6.3Corpus uteri 5.7Brain and nervous system 4.5Non-Hodgkin lymphoma 4.5Kidney 4.4Pancreas 4.3Melanoma of skin 3.6Liver 3.5Rectum 3.1Lymphoid leukaemia 2.9Myeloid leukaemia 2.7
All sites 197.5
Chile, Concepción (2008–2010)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation estimates based on the 2002 census using data from the National Institute of Statistics (2014). Population updates 2002–2012 and population projections 2013–2020, Chile.
173
Central and South America
Chile, Concepción (2008−2010)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
6 0.2 0.2 0.4 0.02 0.03 11 0.3 0.4 0.7 0.05 0.08 12 0.4 0.4 0.8 0.06 0.10 4 0.1 0.1 0.2 0.00 0.02 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.1 0.01 0.01 4 0.1 0.1 0.3 0.02 0.04 5 0.2 0.2 0.3 0.01 0.06 4 0.1 0.1 0.3 0.02 0.04
90 2.8 3.1 5.7 0.11 0.49 518 15.9 17.6 33.2 1.34 3.91 16 0.5 0.5 1.1 0.06 0.15
193 5.9 6.5 12.2 0.60 1.38 69 2.1 2.3 4.3 0.21 0.47 8 0.2 0.3 0.5 0.04 0.05
85 2.6 2.9 5.5 0.21 0.68 123 3.8 4.2 7.8 0.39 0.86 63 1.9 2.1 4.1 0.18 0.51 6 0.2 0.2 0.4 0.03 0.06
28 0.9 1.0 1.8 0.08 0.25 194 6.0 6.6 12.3 0.59 1.37 9 0.3 0.3 0.6 0.03 0.08
12 0.4 0.4 0.8 0.05 0.06 48 1.5 1.6 3.0 0.15 0.30
382 13.0 24.3 0.85 2.56 9 0.3 0.3 0.6 0.03 0.09 7 0.2 0.2 0.4 0.03 0.03
29 0.9 1.0 1.9 0.11 0.16 5 0.2 0.2 0.3 0.01 0.01
6 0.2 0.2 0.4 0.01 0.02 817 25.1 27.7 53.3 1.82 6.66 158 4.9 5.4 9.5 0.72 0.74 2 0.1 0.1 0.1 0.00 0.00
140 4.3 4.8 8.8 0.50 1.03 1 0.0 0.0 0.1 0.00 0.00 2 0.1 0.1 0.1 0.00 0.01
73 2.2 2.5 4.7 0.21 0.49 3 0.1 0.1 0.2 0.01 0.01 5 0.2 0.2 0.5 0.02 0.02
69 2.1 2.3 4.5 0.26 0.42 30 0.9 1.0 1.9 0.14 0.19 1 0.0 0.0 0.1 0.01 0.01 4 0.1 0.1 0.2 0.02 0.03
18 0.6 0.6 1.1 0.06 0.09 100 3.1 3.4 6.3 0.31 0.65 4 0.1 0.1 0.3 0.00 0.05
47 1.4 1.6 3.0 0.10 0.34 42 1.3 1.4 3.2 0.14 0.20 33 1.0 1.1 2.1 0.10 0.17 7 0.2 0.2 0.4 0.01 0.03 3 0.1 0.1 0.2 0.01 0.01 5 0.2 0.2 0.3 0.01 0.01
124 3.8 4.2 7.7 0.27 0.76 3635 123.3 232.6 10.04 25.81 3253 100.0 110.4 208.4 9.20 23.25
6 0.2 0.2 0.2 0.01 0.02 7 0.2 0.2 0.5 0.02 0.04 7 0.2 0.2 0.3 0.01 0.03 2 0.1 0.1 0.1 0.01 0.01 1 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.1 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
44 1.2 1.4 2.0 0.08 0.22 307 8.6 9.9 14.0 0.60 1.45 15 0.4 0.5 0.7 0.04 0.07
227 6.4 7.3 10.7 0.52 1.13 66 1.8 2.1 3.1 0.17 0.30 13 0.4 0.4 0.7 0.05 0.07 79 2.2 2.5 3.5 0.15 0.37
278 7.8 9.0 13.4 0.81 1.50 90 2.5 2.9 4.3 0.22 0.53 6 0.2 0.2 0.3 0.04 0.05 4 0.1 0.1 0.2 0.01 0.01
132 3.7 4.3 6.3 0.30 0.74 6 0.2 0.2 0.4 0.02 0.02 9 0.3 0.3 0.4 0.02 0.03
75 2.1 2.4 3.6 0.19 0.39 427 13.8 19.3 0.82 2.02 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
30 0.8 1.0 1.6 0.09 0.16 798 22.4 25.7 40.9 2.90 4.64 11 0.3 0.4 0.5 0.02 0.06 9 0.3 0.3 0.5 0.03 0.06
281 7.9 9.1 14.4 1.05 1.44 109 3.1 3.5 5.7 0.43 0.74 37 1.0 1.2 1.9 0.15 0.21
130 3.6 4.2 6.9 0.49 0.82 1 0.0 0.0 0.1 0.01 0.01 2 0.1 0.1 0.1 0.01 0.01
81 2.3 2.6 4.4 0.25 0.51 3 0.1 0.1 0.2 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00
40 1.1 1.3 1.7 0.05 0.18 1 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.1 0.00 0.02
81 2.3 2.6 4.5 0.24 0.45 138 3.9 4.4 7.5 0.57 0.71 2 0.1 0.1 0.1 0.00 0.00 6 0.2 0.2 0.3 0.02 0.03
29 0.8 0.9 1.8 0.10 0.14 90 2.5 2.9 4.5 0.24 0.50 4 0.1 0.1 0.2 0.01 0.01
53 1.5 1.7 2.6 0.12 0.35 40 1.1 1.3 2.9 0.14 0.20 50 1.4 1.6 2.7 0.15 0.25 4 0.1 0.1 0.2 0.01 0.02 3 0.1 0.1 0.2 0.01 0.02
10 0.3 0.3 0.4 0.00 0.04
145 4.1 4.7 6.6 0.28 0.64 3995 128.7 197.5 11.49 21.24 3568 100.0 115.0 178.3 10.66 19.22
Chile, Concepción (2008–2010)
174
Central and South America
Chile, ValdiviaCONTRIBUTORSSolange Vargas GallagherAna María Jofré SalazarKaty Heise MoraEnriqueta Bertrán VivesIgnacio Zárate CamposJuan Carlos Velásquez MárquezClelia Vallebuona StagnoCarla CartesFernando SotoNatalia VergaraNora DiazRodolfo PinoMarion ContrerasJaviera Illanes DiazIngrid Lavin BrüningClaudio González Oyarzún
Chile, Valdivia (2008−2012)Average annual person−years by sex and age group
13 731 0- 13 241
13 986 5- 13 463
15 644 10- 15 039
17 560 15- 16 553
16 364 20- 15 454
14 272 25- 13 997
12 428 30- 12 472
12 489 35- 12 563
13 202 40- 13 101
13 951 45- 13 590
11 928 50- 11 813
9 498 55- 9 631
7 486 60- 8 152
5 963 65- 6 764
4 406 70- 5 456
3 230 75- 4 255
3 165 80+ 4 558
Total189 303 190 102Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*High M/I ratios.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 56.8Stomach 33.1Non-melanoma skin cancer 16.5Testis 11.3Trachea, bronchus, and lung 10.3Kidney 9.5Other and unspecified 9.4Colon 8.0Gallbladder etc. 7.9Oesophagus 6.9Non-Hodgkin lymphoma 5.9Rectum 5.4Pancreas 5.4Brain and nervous system 4.4Liver 4.1Bladder 3.5Lymphoid leukaemia 3.3Multiple myeloma 2.9Myeloid leukaemia 2.9Melanoma of skin 2.8
All sites 225.1
Breast 32.8Gallbladder etc. 18.9Non-melanoma skin cancer 14.0Stomach 13.1Cervix uteri 12.8Other and unspecified 9.9Colon 9.1Thyroid 8.0Corpus uteri 6.7Ovary 6.2Kidney 6.0Trachea, bronchus, and lung 4.7Non-Hodgkin lymphoma 4.2Rectum 3.7Brain and nervous system 3.6Pancreas 3.6Lymphoid leukaemia 2.9Melanoma of skin 2.8Oesophagus 2.5Liver 1.9
All sites 182.3
Chile, Valdivia (2008−2012)Average annual person−years by sex and age group
13 731 0- 13 241
13 986 5- 13 463
15 644 10- 15 039
17 560 15- 16 553
16 364 20- 15 454
14 272 25- 13 997
12 428 30- 12 472
12 489 35- 12 563
13 202 40- 13 101
13 951 45- 13 590
11 928 50- 11 813
9 498 55- 9 631
7 486 60- 8 152
5 963 65- 6 764
4 406 70- 5 456
3 230 75- 4 255
3 165 80+ 4 558
Total189 303 190 102Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*High M/I ratios.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 56.8Stomach 33.1Non-melanoma skin cancer 16.5Testis 11.3Trachea, bronchus, and lung 10.3Kidney 9.5Other and unspecified 9.4Colon 8.0Gallbladder etc. 7.9Oesophagus 6.9Non-Hodgkin lymphoma 5.9Rectum 5.4Pancreas 5.4Brain and nervous system 4.4Liver 4.1Bladder 3.5Lymphoid leukaemia 3.3Multiple myeloma 2.9Myeloid leukaemia 2.9Melanoma of skin 2.8
All sites 225.1
Breast 32.8Gallbladder etc. 18.9Non-melanoma skin cancer 14.0Stomach 13.1Cervix uteri 12.8Other and unspecified 9.9Colon 9.1Thyroid 8.0Corpus uteri 6.7Ovary 6.2Kidney 6.0Trachea, bronchus, and lung 4.7Non-Hodgkin lymphoma 4.2Rectum 3.7Brain and nervous system 3.6Pancreas 3.6Lymphoid leukaemia 2.9Melanoma of skin 2.8Oesophagus 2.5Liver 1.9
All sites 182.3
Chile, Valdivia (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation estimates based on the 2002 census using data from the National Institute of Statistics (2014). Population updates 2002–2012 and population projections 2013–2020, Chile.
NOTES ON THE DATA*High M:I ratios.
175
Central and South America
*Chile, Valdivia (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
3 0.1 0.2 0.2 0.01 0.01 5 0.2 0.3 0.5 0.04 0.06 4 0.2 0.2 0.4 0.04 0.04 2 0.1 0.1 0.2 0.01 0.03 1 0.0 0.1 0.1 0.01 0.01 2 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
86 3.6 4.5 6.9 0.19 0.78 400 16.6 21.1 33.1 1.52 3.82 4 0.2 0.2 0.3 0.02 0.04
96 4.0 5.1 8.0 0.33 0.86 65 2.7 3.4 5.4 0.27 0.64 5 0.2 0.3 0.5 0.04 0.05
47 2.0 2.5 4.1 0.25 0.47 95 3.9 5.0 7.9 0.29 0.95 63 2.6 3.3 5.4 0.26 0.65 4 0.2 0.2 0.3 0.01 0.04
12 0.5 0.6 1.0 0.05 0.11 123 5.1 6.5 10.3 0.39 1.32 10 0.4 0.5 0.9 0.05 0.09 11 0.5 0.6 1.1 0.07 0.08 30 1.2 1.6 2.8 0.17 0.33
205 10.8 16.5 0.61 1.75 4 0.2 0.2 0.3 0.02 0.02 3 0.1 0.2 0.3 0.01 0.05
16 0.7 0.8 1.4 0.11 0.12 4 0.2 0.2 0.4 0.01 0.05
9 0.4 0.5 0.8 0.04 0.12 659 27.4 34.8 56.8 1.99 7.79 114 4.7 6.0 11.3 0.83 0.83 2 0.1 0.1 0.3 0.02 0.02
107 4.4 5.7 9.5 0.53 1.22 4 0.2 0.2 0.4 0.01 0.06 1 0.0 0.1 0.1 0.00 0.00
45 1.9 2.4 3.5 0.14 0.33 1 0.0 0.1 0.1 0.00 0.00 2 0.1 0.1 0.2 0.01 0.01
43 1.8 2.3 4.4 0.26 0.41 18 0.7 1.0 1.7 0.12 0.18 1 0.0 0.1 0.1 0.01 0.01 2 0.1 0.1 0.2 0.02 0.02
15 0.6 0.8 1.5 0.12 0.12 66 2.7 3.5 5.9 0.33 0.57 7 0.3 0.4 0.6 0.04 0.05
33 1.4 1.7 2.9 0.20 0.35 29 1.2 1.5 3.3 0.14 0.26 29 1.2 1.5 2.9 0.12 0.26 2 0.1 0.1 0.2 0.01 0.01 4 0.2 0.2 0.3 0.01 0.01 8 0.3 0.4 0.6 0.02 0.04
111 4.6 5.9 9.4 0.38 1.10 2612 138.0 225.1 10.13 26.14 2407 100.0 127.2 208.5 9.52 24.40
1 0.0 0.1 0.1 0.01 0.01 2 0.1 0.1 0.1 0.00 0.04 1 0.0 0.1 0.0 0.00 0.00 7 0.3 0.4 0.5 0.03 0.03 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
42 1.9 2.2 2.5 0.05 0.19 187 8.5 9.8 13.1 0.53 1.56 8 0.4 0.4 0.7 0.02 0.10
135 6.2 7.1 9.1 0.38 0.98 50 2.3 2.6 3.7 0.24 0.40 8 0.4 0.4 0.5 0.02 0.05
27 1.2 1.4 1.9 0.08 0.17 258 11.8 13.6 18.9 1.05 2.22 51 2.3 2.7 3.6 0.21 0.35 2 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
68 3.1 3.6 4.7 0.19 0.55 8 0.4 0.4 0.6 0.02 0.07
10 0.5 0.5 1.1 0.07 0.07 37 1.7 1.9 2.8 0.17 0.27
199 10.5 14.0 0.74 1.50 2 0.1 0.1 0.2 0.00 0.03 1 0.0 0.1 0.1 0.01 0.01
21 1.0 1.1 1.9 0.12 0.16 405 18.5 21.3 32.8 2.38 3.75 11 0.5 0.6 0.7 0.02 0.07 5 0.2 0.3 0.4 0.03 0.03
150 6.9 7.9 12.8 0.96 1.16 81 3.7 4.3 6.7 0.48 0.78 4 0.2 0.2 0.2 0.01 0.03
77 3.5 4.1 6.2 0.47 0.62 2 0.1 0.1 0.1 0.01 0.01 1 0.0 0.1 0.1 0.01 0.01
75 3.4 3.9 6.0 0.38 0.61 1 0.0 0.1 0.1 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
14 0.6 0.7 1.1 0.06 0.15 1 0.0 0.1 0.0 0.00 0.00 1 0.0 0.1 0.1 0.01 0.01
38 1.7 2.0 3.6 0.24 0.32 87 4.0 4.6 8.0 0.61 0.75 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 7 0.3 0.4 0.6 0.04 0.07
57 2.6 3.0 4.2 0.21 0.43 4 0.2 0.2 0.3 0.02 0.04
26 1.2 1.4 1.9 0.07 0.26 28 1.3 1.5 2.9 0.16 0.21 13 0.6 0.7 1.3 0.08 0.09 0 0.0 0.0 0.0 0.00 0.00
12 0.5 0.6 1.0 0.06 0.11 15 0.7 0.8 1.1 0.04 0.16
147 6.7 7.7 9.9 0.36 1.12 2388 125.6 182.3 10.65 19.55 2189 100.0 115.1 168.3 9.91 18.05
*See note following population pyramid
*Chile, Valdivia (2008–2012)
176
Central and South America
Colombia, BucaramangaCONTRIBUTORSClaudia Janeth UribeErika Eliana Meza Durán
Colombia, Bucaramanga (2008−2012)Average annual person−years by sex and age group
41 960 0- 40 003
44 124 5- 42 447
48 423 10- 46 470
49 659 15- 50 597
48 371 20- 48 574
46 530 25- 47 476
39 995 30- 42 393
34 938 35- 39 108
34 446 40- 40 255
32 559 45- 38 487
26 272 50- 31 622
20 505 55- 25 062
15 769 60- 19 836
11 902 65- 15 361
8 799 70- 12 347
5 952 75- 9 117
5 743 80+ 10 332
Total515 947 559 487Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 41.1Stomach 17.3Non-melanoma skin cancer 15.7Trachea, bronchus, and lung 10.4Colon 9.5Other and unspecified 7.3Non-Hodgkin lymphoma 5.4Bladder 5.0Rectum 5.0Brain and nervous system 4.3Kidney 4.0Liver 3.7Larynx 2.7Testis 2.6Myeloid leukaemia 2.6Lymphoid leukaemia 2.6Thyroid 2.5Melanoma of skin 2.4Leukaemia unspecified 2.2Pancreas 2.2
All sites 169.4
Breast 41.3Thyroid 14.4Cervix uteri 12.9Stomach 10.3Colon 9.9Non-melanoma skin cancer 8.7Ovary 7.0Corpus uteri 6.8Other and unspecified 6.8Trachea, bronchus, and lung 5.9Non-Hodgkin lymphoma 4.6Brain and nervous system 4.2Rectum 3.8Gallbladder etc. 2.7Lymphoid leukaemia 2.4Kidney 2.2Liver 2.0Pancreas 1.8Melanoma of skin 1.7Leukaemia unspecified 1.6
All sites 165.2
Colombia, Bucaramanga (2008−2012)Average annual person−years by sex and age group
41 960 0- 40 003
44 124 5- 42 447
48 423 10- 46 470
49 659 15- 50 597
48 371 20- 48 574
46 530 25- 47 476
39 995 30- 42 393
34 938 35- 39 108
34 446 40- 40 255
32 559 45- 38 487
26 272 50- 31 622
20 505 55- 25 062
15 769 60- 19 836
11 902 65- 15 361
8 799 70- 12 347
5 952 75- 9 117
5 743 80+ 10 332
Total515 947 559 487Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 41.1Stomach 17.3Non-melanoma skin cancer 15.7Trachea, bronchus, and lung 10.4Colon 9.5Other and unspecified 7.3Non-Hodgkin lymphoma 5.4Bladder 5.0Rectum 5.0Brain and nervous system 4.3Kidney 4.0Liver 3.7Larynx 2.7Testis 2.6Myeloid leukaemia 2.6Lymphoid leukaemia 2.6Thyroid 2.5Melanoma of skin 2.4Leukaemia unspecified 2.2Pancreas 2.2
All sites 169.4
Breast 41.3Thyroid 14.4Cervix uteri 12.9Stomach 10.3Colon 9.9Non-melanoma skin cancer 8.7Ovary 7.0Corpus uteri 6.8Other and unspecified 6.8Trachea, bronchus, and lung 5.9Non-Hodgkin lymphoma 4.6Brain and nervous system 4.2Rectum 3.8Gallbladder etc. 2.7Lymphoid leukaemia 2.4Kidney 2.2Liver 2.0Pancreas 1.8Melanoma of skin 1.7Leukaemia unspecified 1.6
All sites 165.2
Colombia, Bucaramanga (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation of the Metropolitan Area of Bucaramanga (Bucara-manga, Floridablanca, Girón, and Piedecuesta). National Administrative Department of Statistics (DANE), 2005 census. Population estimates and projections.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
177
Central and South America
Colombia, Bucaramanga (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
2 0.1 0.0 0.1 0.00 0.00 40 1.1 0.8 1.6 0.13 0.16 20 0.5 0.4 0.8 0.05 0.10 20 0.5 0.4 0.8 0.05 0.09 14 0.4 0.3 0.6 0.04 0.07 10 0.3 0.2 0.4 0.03 0.04 3 0.1 0.1 0.1 0.01 0.02 5 0.1 0.1 0.2 0.00 0.02 3 0.1 0.1 0.1 0.01 0.01
43 1.1 0.8 1.8 0.06 0.20 426 11.4 8.3 17.3 0.85 2.06 22 0.6 0.4 1.0 0.04 0.13
228 6.1 4.4 9.5 0.40 1.22 124 3.3 2.4 5.0 0.22 0.56 13 0.3 0.3 0.5 0.03 0.05 90 2.4 1.7 3.7 0.13 0.41 52 1.4 1.0 2.2 0.12 0.27 54 1.4 1.0 2.2 0.13 0.25 17 0.5 0.3 0.7 0.04 0.09 64 1.7 1.2 2.7 0.11 0.38
252 6.7 4.9 10.4 0.46 1.16 18 0.5 0.3 0.7 0.03 0.07 14 0.4 0.3 0.6 0.03 0.05 59 1.6 1.1 2.4 0.13 0.27
395 7.7 15.7 0.58 1.52 4 0.1 0.1 0.2 0.01 0.03
25 0.7 0.5 0.9 0.07 0.08 45 1.2 0.9 1.8 0.11 0.22 10 0.3 0.2 0.4 0.01 0.04
24 0.6 0.5 0.9 0.08 0.11 969 25.9 18.8 41.1 1.51 5.10 77 2.1 1.5 2.6 0.18 0.20 7 0.2 0.1 0.3 0.01 0.03
94 2.5 1.8 4.0 0.28 0.48 1 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
124 3.3 2.4 5.0 0.20 0.52 1 0.0 0.0 0.0 0.00 0.00
18 0.5 0.3 0.7 0.05 0.06 108 2.9 2.1 4.3 0.31 0.44 65 1.7 1.3 2.5 0.18 0.25 3 0.1 0.1 0.1 0.00 0.00 3 0.1 0.1 0.1 0.01 0.01
42 1.1 0.8 1.7 0.10 0.17 135 3.6 2.6 5.4 0.30 0.50 3 0.1 0.1 0.1 0.01 0.01
31 0.8 0.6 1.3 0.07 0.13 62 1.7 1.2 2.6 0.14 0.18 63 1.7 1.2 2.6 0.12 0.31 55 1.5 1.1 2.2 0.15 0.21 3 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
180 4.8 3.5 7.3 0.40 0.84 4140 80.2 169.4 7.95 19.11 3745 100.0 72.6 153.7 7.37 17.59
0 0.0 0.0 0.0 0.00 0.00 23 0.5 0.4 0.7 0.03 0.08 15 0.3 0.3 0.4 0.03 0.04 9 0.2 0.2 0.3 0.01 0.04 5 0.1 0.1 0.2 0.02 0.02 3 0.1 0.1 0.1 0.00 0.02 8 0.2 0.1 0.3 0.01 0.04 5 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
29 0.6 0.5 0.8 0.02 0.10 344 6.9 6.1 10.3 0.55 1.14 18 0.4 0.3 0.6 0.04 0.09
330 6.6 5.9 9.9 0.50 1.17 124 2.5 2.2 3.8 0.22 0.44 31 0.6 0.6 1.0 0.07 0.13 67 1.3 1.2 2.0 0.08 0.24 88 1.8 1.6 2.7 0.14 0.34 60 1.2 1.1 1.8 0.08 0.21 7 0.1 0.1 0.2 0.02 0.03 8 0.2 0.1 0.3 0.02 0.04
200 4.0 3.6 5.9 0.30 0.68 19 0.4 0.3 0.6 0.03 0.07 15 0.3 0.3 0.5 0.03 0.05 54 1.1 1.0 1.7 0.12 0.18
330 5.9 8.7 0.28 0.72 1 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.1 0.00 0.01
40 0.8 0.7 1.3 0.07 0.11 1295 26.1 23.1 41.3 3.07 4.75 20 0.4 0.4 0.6 0.04 0.06 13 0.3 0.2 0.4 0.03 0.03
417 8.4 7.5 12.9 0.95 1.33 210 4.2 3.8 6.8 0.51 0.80 8 0.2 0.1 0.2 0.01 0.02
216 4.3 3.9 7.0 0.56 0.77 4 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
64 1.3 1.1 2.2 0.12 0.22 1 0.0 0.0 0.0 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
46 0.9 0.8 1.3 0.05 0.14 1 0.0 0.0 0.0 0.00 0.00 9 0.2 0.2 0.3 0.02 0.03
125 2.5 2.2 4.2 0.26 0.41 452 9.1 8.1 14.4 1.23 1.42 2 0.0 0.0 0.1 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
30 0.6 0.5 1.0 0.06 0.08 143 2.9 2.6 4.6 0.26 0.45 2 0.0 0.0 0.1 0.01 0.01
29 0.6 0.5 1.0 0.07 0.13 60 1.2 1.1 2.4 0.12 0.17 42 0.8 0.8 1.4 0.07 0.14 47 0.9 0.8 1.6 0.09 0.14 3 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
224 4.5 4.0 6.8 0.35 0.74 5298 94.7 165.2 10.56 17.86 4968 100.0 88.8 156.5 10.28 17.14
§Includes 28 cases of unknown age §Includes 38 cases of unknown age
† See note following population pyramid
Colombia, Bucaramanga (2008–2012)
178
Central and South America
Colombia, CaliCONTRIBUTORSLuis Eduardo BravoEdwin CarrascalLuz Stella GarcíaPaola Andrea Collazos
Colombia, Cali (2008−2012)Average annual person−years by sex and age group
90 327 0- 86 254
91 638 5- 89 631
98 514 10- 95 768
102 375 15- 99 090
99 672 20- 99 482
93 596 25- 99 264
83 458 30- 90 885
74 433 35- 82 552
72 114 40- 83 434
68 051 45- 81 090
55 540 50- 69 257
43 504 55- 55 149
33 045 60- 42 120
24 251 65- 31 712
18 044 70- 26 063
12 473 75- 18 993
7 372 80- 11 112
5 109 85+ 9 325
Total1 073 516 1 171 181Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 60.1Stomach 20.3Trachea, bronchus, and lung 13.9Colon 10.5Other and unspecified 9.5Non-Hodgkin lymphoma 9.3Bladder 6.3Rectum 5.7Brain and nervous system 5.2Liver 5.0Kidney 5.0Pancreas 4.4Lymphoid leukaemia 4.1Larynx 4.0Myeloid leukaemia 3.3Thyroid 3.2Multiple myeloma 3.1Melanoma of skin 2.9Connective and soft tissue 2.6Testis 2.6
All sites 205.6
Breast 44.5Cervix uteri 15.4Thyroid 13.5Stomach 10.8Other and unspecified 9.8Colon 9.7Trachea, bronchus, and lung 8.0Ovary 7.8Non-Hodgkin lymphoma 7.1Corpus uteri 5.3Rectum 4.4Brain and nervous system 4.3Lymphoid leukaemia 3.7Gallbladder etc. 3.7Pancreas 3.6Liver 3.2Kidney 3.1Melanoma of skin 2.7Myeloid leukaemia 2.7Connective and soft tissue 2.2
All sites 186.4
Colombia, Cali (2008−2012)Average annual person−years by sex and age group
90 327 0- 86 254
91 638 5- 89 631
98 514 10- 95 768
102 375 15- 99 090
99 672 20- 99 482
93 596 25- 99 264
83 458 30- 90 885
74 433 35- 82 552
72 114 40- 83 434
68 051 45- 81 090
55 540 50- 69 257
43 504 55- 55 149
33 045 60- 42 120
24 251 65- 31 712
18 044 70- 26 063
12 473 75- 18 993
7 372 80- 11 112
5 109 85+ 9 325
Total1 073 516 1 171 181Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 60.1Stomach 20.3Trachea, bronchus, and lung 13.9Colon 10.5Other and unspecified 9.5Non-Hodgkin lymphoma 9.3Bladder 6.3Rectum 5.7Brain and nervous system 5.2Liver 5.0Kidney 5.0Pancreas 4.4Lymphoid leukaemia 4.1Larynx 4.0Myeloid leukaemia 3.3Thyroid 3.2Multiple myeloma 3.1Melanoma of skin 2.9Connective and soft tissue 2.6Testis 2.6
All sites 205.6
Breast 44.5Cervix uteri 15.4Thyroid 13.5Stomach 10.8Other and unspecified 9.8Colon 9.7Trachea, bronchus, and lung 8.0Ovary 7.8Non-Hodgkin lymphoma 7.1Corpus uteri 5.3Rectum 4.4Brain and nervous system 4.3Lymphoid leukaemia 3.7Gallbladder etc. 3.7Pancreas 3.6Liver 3.2Kidney 3.1Melanoma of skin 2.7Myeloid leukaemia 2.7Connective and soft tissue 2.2
All sites 186.4
Colombia, Cali (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONNational Administrative Department of Statistics (DANE). Estimates and projections of the total national, departmental, and municipal population by area, 1985–2020.
179
Central and South America
Colombia, Cali (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
10 0.1 0.1 0.2 0.01 0.02 64 0.6 0.6 1.3 0.07 0.15 56 0.5 0.5 1.1 0.07 0.13 48 0.5 0.4 0.9 0.04 0.09 44 0.4 0.4 0.8 0.07 0.11 14 0.1 0.1 0.3 0.02 0.04 32 0.3 0.3 0.6 0.04 0.07 3 0.0 0.0 0.1 0.00 0.01 7 0.1 0.1 0.1 0.01 0.02
90 0.9 0.8 1.7 0.06 0.18 1041 10.0 9.7 20.3 0.96 2.34 39 0.4 0.4 0.7 0.04 0.08
539 5.2 5.0 10.5 0.50 1.24 293 2.8 2.7 5.7 0.33 0.67 47 0.5 0.4 0.9 0.06 0.11
249 2.4 2.3 5.0 0.20 0.56 119 1.1 1.1 2.3 0.10 0.26 222 2.1 2.1 4.4 0.19 0.52 39 0.4 0.4 0.7 0.04 0.06
201 1.9 1.9 4.0 0.18 0.50 697 6.7 6.5 13.9 0.48 1.72 35 0.3 0.3 0.6 0.03 0.06 85 0.8 0.8 1.6 0.09 0.14
151 1.5 1.4 2.9 0.16 0.31 34 0.3 0.6 0.02 0.06 9 0.1 0.1 0.2 0.01 0.02
92 0.9 0.9 1.6 0.09 0.13 136 1.3 1.3 2.6 0.16 0.26 26 0.3 0.2 0.5 0.02 0.04
74 0.7 0.7 1.3 0.08 0.12 2937 28.2 27.4 60.1 2.13 7.74 154 1.5 1.4 2.6 0.19 0.20 8 0.1 0.1 0.2 0.01 0.02
243 2.3 2.3 5.0 0.32 0.59 7 0.1 0.1 0.2 0.01 0.02 1 0.0 0.0 0.0 0.00 0.00
319 3.1 3.0 6.3 0.22 0.74 3 0.0 0.0 0.0 0.00 0.00
46 0.4 0.4 0.9 0.04 0.08 271 2.6 2.5 5.2 0.32 0.50 173 1.7 1.6 3.2 0.24 0.35 9 0.1 0.1 0.2 0.01 0.01
13 0.1 0.1 0.3 0.02 0.02 91 0.9 0.8 1.7 0.09 0.16
481 4.6 4.5 9.3 0.53 0.99 21 0.2 0.2 0.4 0.02 0.05
157 1.5 1.5 3.1 0.20 0.37 209 2.0 1.9 4.1 0.20 0.33 171 1.6 1.6 3.3 0.16 0.31 50 0.5 0.5 0.9 0.04 0.08 39 0.4 0.4 0.7 0.03 0.07 50 0.5 0.5 1.0 0.03 0.08
483 4.6 4.5 9.5 0.43 1.07 10432 97.2 205.6 9.36 23.80 10398 100.0 96.9 205.0 9.34 23.74
9 0.1 0.1 0.1 0.01 0.01 65 0.5 0.6 1.0 0.05 0.11 48 0.4 0.4 0.7 0.04 0.08 64 0.5 0.5 0.9 0.05 0.10 23 0.2 0.2 0.3 0.03 0.03 3 0.0 0.0 0.1 0.00 0.01
17 0.1 0.1 0.2 0.02 0.02 3 0.0 0.0 0.0 0.00 0.01 1 0.0 0.0 0.0 0.00 0.00
72 0.6 0.6 1.0 0.04 0.12 769 6.1 6.6 10.8 0.50 1.16 37 0.3 0.3 0.5 0.03 0.06
686 5.5 5.9 9.7 0.46 1.07 310 2.5 2.6 4.4 0.24 0.50 126 1.0 1.1 1.9 0.12 0.27 222 1.8 1.9 3.2 0.11 0.36 260 2.1 2.2 3.7 0.16 0.42 257 2.0 2.2 3.6 0.13 0.44 18 0.1 0.2 0.3 0.02 0.02 37 0.3 0.3 0.6 0.04 0.07
568 4.5 4.8 8.0 0.35 0.89 21 0.2 0.2 0.3 0.02 0.04 83 0.7 0.7 1.3 0.08 0.12
180 1.4 1.5 2.7 0.18 0.30 47 0.4 0.7 0.05 0.07 7 0.1 0.1 0.1 0.01 0.01
10 0.1 0.1 0.1 0.01 0.01 140 1.1 1.2 2.2 0.13 0.21
2972 23.7 25.4 44.5 3.20 5.01 60 0.5 0.5 0.8 0.04 0.08 43 0.3 0.4 0.6 0.03 0.08
1037 8.3 8.9 15.4 1.17 1.62 347 2.8 3.0 5.3 0.36 0.66 37 0.3 0.3 0.5 0.03 0.05
514 4.1 4.4 7.8 0.54 0.87 16 0.1 0.1 0.3 0.02 0.03 8 0.1 0.1 0.1 0.01 0.01
204 1.6 1.7 3.1 0.19 0.35 3 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00
121 1.0 1.0 1.6 0.06 0.17 4 0.0 0.0 0.1 0.00 0.01
37 0.3 0.3 0.6 0.02 0.05 268 2.1 2.3 4.3 0.25 0.43 893 7.1 7.6 13.5 1.05 1.42 13 0.1 0.1 0.3 0.01 0.02 4 0.0 0.0 0.1 0.01 0.01
63 0.5 0.5 1.0 0.06 0.08 485 3.9 4.1 7.1 0.39 0.77 24 0.2 0.2 0.4 0.03 0.04
144 1.1 1.2 2.1 0.12 0.26 217 1.7 1.9 3.7 0.19 0.29 175 1.4 1.5 2.7 0.15 0.28 44 0.4 0.4 0.6 0.03 0.08 46 0.4 0.4 0.7 0.03 0.07 67 0.5 0.6 0.9 0.03 0.08
679 5.4 5.8 9.8 0.46 1.10 12610 107.7 186.4 11.37 20.45 12563 100.0 107.3 185.7 11.32 20.38
§Includes 47 cases of unknown age §Includes 86 cases of unknown age
Colombia, Cali (2008–2012)
180
Central and South America
Colombia, ManizalesCONTRIBUTORSNelson Arias-OrtizGuillermo López-GuarnizoDaniela Morantes-Arenas
Colombia, Manizales (2008−2012)Average annual person−years by sex and age group
13 636 0- 13 078
14 025 5- 13 590
15 370 10- 14 679
17 140 15- 16 573
19 965 20- 18 770
16 074 25- 16 272
12 659 30- 13 686
10 950 35- 12 879
11 682 40- 14 729
11 957 45- 14 879
10 962 50- 13 959
9 272 55- 11 837
7 078 60- 8 794
5 032 65- 6 559
3 664 70- 5 232
2 524 75- 3 856
2 774 80+ 4 309
Total184 764 203 681Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*High M/I ratios.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 44.1Stomach 20.3Trachea, bronchus, and lung 10.3Colon 8.4Non-melanoma skin cancer 7.0Non-Hodgkin lymphoma 6.9Rectum 6.3Other and unspecified 5.9Thyroid 4.6Bladder 4.3Larynx 4.1Testis 4.0Kidney 3.7Brain and nervous system 3.3Lymphoid leukaemia 3.2Oesophagus 3.2Melanoma of skin 2.6Pancreas 2.3Connective and soft tissue 1.9Liver 1.8
All sites 163.0
Breast 37.2Thyroid 23.2Cervix uteri 17.5Colon 10.0Stomach 9.7Non-Hodgkin lymphoma 6.5Trachea, bronchus, and lung 6.4Corpus uteri 6.1Other and unspecified 5.5Non-melanoma skin cancer 5.4Ovary 5.0Rectum 4.7Gallbladder etc. 3.3Melanoma of skin 2.9Pancreas 2.3Bladder 2.0Lymphoid leukaemia 1.8Hodgkin lymphoma 1.7Myeloid leukaemia 1.7Brain and nervous system 1.6
All sites 170.2
Colombia, Manizales (2008−2012)Average annual person−years by sex and age group
13 636 0- 13 078
14 025 5- 13 590
15 370 10- 14 679
17 140 15- 16 573
19 965 20- 18 770
16 074 25- 16 272
12 659 30- 13 686
10 950 35- 12 879
11 682 40- 14 729
11 957 45- 14 879
10 962 50- 13 959
9 272 55- 11 837
7 078 60- 8 794
5 032 65- 6 559
3 664 70- 5 232
2 524 75- 3 856
2 774 80+ 4 309
Total184 764 203 681Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*High M/I ratios.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 44.1Stomach 20.3Trachea, bronchus, and lung 10.3Colon 8.4Non-melanoma skin cancer 7.0Non-Hodgkin lymphoma 6.9Rectum 6.3Other and unspecified 5.9Thyroid 4.6Bladder 4.3Larynx 4.1Testis 4.0Kidney 3.7Brain and nervous system 3.3Lymphoid leukaemia 3.2Oesophagus 3.2Melanoma of skin 2.6Pancreas 2.3Connective and soft tissue 1.9Liver 1.8
All sites 163.0
Breast 37.2Thyroid 23.2Cervix uteri 17.5Colon 10.0Stomach 9.7Non-Hodgkin lymphoma 6.5Trachea, bronchus, and lung 6.4Corpus uteri 6.1Other and unspecified 5.5Non-melanoma skin cancer 5.4Ovary 5.0Rectum 4.7Gallbladder etc. 3.3Melanoma of skin 2.9Pancreas 2.3Bladder 2.0Lymphoid leukaemia 1.8Hodgkin lymphoma 1.7Myeloid leukaemia 1.7Brain and nervous system 1.6
All sites 170.2
Colombia, Manizales (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the population projections provided by the National Administrative Department of Statistics (DANE), 2005 national census.
NOTES ON THE DATA*High M:I ratios.
181
Central and South America
*Colombia, Manizales (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.1 0.1 0.1 0.01 0.01 5 0.3 0.3 0.4 0.03 0.03 3 0.2 0.2 0.3 0.01 0.06 6 0.4 0.3 0.6 0.02 0.07 4 0.3 0.2 0.4 0.05 0.05 1 0.1 0.1 0.1 0.01 0.01 2 0.1 0.1 0.2 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
33 2.1 1.8 3.2 0.19 0.34 212 13.4 11.5 20.3 1.13 2.38 9 0.6 0.5 0.9 0.05 0.11
90 5.7 4.9 8.4 0.46 0.85 65 4.1 3.5 6.3 0.35 0.72 8 0.5 0.4 0.7 0.04 0.04
18 1.1 1.0 1.8 0.09 0.21 11 0.7 0.6 1.1 0.06 0.16 23 1.4 1.2 2.3 0.12 0.33 3 0.2 0.2 0.3 0.01 0.03
41 2.6 2.2 4.1 0.17 0.57 105 6.6 5.7 10.3 0.47 1.17 2 0.1 0.1 0.2 0.01 0.04 9 0.6 0.5 0.9 0.06 0.10
28 1.8 1.5 2.6 0.16 0.26 75 4.1 7.0 0.27 0.78 1 0.1 0.1 0.1 0.00 0.02 4 0.3 0.2 0.4 0.04 0.04
19 1.2 1.0 1.9 0.14 0.19 0 0.0 0.0 0.0 0.00 0.00
9 0.6 0.5 0.8 0.03 0.08 448 28.2 24.2 44.1 1.56 5.75 41 2.6 2.2 4.0 0.28 0.33 2 0.1 0.1 0.2 0.01 0.01
37 2.3 2.0 3.7 0.17 0.46 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
45 2.8 2.4 4.3 0.21 0.47 0 0.0 0.0 0.0 0.00 0.00 6 0.4 0.3 0.8 0.05 0.05
31 2.0 1.7 3.3 0.25 0.32 47 3.0 2.5 4.6 0.33 0.52 3 0.2 0.2 0.3 0.03 0.06 2 0.1 0.1 0.2 0.02 0.02
17 1.1 0.9 1.7 0.10 0.17 69 4.3 3.7 6.9 0.52 0.78 3 0.2 0.2 0.3 0.01 0.05
10 0.6 0.5 1.0 0.05 0.12 30 1.9 1.6 3.2 0.16 0.22 15 0.9 0.8 1.4 0.06 0.14 7 0.4 0.4 0.7 0.02 0.07 0 0.0 0.0 0.0 0.00 0.00 3 0.2 0.2 0.3 0.01 0.04
60 3.8 3.2 5.9 0.37 0.64 1663 90.0 163.0 8.21 18.86 1588 100.0 85.9 156.0 7.94 18.09
0 0.0 0.0 0.0 0.00 0.00 6 0.3 0.3 0.5 0.02 0.08 9 0.4 0.4 0.6 0.03 0.07 8 0.4 0.4 0.6 0.04 0.07 3 0.1 0.1 0.2 0.01 0.01 1 0.0 0.0 0.1 0.00 0.02 1 0.0 0.0 0.1 0.01 0.01 1 0.0 0.0 0.1 0.00 0.02 1 0.0 0.0 0.1 0.00 0.00
22 1.0 1.1 1.4 0.04 0.15 134 6.2 6.6 9.7 0.52 1.06 8 0.4 0.4 0.6 0.03 0.07
138 6.4 6.8 10.0 0.55 1.19 65 3.0 3.2 4.7 0.26 0.54 14 0.6 0.7 1.0 0.05 0.12 13 0.6 0.6 0.9 0.02 0.11 46 2.1 2.3 3.3 0.17 0.39 35 1.6 1.7 2.3 0.11 0.25 2 0.1 0.1 0.1 0.01 0.01
13 0.6 0.6 0.9 0.04 0.09 89 4.1 4.4 6.4 0.36 0.73 5 0.2 0.2 0.4 0.03 0.05 8 0.4 0.4 0.7 0.05 0.05
38 1.8 1.9 2.9 0.21 0.32 79 3.9 5.4 0.22 0.58 2 0.1 0.1 0.2 0.01 0.01 1 0.0 0.0 0.1 0.01 0.01
12 0.6 0.6 1.0 0.04 0.12 489 22.6 24.0 37.2 2.77 4.14 10 0.5 0.5 0.7 0.01 0.14 6 0.3 0.3 0.4 0.02 0.06
222 10.3 10.9 17.5 1.29 1.85 80 3.7 3.9 6.1 0.46 0.77 13 0.6 0.6 1.0 0.06 0.14 64 3.0 3.1 5.0 0.39 0.56 2 0.1 0.1 0.2 0.01 0.03 1 0.0 0.0 0.1 0.01 0.01
20 0.9 1.0 1.5 0.10 0.17 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
27 1.2 1.3 2.0 0.12 0.28 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.1 0.01 0.01
18 0.8 0.9 1.6 0.11 0.13 285 13.2 14.0 23.2 1.83 2.36 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.2 0.00 0.02
19 0.9 0.9 1.7 0.12 0.14 80 3.7 3.9 6.5 0.39 0.75 5 0.2 0.2 0.3 0.01 0.01
16 0.7 0.8 1.1 0.08 0.09 19 0.9 0.9 1.8 0.11 0.19 19 0.9 0.9 1.7 0.09 0.16 9 0.4 0.4 0.6 0.03 0.07 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.2 0.01 0.01
76 3.5 3.7 5.5 0.31 0.58 2241 110.0 170.2 11.16 18.77 2162 100.0 106.1 164.8 10.94 18.19
*See note following population pyramid
*Colombia, Manizales (2008–2012)
182
Central and South America
Colombia, PastoCONTRIBUTORSMaría Clara YépezDaniel JuradoLuisa Mercedes Bravo
Colombia, Pasto (2008−2012)Average annual person−years by sex and age group
16 477 0- 15 793
17 288 5- 17 326
18 844 10- 18 817
19 169 15- 18 174
18 550 20- 18 633
18 434 25- 19 242
16 068 30- 17 480
13 313 35- 15 935
13 217 40- 15 608
11 530 45- 13 698
9 198 50- 11 227
7 250 55- 8 925
5 920 60- 6 911
4 523 65- 5 486
3 333 70- 4 251
2 331 75- 3 297
1 398 80- 1 978
966 85+ 1 074
Total197 809 213 855Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 30.8Prostate 27.1Stomach 26.5Non-Hodgkin lymphoma 8.8Other and unspecified 7.1Trachea, bronchus, and lung 6.8Colon 4.5Lymphoid leukaemia 3.8Rectum 3.8Brain and nervous system 3.7Testis 3.6Bladder 3.5Melanoma of skin 3.0Pancreas 2.8Thyroid 2.6Liver 2.6Gallbladder etc. 2.5Multiple myeloma 2.5Connective and soft tissue 2.1Kidney 2.0
All sites 164.9
Non-melanoma skin cancer 39.4Breast 27.8Cervix uteri 18.1Stomach 11.9Thyroid 11.8Other and unspecified 9.1Ovary 7.3Colon 5.4Trachea, bronchus, and lung 5.0Non-Hodgkin lymphoma 4.9Gallbladder etc. 4.2Brain and nervous system 4.2Corpus uteri 4.1Melanoma of skin 3.9Pancreas 3.7Rectum 3.6Liver 2.7Lymphoid leukaemia 2.2Bladder 1.6Kidney 1.5
All sites 184.9
Colombia, Pasto (2008−2012)Average annual person−years by sex and age group
16 477 0- 15 793
17 288 5- 17 326
18 844 10- 18 817
19 169 15- 18 174
18 550 20- 18 633
18 434 25- 19 242
16 068 30- 17 480
13 313 35- 15 935
13 217 40- 15 608
11 530 45- 13 698
9 198 50- 11 227
7 250 55- 8 925
5 920 60- 6 911
4 523 65- 5 486
3 333 70- 4 251
2 331 75- 3 297
1 398 80- 1 978
966 85+ 1 074
Total197 809 213 855Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleNon-melanoma skin cancer 30.8Prostate 27.1Stomach 26.5Non-Hodgkin lymphoma 8.8Other and unspecified 7.1Trachea, bronchus, and lung 6.8Colon 4.5Lymphoid leukaemia 3.8Rectum 3.8Brain and nervous system 3.7Testis 3.6Bladder 3.5Melanoma of skin 3.0Pancreas 2.8Thyroid 2.6Liver 2.6Gallbladder etc. 2.5Multiple myeloma 2.5Connective and soft tissue 2.1Kidney 2.0
All sites 164.9
Non-melanoma skin cancer 39.4Breast 27.8Cervix uteri 18.1Stomach 11.9Thyroid 11.8Other and unspecified 9.1Ovary 7.3Colon 5.4Trachea, bronchus, and lung 5.0Non-Hodgkin lymphoma 4.9Gallbladder etc. 4.2Brain and nervous system 4.2Corpus uteri 4.1Melanoma of skin 3.9Pancreas 3.7Rectum 3.6Liver 2.7Lymphoid leukaemia 2.2Bladder 1.6Kidney 1.5
All sites 184.9
Colombia, Pasto (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation data of Pasto 2008–2012 estimated by the National Administrative Department of Statistics (DANE) using the information from the 2005 census about basic components of population dynamics: fertility, mortality, and migration (internal and international). The data were adjusted through censal conciliation with the 1985 and 1993 censuses and projected until 2020. DANE: Estimates and Projections for the Population, Period 1985–2020. Consulted April 2015.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
183
Central and South America
Colombia, Pasto (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 2 0.2 0.1 0.2 0.01 0.01 3 0.2 0.2 0.3 0.01 0.04 5 0.4 0.3 0.6 0.04 0.04 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
15 1.2 0.8 1.5 0.05 0.13 247 19.7 12.5 26.5 1.23 2.97 4 0.3 0.2 0.5 0.04 0.07
43 3.4 2.2 4.5 0.20 0.45 34 2.7 1.7 3.8 0.21 0.50 2 0.2 0.1 0.2 0.00 0.02
26 2.1 1.3 2.6 0.08 0.21 22 1.8 1.1 2.5 0.16 0.33 24 1.9 1.2 2.8 0.15 0.36 4 0.3 0.2 0.5 0.01 0.08
12 1.0 0.6 1.4 0.06 0.19 59 4.7 3.0 6.8 0.32 0.90 3 0.2 0.2 0.3 0.01 0.04 5 0.4 0.3 0.5 0.03 0.03
28 2.2 1.4 3.0 0.16 0.36 283 14.3 30.8 1.48 3.37 3 0.2 0.2 0.3 0.02 0.05 8 0.6 0.4 0.8 0.03 0.09
19 1.5 1.0 2.1 0.15 0.26 3 0.2 0.2 0.4 0.02 0.04
18 1.4 0.9 1.9 0.14 0.23 248 19.8 12.5 27.1 1.04 3.01 41 3.3 2.1 3.6 0.28 0.28 1 0.1 0.1 0.1 0.00 0.00
16 1.3 0.8 2.0 0.11 0.21 1 0.1 0.1 0.1 0.00 0.02 0 0.0 0.0 0.0 0.00 0.00
33 2.6 1.7 3.5 0.15 0.37 1 0.1 0.1 0.1 0.01 0.01 5 0.4 0.3 0.6 0.03 0.05
35 2.8 1.8 3.7 0.25 0.31 28 2.2 1.4 2.6 0.19 0.23 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
14 1.1 0.7 1.5 0.11 0.17 82 6.6 4.1 8.8 0.41 0.98 1 0.1 0.1 0.1 0.01 0.01
23 1.8 1.2 2.5 0.17 0.28 35 2.8 1.8 3.8 0.17 0.28 15 1.2 0.8 1.6 0.09 0.23 4 0.3 0.2 0.4 0.03 0.03 3 0.2 0.2 0.3 0.01 0.03 9 0.7 0.5 0.8 0.01 0.04
66 5.3 3.3 7.1 0.24 0.77 1534 77.5 164.9 7.96 18.10 1251 100.0 63.2 134.1 6.47 14.73
0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.2 0.3 0.01 0.03 1 0.1 0.0 0.1 0.01 0.01 1 0.1 0.0 0.1 0.01 0.01 1 0.1 0.0 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
11 0.7 0.5 1.0 0.01 0.14 138 8.3 6.5 11.9 0.55 1.39 6 0.4 0.3 0.6 0.03 0.08
62 3.7 2.9 5.4 0.30 0.60 42 2.5 2.0 3.6 0.23 0.39 6 0.4 0.3 0.5 0.02 0.07
32 1.9 1.5 2.7 0.14 0.20 49 2.9 2.3 4.2 0.18 0.50 41 2.5 1.9 3.7 0.14 0.48 2 0.1 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
59 3.5 2.8 5.0 0.18 0.65 3 0.2 0.1 0.3 0.01 0.04 8 0.5 0.4 0.7 0.04 0.04
44 2.6 2.1 3.9 0.23 0.47 460 21.5 39.4 1.72 4.36 1 0.1 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
11 0.7 0.5 0.9 0.04 0.06 313 18.8 14.6 27.8 1.98 3.14 6 0.4 0.3 0.5 0.00 0.04 3 0.2 0.1 0.3 0.02 0.02
211 12.7 9.9 18.1 1.35 1.96 43 2.6 2.0 4.1 0.28 0.55 3 0.2 0.1 0.3 0.02 0.02
84 5.0 3.9 7.3 0.52 0.79 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.0 0.1 0.01 0.01
15 0.9 0.7 1.5 0.12 0.16 1 0.1 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
19 1.1 0.9 1.6 0.05 0.14 1 0.1 0.0 0.1 0.00 0.00 2 0.1 0.1 0.2 0.01 0.01
46 2.8 2.2 4.2 0.30 0.39 139 8.3 6.5 11.8 0.87 1.18 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.2 0.02 0.02
12 0.7 0.6 1.1 0.06 0.13 59 3.5 2.8 4.9 0.28 0.45 2 0.1 0.1 0.2 0.02 0.02
16 1.0 0.7 1.4 0.12 0.16 23 1.4 1.1 2.2 0.11 0.19 16 1.0 0.7 1.4 0.07 0.17 6 0.4 0.3 0.5 0.01 0.05 8 0.5 0.4 0.6 0.01 0.06
13 0.8 0.6 1.0 0.02 0.06
101 6.1 4.7 9.1 0.37 1.08 2127 99.5 184.9 10.51 20.31 1667 100.0 77.9 145.6 8.78 15.95
§Includes 1 case of unknown age §Includes 3 cases of unknown age
† See note following population pyramid
Colombia, Pasto (2008–2012)
184
Central and South America
Costa RicaCONTRIBUTORSMaría Ethel Trejos S.Rosa María Vargas A.Guillermo Torres A.Bernardo Moreira M.María Guevara O.
Costa Rica (2008−2011)Average annual person−years by sex and age group
180 740 0- 172 275
191 908 5- 182 352
208 603 10- 197 574
220 167 15- 208 382
224 185 20- 213 446
205 814 25- 196 071
181 599 30- 172 650
158 527 35- 152 232
158 493 40- 153 351
149 092 45- 145 515
123 442 50- 121 194
93 059 55- 93 231
67 256 60- 68 891
47 939 65- 50 934
35 896 70- 39 509
25 131 75- 29 785
16 257 80- 20 591
11 939 85+ 16 864
Total2 300 047 2 234 847Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 54.2Non-melanoma skin cancer 53.0Stomach 20.9Other and unspecified 11.8Colon 9.5Trachea, bronchus, and lung 8.8Non-Hodgkin lymphoma 7.1Bladder 5.3Liver 5.3Rectum 5.2Kidney 3.9Brain and nervous system 3.7Testis 3.6Pancreas 3.5Lymphoid leukaemia 3.2Thyroid 3.1Larynx 2.7Melanoma of skin 2.3Hodgkin lymphoma 2.1Oesophagus 1.8
All sites 226.8
Non-melanoma skin cancer 45.1Breast 42.3Thyroid 18.5Cervix uteri 13.2Stomach 12.7Colon 10.0Other and unspecified 9.9Corpus uteri 7.2Ovary 5.3Non-Hodgkin lymphoma 5.1Trachea, bronchus, and lung 4.3Rectum 4.0Liver 3.6Pancreas 3.1Brain and nervous system 2.9Kidney 2.5Lymphoid leukaemia 2.4Melanoma of skin 2.1Connective and soft tissue 2.0Gallbladder etc. 1.9
All sites 212.1
Costa Rica (2008−2011)Average annual person−years by sex and age group
180 740 0- 172 275
191 908 5- 182 352
208 603 10- 197 574
220 167 15- 208 382
224 185 20- 213 446
205 814 25- 196 071
181 599 30- 172 650
158 527 35- 152 232
158 493 40- 153 351
149 092 45- 145 515
123 442 50- 121 194
93 059 55- 93 231
67 256 60- 68 891
47 939 65- 50 934
35 896 70- 39 509
25 131 75- 29 785
16 257 80- 20 591
11 939 85+ 16 864
Total2 300 047 2 234 847Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 54.2Non-melanoma skin cancer 53.0Stomach 20.9Other and unspecified 11.8Colon 9.5Trachea, bronchus, and lung 8.8Non-Hodgkin lymphoma 7.1Bladder 5.3Liver 5.3Rectum 5.2Kidney 3.9Brain and nervous system 3.7Testis 3.6Pancreas 3.5Lymphoid leukaemia 3.2Thyroid 3.1Larynx 2.7Melanoma of skin 2.3Hodgkin lymphoma 2.1Oesophagus 1.8
All sites 226.8
Non-melanoma skin cancer 45.1Breast 42.3Thyroid 18.5Cervix uteri 13.2Stomach 12.7Colon 10.0Other and unspecified 9.9Corpus uteri 7.2Ovary 5.3Non-Hodgkin lymphoma 5.1Trachea, bronchus, and lung 4.3Rectum 4.0Liver 3.6Pancreas 3.1Brain and nervous system 2.9Kidney 2.5Lymphoid leukaemia 2.4Melanoma of skin 2.1Connective and soft tissue 2.0Gallbladder etc. 1.9
All sites 212.1
Costa Rica (2008–2011)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation projections and estimates, National Institute of Statistics and Census (INEC), 1950–2050.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
185
Central and South America
Costa Rica (2008−2011)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
3 0.0 0.0 0.0 0.00 0.00 61 0.4 0.3 0.7 0.04 0.08 72 0.5 0.4 0.9 0.04 0.11 69 0.5 0.4 0.8 0.02 0.08 45 0.3 0.2 0.5 0.05 0.06 13 0.1 0.1 0.1 0.01 0.01 55 0.4 0.3 0.6 0.04 0.05 19 0.1 0.1 0.2 0.01 0.02 12 0.1 0.1 0.1 0.01 0.01
151 1.0 0.8 1.8 0.06 0.21 1811 12.3 9.8 20.9 0.90 2.41 56 0.4 0.3 0.7 0.03 0.09
824 5.6 4.5 9.5 0.45 1.09 442 3.0 2.4 5.2 0.28 0.60 31 0.2 0.2 0.4 0.02 0.04
439 3.0 2.4 5.3 0.22 0.63 108 0.7 0.6 1.3 0.06 0.15 299 2.0 1.6 3.5 0.14 0.39 26 0.2 0.1 0.3 0.02 0.03
229 1.6 1.2 2.7 0.12 0.36 733 5.0 4.0 8.8 0.33 1.07 37 0.3 0.2 0.4 0.02 0.03 98 0.7 0.5 1.1 0.07 0.09
205 1.4 1.1 2.3 0.12 0.26 4586 24.9 53.0 2.29 5.87
8 0.1 0.0 0.1 0.01 0.01 38 0.3 0.2 0.4 0.03 0.03
159 1.1 0.9 1.8 0.10 0.21 38 0.3 0.2 0.4 0.02 0.05
111 0.8 0.6 1.3 0.07 0.13 4368 29.6 23.7 54.2 2.08 6.91 379 2.6 2.1 3.6 0.25 0.26 5 0.0 0.0 0.1 0.00 0.01
328 2.2 1.8 3.9 0.24 0.44 3 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
447 3.0 2.4 5.3 0.19 0.59 0 0.0 0.0 0.0 0.00 0.00
49 0.3 0.3 0.6 0.03 0.05 325 2.2 1.8 3.7 0.24 0.35 296 2.0 1.6 3.1 0.24 0.32 15 0.1 0.1 0.2 0.01 0.01 8 0.1 0.0 0.1 0.00 0.01
197 1.3 1.1 2.1 0.14 0.18 614 4.2 3.3 7.1 0.40 0.77 12 0.1 0.1 0.1 0.01 0.02 82 0.6 0.4 1.0 0.03 0.11
254 1.7 1.4 3.2 0.17 0.21 132 0.9 0.7 1.5 0.08 0.15 13 0.1 0.1 0.1 0.01 0.01 2 0.0 0.0 0.0 0.00 0.00 4 0.0 0.0 0.0 0.00 0.01
1028 7.0 5.6 11.8 0.56 1.26 19339 105.1 226.8 10.25 25.86 14753 100.0 80.2 173.9 7.96 19.99
2 0.0 0.0 0.0 0.00 0.00 48 0.3 0.3 0.5 0.03 0.06 44 0.3 0.2 0.4 0.02 0.05 51 0.3 0.3 0.5 0.03 0.05 10 0.1 0.1 0.1 0.01 0.02 4 0.0 0.0 0.1 0.00 0.00
26 0.2 0.1 0.3 0.02 0.03 3 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
61 0.4 0.3 0.6 0.02 0.06 1231 7.9 6.9 12.7 0.64 1.39 45 0.3 0.3 0.5 0.02 0.06
932 6.0 5.2 10.0 0.53 1.18 377 2.4 2.1 4.0 0.25 0.42 42 0.3 0.2 0.5 0.02 0.05
338 2.2 1.9 3.6 0.16 0.39 180 1.2 1.0 1.9 0.09 0.23 304 2.0 1.7 3.1 0.12 0.33 21 0.1 0.1 0.2 0.01 0.02 33 0.2 0.2 0.4 0.02 0.04
395 2.5 2.2 4.3 0.19 0.51 17 0.1 0.1 0.2 0.01 0.01 87 0.6 0.5 1.0 0.07 0.09
201 1.3 1.1 2.1 0.14 0.21 4357 24.4 45.1 2.21 4.84
4 0.0 0.0 0.0 0.00 0.00 5 0.0 0.0 0.0 0.00 0.00
188 1.2 1.1 2.0 0.13 0.19 3843 24.7 21.5 42.3 3.02 4.88 70 0.4 0.4 0.7 0.03 0.09 59 0.4 0.3 0.6 0.04 0.07
1284 8.3 7.2 13.2 0.99 1.26 639 4.1 3.6 7.2 0.53 0.89 61 0.4 0.3 0.6 0.04 0.06
493 3.2 2.8 5.3 0.37 0.57 10 0.1 0.1 0.1 0.01 0.01 12 0.1 0.1 0.1 0.01 0.01
218 1.4 1.2 2.5 0.17 0.30 6 0.0 0.0 0.1 0.00 0.01 1 0.0 0.0 0.0 0.00 0.00
160 1.0 0.9 1.6 0.06 0.16 4 0.0 0.0 0.0 0.00 0.00
34 0.2 0.2 0.5 0.02 0.03 253 1.6 1.4 2.9 0.19 0.30
1762 11.3 9.9 18.5 1.53 1.84 26 0.2 0.1 0.3 0.01 0.02 9 0.1 0.1 0.1 0.00 0.01
170 1.1 1.0 1.7 0.11 0.14 462 3.0 2.6 5.1 0.29 0.61 14 0.1 0.1 0.1 0.01 0.01 54 0.3 0.3 0.6 0.03 0.08
183 1.2 1.0 2.4 0.13 0.15 111 0.7 0.6 1.2 0.07 0.12 12 0.1 0.1 0.1 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00
962 6.2 5.4 9.9 0.51 0.99 19920 111.4 212.1 12.94 22.89 15563 100.0 87.0 167.0 10.73 18.06
† See note following population pyramid
Costa Rica (2008–2011)
186
Central and South America
Ecuador, CuencaCONTRIBUTORSFray Martinez-ReyesRaul Alvarado-CorralLorena Abril-MogrovejoChristian Castro-HugoLourdes Perez-Meza
Ecuador, Cuenca (2008−2012)Average annual person−years by sex and age group
24 161 0- 23 434
24 622 5- 24 073
25 355 10- 24 987
26 255 15- 25 889
24 882 20- 26 158
21 859 25- 23 972
17 174 30- 20 175
14 059 35- 17 470
11 864 40- 15 594
10 997 45- 14 167
9 171 50- 11 865
7 686 55- 9 631
6 383 60- 7 883
4 970 65- 6 686
3 679 70- 5 036
6 380 75+ 9 068
Total239 497 266 088Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 44.7Non-melanoma skin cancer 27.0Stomach 19.6Non-Hodgkin lymphoma 9.0Other and unspecified 7.3Trachea, bronchus, and lung 6.0Kidney 5.5Liver 4.8Colon 4.5Thyroid 4.2Brain and nervous system 4.2Bladder 3.7Melanoma of skin 3.6Gallbladder etc. 3.5Testis 3.4Lymphoid leukaemia 3.4Pancreas 3.3Rectum 2.8Myeloid leukaemia 2.7Connective and soft tissue 2.5
All sites 179.7
Breast 24.5Non-melanoma skin cancer 23.8Thyroid 18.2Cervix uteri 14.1Stomach 14.1Ovary 8.5Non-Hodgkin lymphoma 8.5Other and unspecified 5.9Gallbladder etc. 5.6Colon 5.0Rectum 4.3Liver 4.0Corpus uteri 3.9Melanoma of skin 3.7Pancreas 3.6Brain and nervous system 3.0Trachea, bronchus, and lung 2.8Kidney 2.7Lymphoid leukaemia 2.4Connective and soft tissue 2.2
All sites 173.2
Ecuador, Cuenca (2008−2012)Average annual person−years by sex and age group
24 161 0- 23 434
24 622 5- 24 073
25 355 10- 24 987
26 255 15- 25 889
24 882 20- 26 158
21 859 25- 23 972
17 174 30- 20 175
14 059 35- 17 470
11 864 40- 15 594
10 997 45- 14 167
9 171 50- 11 865
7 686 55- 9 631
6 383 60- 7 883
4 970 65- 6 686
3 679 70- 5 036
6 380 75+ 9 068
Total239 497 266 088Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
20 major cancers, ASR (World) per 100 000Male FemaleProstate 44.7Non-melanoma skin cancer 27.0Stomach 19.6Non-Hodgkin lymphoma 9.0Other and unspecified 7.3Trachea, bronchus, and lung 6.0Kidney 5.5Liver 4.8Colon 4.5Thyroid 4.2Brain and nervous system 4.2Bladder 3.7Melanoma of skin 3.6Gallbladder etc. 3.5Testis 3.4Lymphoid leukaemia 3.4Pancreas 3.3Rectum 2.8Myeloid leukaemia 2.7Connective and soft tissue 2.5
All sites 179.7
Breast 24.5Non-melanoma skin cancer 23.8Thyroid 18.2Cervix uteri 14.1Stomach 14.1Ovary 8.5Non-Hodgkin lymphoma 8.5Other and unspecified 5.9Gallbladder etc. 5.6Colon 5.0Rectum 4.3Liver 4.0Corpus uteri 3.9Melanoma of skin 3.7Pancreas 3.6Brain and nervous system 3.0Trachea, bronchus, and lung 2.8Kidney 2.7Lymphoid leukaemia 2.4Connective and soft tissue 2.2
All sites 173.2
Ecuador, Cuenca (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2010 census. National Institute of Statistics and Census, Ecuador (INEC; http://www.inec.gob.ec), allowing for births and deaths, but it was not possible to estimate migration into and out of the registration area.
187
Central and South America
Ecuador, Cuenca (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 5 0.3 0.2 0.5 0.03 0.05 8 0.5 0.3 0.8 0.09 0.09 5 0.3 0.2 0.5 0.03 0.05 3 0.2 0.1 0.3 0.02 0.07 3 0.2 0.1 0.3 0.01 0.05 1 0.1 0.0 0.1 0.01 0.01 1 0.1 0.0 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
17 1.0 0.7 1.6 0.05 0.21 219 13.4 9.1 19.6 1.02 1.88 5 0.3 0.2 0.4 0.01 0.04
47 2.9 2.0 4.5 0.25 0.49 28 1.7 1.2 2.8 0.13 0.33 1 0.1 0.0 0.1 0.00 0.02
50 3.1 2.1 4.8 0.15 0.61 38 2.3 1.6 3.5 0.20 0.33 33 2.0 1.4 3.3 0.08 0.50 3 0.2 0.1 0.3 0.01 0.07
14 0.9 0.6 1.3 0.04 0.16 68 4.1 2.8 6.0 0.29 0.59 5 0.3 0.2 0.4 0.02 0.04
10 0.6 0.4 0.8 0.04 0.09 37 2.3 1.5 3.6 0.26 0.40
288 12.0 27.0 1.11 3.17 1 0.1 0.0 0.1 0.00 0.03 1 0.1 0.0 0.1 0.01 0.01
27 1.6 1.1 2.5 0.16 0.25 6 0.4 0.3 0.6 0.03 0.08
6 0.4 0.3 0.6 0.03 0.07 465 28.4 19.4 44.7 1.81 5.70 43 2.6 1.8 3.4 0.25 0.25 2 0.1 0.1 0.2 0.01 0.01
54 3.3 2.3 5.5 0.35 0.66 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
42 2.6 1.8 3.7 0.15 0.40 2 0.1 0.1 0.2 0.00 0.00 4 0.2 0.2 0.4 0.03 0.05
47 2.9 2.0 4.2 0.27 0.33 46 2.8 1.9 4.2 0.30 0.40 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.0 0.1 0.01 0.01
14 0.9 0.6 1.2 0.05 0.15 98 6.0 4.1 9.0 0.46 0.98 0 0.0 0.0 0.0 0.00 0.00
22 1.3 0.9 2.1 0.14 0.23 38 2.3 1.6 3.4 0.19 0.26 32 2.0 1.3 2.7 0.14 0.27 4 0.2 0.2 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 5 0.3 0.2 0.5 0.01 0.07
78 4.8 3.3 7.3 0.31 0.83 1927 80.5 179.7 8.55 20.30 1639 100.0 68.4 152.7 7.44 17.13
0 0.0 0.0 0.0 0.00 0.00 8 0.4 0.3 0.5 0.03 0.05 8 0.4 0.3 0.5 0.02 0.05 3 0.1 0.1 0.3 0.01 0.04 1 0.0 0.0 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 2 0.1 0.1 0.1 0.01 0.01
219 10.6 8.2 14.1 0.59 1.34 10 0.5 0.4 0.7 0.04 0.09 73 3.5 2.7 5.0 0.27 0.51 58 2.8 2.2 4.3 0.30 0.45 8 0.4 0.3 0.5 0.03 0.07
61 3.0 2.3 4.0 0.09 0.49 78 3.8 2.9 5.6 0.29 0.65 58 2.8 2.2 3.6 0.09 0.38 3 0.1 0.1 0.2 0.01 0.03 3 0.1 0.1 0.2 0.01 0.01
41 2.0 1.5 2.8 0.14 0.28 2 0.1 0.1 0.1 0.01 0.01 6 0.3 0.2 0.4 0.03 0.03
52 2.5 2.0 3.7 0.21 0.39 360 13.5 23.8 1.05 2.47 2 0.1 0.1 0.1 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
29 1.4 1.1 2.2 0.14 0.26 311 15.1 11.7 24.5 1.97 2.62 8 0.4 0.3 0.4 0.00 0.04 3 0.1 0.1 0.2 0.00 0.02
190 9.2 7.1 14.1 1.10 1.41 46 2.2 1.7 3.9 0.34 0.49 17 0.8 0.6 1.2 0.06 0.13
112 5.4 4.2 8.5 0.48 1.09 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.2 0.01 0.01
36 1.7 1.4 2.7 0.21 0.27 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
23 1.1 0.9 1.5 0.07 0.15 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.2 0.02 0.02
39 1.9 1.5 3.0 0.18 0.30 242 11.8 9.1 18.2 1.50 1.72 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
12 0.6 0.5 0.9 0.04 0.10 118 5.7 4.4 8.5 0.52 0.97 3 0.1 0.1 0.2 0.00 0.02
18 0.9 0.7 1.3 0.07 0.17 30 1.5 1.1 2.4 0.13 0.15 27 1.3 1.0 2.0 0.12 0.22 3 0.1 0.1 0.2 0.01 0.01 1 0.0 0.0 0.1 0.00 0.01 2 0.1 0.1 0.2 0.01 0.01
86 4.2 3.2 5.9 0.35 0.57 2418 90.9 173.2 10.57 18.12 2058 100.0 77.3 149.4 9.53 15.65
§Includes 1 case of unknown age
Ecuador, Cuenca (2008–2012)
188
Central and South America
Ecuador, GuayaquilCONTRIBUTORSJuan Tanca CampozanoLeyda Jaramillo FeijooRina Quinto BrionesCarlos CampoverdeCarlos CastroRonald BastidasGeovanny LoorJorge Villarroel
Ecuador, Guayaquil (2008−2012)Average annual person−years by sex and age group
108 443 0- 112 765
109 892 5- 114 272
113 966 10- 118 509
106 406 15- 110 647
105 311 20- 109 509
101 407 25- 105 449
95 628 30- 99 440
80 807 35- 84 028
72 072 40- 74 944
67 473 45- 70 162
55 802 50- 58 026
45 623 55- 47 442
31 846 60- 33 116
23 555 65- 24 494
16 799 70- 17 468
11 837 75- 12 309
8 370 80- 8 704
7 088 85+ 7 370
Total1 162 325 1 208 654Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 27.8Non-melanoma skin cancer 22.1Stomach 14.0Trachea, bronchus, and lung 7.7Non-Hodgkin lymphoma 7.1Colon 6.4Other and unspecified 6.1Liver 4.2Brain and nervous system 4.2Kidney 4.2Lymphoid leukaemia 3.4Bladder 3.0Rectum 2.8Pancreas 2.7Myeloid leukaemia 2.4Larynx 2.0Testis 1.9Connective and soft tissue 1.8Multiple myeloma 1.7Thyroid 1.5
All sites 142.1
Breast 31.7Non-melanoma skin cancer 21.6Cervix uteri 20.2Stomach 9.5Other and unspecified 7.0Thyroid 6.9Colon 6.8Corpus uteri 6.0Ovary 5.8Non-Hodgkin lymphoma 5.6Trachea, bronchus, and lung 4.8Liver 4.5Brain and nervous system 3.8Kidney 3.5Rectum 2.9Lymphoid leukaemia 2.7Pancreas 2.5Gallbladder etc. 2.3Myeloid leukaemia 2.2Connective and soft tissue 1.6
All sites 165.5
Ecuador, Guayaquil (2008−2012)Average annual person−years by sex and age group
108 443 0- 112 765
109 892 5- 114 272
113 966 10- 118 509
106 406 15- 110 647
105 311 20- 109 509
101 407 25- 105 449
95 628 30- 99 440
80 807 35- 84 028
72 072 40- 74 944
67 473 45- 70 162
55 802 50- 58 026
45 623 55- 47 442
31 846 60- 33 116
23 555 65- 24 494
16 799 70- 17 468
11 837 75- 12 309
8 370 80- 8 704
7 088 85+ 7 370
Total1 162 325 1 208 654Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 27.8Non-melanoma skin cancer 22.1Stomach 14.0Trachea, bronchus, and lung 7.7Non-Hodgkin lymphoma 7.1Colon 6.4Other and unspecified 6.1Liver 4.2Brain and nervous system 4.2Kidney 4.2Lymphoid leukaemia 3.4Bladder 3.0Rectum 2.8Pancreas 2.7Myeloid leukaemia 2.4Larynx 2.0Testis 1.9Connective and soft tissue 1.8Multiple myeloma 1.7Thyroid 1.5
All sites 142.1
Breast 31.7Non-melanoma skin cancer 21.6Cervix uteri 20.2Stomach 9.5Other and unspecified 7.0Thyroid 6.9Colon 6.8Corpus uteri 6.0Ovary 5.8Non-Hodgkin lymphoma 5.6Trachea, bronchus, and lung 4.8Liver 4.5Brain and nervous system 3.8Kidney 3.5Rectum 2.9Lymphoid leukaemia 2.7Pancreas 2.5Gallbladder etc. 2.3Myeloid leukaemia 2.2Connective and soft tissue 1.6
All sites 165.5
Ecuador, Guayaquil (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2010 census. National Institute of Statistics and Census, Ecuador (INEC; http://www.inec.gob.ec).
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
189
Central and South America
Ecuador, Guayaquil (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.0 0.0 0.0 0.00 0.00 44 0.7 0.4 0.8 0.04 0.08 25 0.4 0.2 0.5 0.03 0.04 18 0.3 0.2 0.4 0.02 0.06 22 0.3 0.2 0.4 0.03 0.05 2 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.01 2 0.0 0.0 0.0 0.00 0.00
58 0.9 0.5 1.1 0.06 0.15 725 11.4 6.2 14.0 0.61 1.66 48 0.8 0.4 0.9 0.05 0.11
334 5.3 2.9 6.4 0.34 0.73 150 2.4 1.3 2.8 0.16 0.32 13 0.2 0.1 0.2 0.01 0.02
226 3.6 1.9 4.2 0.20 0.45 73 1.2 0.6 1.5 0.05 0.20
139 2.2 1.2 2.7 0.11 0.34 14 0.2 0.1 0.3 0.02 0.02 99 1.6 0.9 2.0 0.10 0.26
407 6.4 3.5 7.7 0.33 0.84 27 0.4 0.2 0.5 0.04 0.05 48 0.8 0.4 0.8 0.05 0.06 76 1.2 0.7 1.5 0.06 0.18
1181 10.2 22.1 0.98 2.42 11 0.2 0.1 0.2 0.02 0.02 56 0.9 0.5 0.9 0.06 0.09
103 1.6 0.9 1.8 0.13 0.16 18 0.3 0.2 0.3 0.03 0.03
47 0.7 0.4 0.9 0.06 0.11 1441 22.7 12.4 27.8 0.81 3.08 117 1.8 1.0 1.9 0.12 0.14 3 0.0 0.0 0.1 0.01 0.01
212 3.3 1.8 4.2 0.29 0.48 3 0.0 0.0 0.1 0.00 0.01 1 0.0 0.0 0.0 0.00 0.00
167 2.6 1.4 3.0 0.13 0.31 3 0.0 0.0 0.0 0.00 0.00
29 0.5 0.2 0.6 0.03 0.03 234 3.7 2.0 4.2 0.28 0.35 84 1.3 0.7 1.5 0.11 0.17 2 0.0 0.0 0.0 0.00 0.01 2 0.0 0.0 0.0 0.00 0.01
86 1.4 0.7 1.5 0.09 0.12 379 6.0 3.3 7.1 0.43 0.76 13 0.2 0.1 0.3 0.01 0.03 87 1.4 0.7 1.7 0.10 0.21
180 2.8 1.5 3.4 0.16 0.22 136 2.1 1.2 2.4 0.14 0.21 19 0.3 0.2 0.4 0.02 0.04 4 0.1 0.0 0.1 0.01 0.01
33 0.5 0.3 0.6 0.03 0.06
319 5.0 2.7 6.1 0.32 0.75 7525 64.7 142.1 6.68 15.47 6344 100.0 54.6 120.0 5.70 13.05
1 0.0 0.0 0.0 0.00 0.00 37 0.5 0.3 0.7 0.04 0.08 23 0.3 0.2 0.4 0.02 0.04 16 0.2 0.1 0.3 0.02 0.04 10 0.1 0.1 0.2 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.0 0.00 0.00
38 0.5 0.3 0.7 0.03 0.07 556 6.9 4.6 9.5 0.44 0.93 32 0.4 0.3 0.6 0.03 0.06
388 4.8 3.2 6.8 0.31 0.67 158 2.0 1.3 2.9 0.17 0.33 60 0.7 0.5 1.2 0.06 0.18
256 3.2 2.1 4.5 0.15 0.47 129 1.6 1.1 2.3 0.11 0.25 141 1.7 1.2 2.5 0.10 0.27 14 0.2 0.1 0.2 0.01 0.02 11 0.1 0.1 0.2 0.01 0.02
264 3.3 2.2 4.8 0.21 0.54 15 0.2 0.1 0.3 0.02 0.03 43 0.5 0.4 0.7 0.05 0.06 52 0.6 0.4 0.9 0.04 0.10
1194 9.9 21.6 0.96 2.42 5 0.1 0.0 0.1 0.00 0.01 6 0.1 0.0 0.1 0.00 0.01
90 1.1 0.7 1.6 0.10 0.16 1751 21.7 14.5 31.7 2.29 3.56 29 0.4 0.2 0.5 0.02 0.05 19 0.2 0.2 0.4 0.02 0.03
1169 14.5 9.7 20.2 1.53 2.13 319 3.9 2.6 6.0 0.39 0.75 34 0.4 0.3 0.5 0.03 0.04
329 4.1 2.7 5.8 0.42 0.62 2 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
179 2.2 1.5 3.5 0.19 0.40 3 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
58 0.7 0.5 1.1 0.04 0.12 2 0.0 0.0 0.0 0.00 0.00
17 0.2 0.1 0.3 0.01 0.02 219 2.7 1.8 3.8 0.23 0.32 405 5.0 3.4 6.9 0.50 0.71 3 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
54 0.7 0.4 0.9 0.07 0.08 313 3.9 2.6 5.6 0.31 0.58 19 0.2 0.2 0.3 0.01 0.04 72 0.9 0.6 1.4 0.07 0.19
151 1.9 1.2 2.7 0.16 0.19 123 1.5 1.0 2.2 0.13 0.22 30 0.4 0.2 0.5 0.03 0.05 9 0.1 0.1 0.2 0.01 0.01
34 0.4 0.3 0.6 0.03 0.09
383 4.7 3.2 7.0 0.40 0.81 9272 76.7 165.5 9.80 17.80 8078 100.0 66.8 143.9 8.84 15.38
§Includes 13 cases of unknown age §Includes 10 cases of unknown age
† See note following population pyramid
Ecuador, Guayaquil (2008–2012)
190
Central and South America
Ecuador, LojaCONTRIBUTORSJhoanna Castillo CalvasAnny Gomez Castillo
Ecuador, Loja (2008−2010)Average annual person−years by sex and age group
10 491 0- 10 294
10 780 5- 10 677
10 971 10- 11 047
10 741 15- 10 868
9 280 20- 10 065
7 953 25- 8 538
6 276 30- 7 184
5 588 35- 6 340
5 009 40- 5 771
4 778 45- 5 464
4 087 50- 4 518
3 526 55- 3 879
2 800 60- 3 118
2 320 65- 2 629
1 695 70- 1 948
1 030 75- 1 278
754 80- 926
801 85+ 1 039
Total98 880 105 583Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Rates based on low numbers due to small population.
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 36.6Stomach 33.2Non-melanoma skin cancer 32.0Trachea, bronchus, and lung 10.2Colon 9.5Non-Hodgkin lymphoma 8.3Kidney 5.8Gallbladder etc. 5.1Rectum 5.1Myeloid leukaemia 4.6Other and unspecified 4.2Liver 4.2Brain and nervous system 4.1Thyroid 3.9Melanoma of skin 3.5Lymphoid leukaemia 3.3Testis 3.2Multiple myeloma 3.1Connective and soft tissue 2.8Bladder 2.5
All sites 200.1
Thyroid 30.0Non-melanoma skin cancer 29.0Breast 28.3Cervix uteri 24.9Stomach 21.2Colon 11.3Non-Hodgkin lymphoma 10.4Ovary 7.7Other and unspecified 7.1Gallbladder etc. 7.0Liver 6.2Rectum 5.8Melanoma of skin 4.9Brain and nervous system 4.6Corpus uteri 4.4Trachea, bronchus, and lung 3.9Lymphoid leukaemia 3.0Myeloid leukaemia 2.7Connective and soft tissue 2.6Kidney 2.5
All sites 235.8
Ecuador, Loja (2008−2010)Average annual person−years by sex and age group
10 491 0- 10 294
10 780 5- 10 677
10 971 10- 11 047
10 741 15- 10 868
9 280 20- 10 065
7 953 25- 8 538
6 276 30- 7 184
5 588 35- 6 340
5 009 40- 5 771
4 778 45- 5 464
4 087 50- 4 518
3 526 55- 3 879
2 800 60- 3 118
2 320 65- 2 629
1 695 70- 1 948
1 030 75- 1 278
754 80- 926
801 85+ 1 039
Total98 880 105 583Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Rates based on low numbers due to small population.
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 36.6Stomach 33.2Non-melanoma skin cancer 32.0Trachea, bronchus, and lung 10.2Colon 9.5Non-Hodgkin lymphoma 8.3Kidney 5.8Gallbladder etc. 5.1Rectum 5.1Myeloid leukaemia 4.6Other and unspecified 4.2Liver 4.2Brain and nervous system 4.1Thyroid 3.9Melanoma of skin 3.5Lymphoid leukaemia 3.3Testis 3.2Multiple myeloma 3.1Connective and soft tissue 2.8Bladder 2.5
All sites 200.1
Thyroid 30.0Non-melanoma skin cancer 29.0Breast 28.3Cervix uteri 24.9Stomach 21.2Colon 11.3Non-Hodgkin lymphoma 10.4Ovary 7.7Other and unspecified 7.1Gallbladder etc. 7.0Liver 6.2Rectum 5.8Melanoma of skin 4.9Brain and nervous system 4.6Corpus uteri 4.4Trachea, bronchus, and lung 3.9Lymphoid leukaemia 3.0Myeloid leukaemia 2.7Connective and soft tissue 2.6Kidney 2.5
All sites 235.8
Ecuador, Loja (2008–2010)Average annual person–years by sex and age group
SOURCE OF POPULATIONBased on the 2010 census. National Institute of Statistics and Census, Ecuador (INEC; http://www.inec.gob.ec), allowing for births and deaths, but it was not possible to estimate migration into and out of the registration area.
NOTES ON THE DATA*Rates based on low numbers due to small population. †C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
191
Central and South America
*Ecuador, Loja (2008−2010)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.4 0.03 0.03 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 4 0.8 0.7 1.5 0.06 0.23
96 19.9 16.2 33.2 1.32 3.67 6 1.2 1.0 1.8 0.06 0.15
25 5.2 4.2 9.5 0.44 1.31 14 2.9 2.4 5.1 0.38 0.38 0 0.0 0.0 0.0 0.00 0.00
13 2.7 2.2 4.2 0.18 0.45 15 3.1 2.5 5.1 0.24 0.56 6 1.2 1.0 2.2 0.14 0.24 1 0.2 0.2 0.3 0.00 0.00 2 0.4 0.3 0.6 0.05 0.05
29 6.0 4.9 10.2 0.48 1.09 1 0.2 0.2 0.4 0.05 0.05 3 0.6 0.5 1.2 0.12 0.12 9 1.9 1.5 3.5 0.18 0.44
87 14.7 32.0 1.63 3.92 0 0.0 0.0 0.0 0.00 0.00 2 0.4 0.3 0.6 0.00 0.00 8 1.7 1.3 2.8 0.23 0.23 1 0.2 0.2 0.2 0.00 0.00
4 0.8 0.7 1.4 0.07 0.17 111 23.0 18.7 36.6 1.24 3.87 9 1.9 1.5 3.2 0.22 0.22 0 0.0 0.0 0.0 0.00 0.00
15 3.1 2.5 5.8 0.41 0.62 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 7 1.5 1.2 2.5 0.00 0.39 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.4 0.02 0.02
12 2.5 2.0 4.1 0.32 0.32 10 2.1 1.7 3.9 0.29 0.36 1 0.2 0.2 0.3 0.03 0.03 0 0.0 0.0 0.0 0.00 0.00 4 0.8 0.7 1.1 0.02 0.11
24 5.0 4.0 8.3 0.35 0.60 0 0.0 0.0 0.0 0.00 0.00 8 1.7 1.3 3.1 0.21 0.28
10 2.1 1.7 3.3 0.11 0.38 12 2.5 2.0 4.6 0.26 0.47 2 0.4 0.3 0.4 0.00 0.00 4 0.8 0.7 1.7 0.10 0.23 1 0.2 0.2 0.3 0.00 0.00
11 2.3 1.9 4.2 0.37 0.44 569 95.9 200.1 9.57 21.42 482 100.0 81.2 168.1 7.94 17.49
0 0.0 0.0 0.0 0.00 0.00 3 0.5 0.5 0.9 0.07 0.07 3 0.5 0.5 0.7 0.00 0.09 1 0.2 0.2 0.4 0.00 0.06 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 1 0.2 0.2 0.3 0.03 0.03
75 11.6 11.8 21.2 0.74 2.40 1 0.2 0.2 0.3 0.00 0.09
34 5.2 5.4 11.3 0.91 1.25 19 2.9 3.0 5.8 0.30 0.60 2 0.3 0.3 0.8 0.08 0.08
20 3.1 3.2 6.2 0.18 0.69 22 3.4 3.5 7.0 0.34 0.94 7 1.1 1.1 1.5 0.04 0.13 3 0.5 0.5 1.0 0.06 0.14 0 0.0 0.0 0.0 0.00 0.00
13 2.0 2.1 3.9 0.20 0.35 2 0.3 0.3 0.5 0.04 0.04 2 0.3 0.3 0.7 0.03 0.09
17 2.6 2.7 4.9 0.30 0.53 102 16.1 29.0 1.18 3.19 1 0.2 0.2 0.4 0.05 0.05 0 0.0 0.0 0.0 0.00 0.00 8 1.2 1.3 2.6 0.19 0.25
82 12.7 12.9 28.3 2.11 3.13 3 0.5 0.5 0.9 0.05 0.14 0 0.0 0.0 0.0 0.00 0.00
76 11.7 12.0 24.9 1.61 2.58 12 1.9 1.9 4.4 0.16 0.55 5 0.8 0.8 1.5 0.09 0.09
23 3.5 3.6 7.7 0.58 0.82 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
10 1.5 1.6 2.5 0.09 0.09 1 0.2 0.2 0.3 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 5 0.8 0.8 1.3 0.05 0.05 0 0.0 0.0 0.0 0.00 0.00 4 0.6 0.6 1.4 0.12 0.12
14 2.2 2.2 4.6 0.16 0.54 89 13.7 14.0 30.0 2.49 2.89 1 0.2 0.2 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 4 0.6 0.6 1.4 0.00 0.30
33 5.1 5.2 10.4 0.58 1.09 0 0.0 0.0 0.0 0.00 0.00 4 0.6 0.6 1.0 0.04 0.13
10 1.5 1.6 3.0 0.11 0.20 8 1.2 1.3 2.7 0.11 0.33 1 0.2 0.2 0.3 0.02 0.02 7 1.1 1.1 2.4 0.10 0.17 0 0.0 0.0 0.0 0.00 0.00
22 3.4 3.5 7.1 0.45 0.69 750 118.4 235.8 13.71 25.00 648 100.0 102.3 206.8 12.52 21.82
§Includes 1 case of unknown age §Includes 2 cases of unknown age
†*See note following population pyramid
*Ecuador, Loja (2008–2010)
192
Central and South America
Ecuador, ManabíCONTRIBUTORSMariela Mendoza MendozaJuan Carlos González MacíasVanessa Zambrano AzúaMargarita BasurtoRubén Espinoza Guevara
Ecuador, Manabí (2008−2012)Average annual person−years by sex and age group
76 289 0- 73 468
77 328 5- 74 164
76 782 10- 73 880
68 437 15- 67 018
60 238 20- 59 583
54 135 25- 54 022
49 587 30- 49 331
44 374 35- 44 229
40 032 40- 39 177
35 411 45- 34 406
30 219 50- 29 293
24 718 55- 23 907
19 435 60- 18 640
14 946 65- 14 645
11 627 70- 11 385
8 386 75- 8 528
5 119 80- 4 653
4 231 85+ 5 863
Total701 294 686 192Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Low MV% and high DCO%.
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 19.7Stomach 18.7Non-melanoma skin cancer 17.8Non-Hodgkin lymphoma 6.0Trachea, bronchus, and lung 5.7Other and unspecified 4.1Colon 4.1Liver 3.3Lymphoid leukaemia 2.5Brain and nervous system 1.9Rectum 1.6Kidney 1.6Connective and soft tissue 1.6Pancreas 1.6Oesophagus 1.4Myeloid leukaemia 1.4Testis 1.4Bladder 1.2Hodgkin lymphoma 1.2Penis 1.1
All sites 107.3
Breast 20.5Non-melanoma skin cancer 17.4Cervix uteri 16.1Stomach 10.3Thyroid 7.5Non-Hodgkin lymphoma 5.0Colon 4.8Other and unspecified 4.2Ovary 3.5Trachea, bronchus, and lung 3.3Liver 3.2Corpus uteri 2.7Lymphoid leukaemia 2.1Brain and nervous system 1.8Rectum 1.8Connective and soft tissue 1.5Pancreas 1.3Gallbladder etc. 1.2Kidney 1.1Myeloid leukaemia 1.0
All sites 119.6
Ecuador, Manabí (2008−2012)Average annual person−years by sex and age group
76 289 0- 73 468
77 328 5- 74 164
76 782 10- 73 880
68 437 15- 67 018
60 238 20- 59 583
54 135 25- 54 022
49 587 30- 49 331
44 374 35- 44 229
40 032 40- 39 177
35 411 45- 34 406
30 219 50- 29 293
24 718 55- 23 907
19 435 60- 18 640
14 946 65- 14 645
11 627 70- 11 385
8 386 75- 8 528
5 119 80- 4 653
4 231 85+ 5 863
Total701 294 686 192Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Low MV% and high DCO%.
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 19.7Stomach 18.7Non-melanoma skin cancer 17.8Non-Hodgkin lymphoma 6.0Trachea, bronchus, and lung 5.7Other and unspecified 4.1Colon 4.1Liver 3.3Lymphoid leukaemia 2.5Brain and nervous system 1.9Rectum 1.6Kidney 1.6Connective and soft tissue 1.6Pancreas 1.6Oesophagus 1.4Myeloid leukaemia 1.4Testis 1.4Bladder 1.2Hodgkin lymphoma 1.2Penis 1.1
All sites 107.3
Breast 20.5Non-melanoma skin cancer 17.4Cervix uteri 16.1Stomach 10.3Thyroid 7.5Non-Hodgkin lymphoma 5.0Colon 4.8Other and unspecified 4.2Ovary 3.5Trachea, bronchus, and lung 3.3Liver 3.2Corpus uteri 2.7Lymphoid leukaemia 2.1Brain and nervous system 1.8Rectum 1.8Connective and soft tissue 1.5Pancreas 1.3Gallbladder etc. 1.2Kidney 1.1Myeloid leukaemia 1.0
All sites 119.6
Ecuador, Manabí (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation estimates based on intercensal 2001–2010 popula-tion projections and 2010 census projections. National Institute of Statistics and Census, Ecuador (INEC; http://www.inec.gob.ec).
NOTES ON THE DATA*Low MV%. High DCO%. †C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
193
Central and South America
*Ecuador, Manabí (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 12 0.4 0.2 0.4 0.02 0.03 11 0.4 0.2 0.3 0.02 0.05 8 0.3 0.1 0.3 0.02 0.03 5 0.2 0.1 0.2 0.01 0.02 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 7 0.2 0.1 0.2 0.01 0.02
44 1.5 0.6 1.4 0.07 0.18 587 20.0 8.4 18.7 1.00 2.25 11 0.4 0.2 0.4 0.02 0.04
135 4.6 1.9 4.1 0.20 0.43 52 1.8 0.7 1.6 0.09 0.20 8 0.3 0.1 0.2 0.01 0.01
103 3.5 1.5 3.3 0.18 0.39 27 0.9 0.4 0.9 0.06 0.10 49 1.7 0.7 1.6 0.09 0.19 4 0.1 0.1 0.1 0.01 0.02
33 1.1 0.5 1.1 0.06 0.14 190 6.5 2.7 5.7 0.23 0.60 7 0.2 0.1 0.2 0.01 0.02
27 0.9 0.4 0.8 0.04 0.07 30 1.0 0.4 0.9 0.05 0.10
578 8.2 17.8 0.85 1.97 2 0.1 0.0 0.1 0.00 0.00 4 0.1 0.1 0.1 0.01 0.01
56 1.9 0.8 1.6 0.08 0.13 8 0.3 0.1 0.3 0.02 0.03
36 1.2 0.5 1.1 0.07 0.13 670 22.9 9.6 19.7 0.51 2.16 49 1.7 0.7 1.4 0.08 0.10 2 0.1 0.0 0.1 0.01 0.01
51 1.7 0.7 1.6 0.12 0.17 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
44 1.5 0.6 1.2 0.03 0.12 0 0.0 0.0 0.0 0.00 0.00 8 0.3 0.1 0.2 0.01 0.02
64 2.2 0.9 1.9 0.13 0.15 32 1.1 0.5 1.0 0.08 0.09 4 0.1 0.1 0.1 0.02 0.02 2 0.1 0.0 0.1 0.00 0.00
41 1.4 0.6 1.2 0.08 0.11 197 6.7 2.8 6.0 0.39 0.61 5 0.2 0.1 0.2 0.01 0.01
24 0.8 0.3 0.8 0.05 0.10 88 3.0 1.3 2.5 0.12 0.15 45 1.5 0.6 1.4 0.11 0.13 9 0.3 0.1 0.3 0.02 0.03 2 0.1 0.0 0.1 0.00 0.00 3 0.1 0.0 0.1 0.01 0.02
136 4.6 1.9 4.1 0.22 0.44 3510 50.1 107.3 5.24 11.63 2932 100.0 41.8 89.4 4.38 9.66
0 0.0 0.0 0.0 0.00 0.00 20 0.6 0.3 0.7 0.05 0.07 10 0.3 0.1 0.3 0.02 0.03 11 0.3 0.2 0.3 0.03 0.03 1 0.0 0.0 0.0 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
13 0.4 0.2 0.4 0.04 0.04 343 10.6 5.0 10.3 0.47 1.16 5 0.2 0.1 0.2 0.01 0.02
161 5.0 2.3 4.8 0.25 0.52 55 1.7 0.8 1.8 0.10 0.20 21 0.6 0.3 0.7 0.05 0.08
107 3.3 1.6 3.2 0.13 0.31 41 1.3 0.6 1.2 0.07 0.13 44 1.4 0.6 1.3 0.05 0.13 3 0.1 0.0 0.1 0.00 0.00 7 0.2 0.1 0.2 0.01 0.01
106 3.3 1.5 3.3 0.14 0.38 2 0.1 0.0 0.1 0.01 0.01
24 0.7 0.3 0.7 0.05 0.06 21 0.6 0.3 0.6 0.04 0.06
574 8.4 17.4 0.91 1.90 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
48 1.5 0.7 1.5 0.08 0.17 620 19.2 9.0 20.5 1.58 2.26 15 0.5 0.2 0.5 0.01 0.06 16 0.5 0.2 0.6 0.04 0.07
499 15.4 7.3 16.1 1.16 1.75 81 2.5 1.2 2.7 0.20 0.31 19 0.6 0.3 0.6 0.04 0.07
109 3.4 1.6 3.5 0.25 0.37 2 0.1 0.0 0.1 0.00 0.01 1 0.0 0.0 0.0 0.00 0.00
35 1.1 0.5 1.1 0.06 0.09 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
33 1.0 0.5 0.9 0.03 0.09 2 0.1 0.0 0.1 0.00 0.01 9 0.3 0.1 0.3 0.01 0.01
57 1.8 0.8 1.8 0.14 0.16 234 7.2 3.4 7.5 0.61 0.74 1 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
30 0.9 0.4 0.9 0.05 0.09 155 4.8 2.3 5.0 0.30 0.58 3 0.1 0.0 0.1 0.00 0.01
15 0.5 0.2 0.5 0.05 0.07 66 2.0 1.0 2.1 0.10 0.14 36 1.1 0.5 1.0 0.06 0.07 15 0.5 0.2 0.4 0.02 0.04 2 0.1 0.0 0.1 0.01 0.01 5 0.2 0.1 0.1 0.00 0.02
131 4.0 1.9 4.2 0.23 0.47 3810 55.5 119.6 7.46 12.86 3236 100.0 47.2 102.2 6.55 10.95
§Includes 20 cases of unknown age §Includes 16 cases of unknown age
†*See note following population pyramid
*Ecuador, Manabí (2008–2012)
194
Central and South America
Ecuador, QuitoCONTRIBUTORSPatricia Cueva AyalaJosé Yépez MaldonadoMaría Belén MorejónMónica GalarzaDoris ChaucaPaulina BedónSilvia Jacho
Ecuador, Quito (2008−2012)Average annual person−years by sex and age group
73 398 0- 70 626
74 688 5- 73 113
73 799 10- 71 894
73 208 15- 74 387
77 682 20- 81 205
75 089 25- 79 293
64 496 30- 68 937
54 014 35- 60 505
46 207 40- 52 211
42 173 45- 48 906
34 537 50- 39 703
28 400 55- 32 557
21 613 60- 25 081
16 425 65- 19 727
11 342 70- 14 088
7 774 75- 10 170
5 420 80- 7 647
4 221 85+ 6 725
Total784 486 836 775Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 59.3Non-melanoma skin cancer 35.8Stomach 21.2Non-Hodgkin lymphoma 13.1Trachea, bronchus, and lung 8.0Colon 7.7Bladder 6.0Liver 5.6Brain and nervous system 5.5Testis 5.4Thyroid 5.2Rectum 5.1Kidney 5.0Other and unspecified 4.6Lymphoid leukaemia 4.6Gallbladder etc. 4.2Melanoma of skin 3.6Connective and soft tissue 3.5Myeloid leukaemia 3.5Pancreas 3.0
All sites 228.6
Breast 38.5Non-melanoma skin cancer 31.2Thyroid 30.9Cervix uteri 17.6Stomach 14.5Non-Hodgkin lymphoma 11.2Colon 7.8Ovary 7.2Trachea, bronchus, and lung 5.9Other and unspecified 5.4Corpus uteri 5.4Gallbladder etc. 5.3Liver 5.3Brain and nervous system 4.4Rectum 3.9Melanoma of skin 3.7Pancreas 3.6Lymphoid leukaemia 3.4Kidney 3.0Myeloid leukaemia 2.6
All sites 230.1
Ecuador, Quito (2008−2012)Average annual person−years by sex and age group
73 398 0- 70 626
74 688 5- 73 113
73 799 10- 71 894
73 208 15- 74 387
77 682 20- 81 205
75 089 25- 79 293
64 496 30- 68 937
54 014 35- 60 505
46 207 40- 52 211
42 173 45- 48 906
34 537 50- 39 703
28 400 55- 32 557
21 613 60- 25 081
16 425 65- 19 727
11 342 70- 14 088
7 774 75- 10 170
5 420 80- 7 647
4 221 85+ 6 725
Total784 486 836 775Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 59.3Non-melanoma skin cancer 35.8Stomach 21.2Non-Hodgkin lymphoma 13.1Trachea, bronchus, and lung 8.0Colon 7.7Bladder 6.0Liver 5.6Brain and nervous system 5.5Testis 5.4Thyroid 5.2Rectum 5.1Kidney 5.0Other and unspecified 4.6Lymphoid leukaemia 4.6Gallbladder etc. 4.2Melanoma of skin 3.6Connective and soft tissue 3.5Myeloid leukaemia 3.5Pancreas 3.0
All sites 228.6
Breast 38.5Non-melanoma skin cancer 31.2Thyroid 30.9Cervix uteri 17.6Stomach 14.5Non-Hodgkin lymphoma 11.2Colon 7.8Ovary 7.2Trachea, bronchus, and lung 5.9Other and unspecified 5.4Corpus uteri 5.4Gallbladder etc. 5.3Liver 5.3Brain and nervous system 4.4Rectum 3.9Melanoma of skin 3.7Pancreas 3.6Lymphoid leukaemia 3.4Kidney 3.0Myeloid leukaemia 2.6
All sites 230.1
Ecuador, Quito (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation estimates based on intercensal 2001–2010 popula-tion projections and 2010 census projections. National Institute of Statistics and Census, Ecuador (INEC; http://www.inec.gob.ec).
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
195
Central and South America
Ecuador, Quito (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 24 0.4 0.3 0.7 0.05 0.07 10 0.1 0.1 0.3 0.01 0.04 26 0.4 0.3 0.7 0.05 0.08 10 0.1 0.1 0.3 0.03 0.03 0 0.0 0.0 0.0 0.00 0.00 3 0.0 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 5 0.1 0.1 0.1 0.01 0.01
63 0.9 0.8 1.7 0.06 0.14 729 10.9 9.3 21.2 0.94 2.49 40 0.6 0.5 1.2 0.05 0.15
264 4.0 3.4 7.7 0.38 0.88 176 2.6 2.2 5.1 0.24 0.60 9 0.1 0.1 0.3 0.02 0.02
189 2.8 2.4 5.6 0.21 0.63 143 2.1 1.8 4.2 0.16 0.46 103 1.5 1.3 3.0 0.12 0.35 16 0.2 0.2 0.5 0.02 0.04 57 0.9 0.7 1.8 0.09 0.22
278 4.2 3.5 8.0 0.31 0.86 15 0.2 0.2 0.4 0.02 0.03 62 0.9 0.8 1.6 0.09 0.13
125 1.9 1.6 3.6 0.18 0.39 1243 15.8 35.8 1.56 3.89
9 0.1 0.1 0.3 0.01 0.04 37 0.6 0.5 1.0 0.07 0.10
126 1.9 1.6 3.5 0.20 0.41 17 0.3 0.2 0.5 0.03 0.05
34 0.5 0.4 1.0 0.04 0.10 1959 29.3 25.0 59.3 2.10 7.31 235 3.5 3.0 5.4 0.37 0.40 3 0.0 0.0 0.1 0.00 0.01
167 2.5 2.1 5.0 0.29 0.59 3 0.0 0.0 0.1 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
208 3.1 2.7 6.0 0.21 0.64 1 0.0 0.0 0.0 0.00 0.00
30 0.4 0.4 0.8 0.03 0.05 204 3.1 2.6 5.5 0.37 0.54 191 2.9 2.4 5.2 0.41 0.55 6 0.1 0.1 0.2 0.01 0.02 5 0.1 0.1 0.1 0.01 0.01
36 0.5 0.5 0.9 0.06 0.08 459 6.9 5.9 13.1 0.78 1.46 7 0.1 0.1 0.2 0.02 0.03
96 1.4 1.2 2.9 0.19 0.35 168 2.5 2.1 4.6 0.25 0.32 132 2.0 1.7 3.5 0.22 0.29 16 0.2 0.2 0.4 0.02 0.02 9 0.1 0.1 0.3 0.02 0.03
13 0.2 0.2 0.3 0.01 0.04
159 2.4 2.0 4.6 0.23 0.51 7921 101.0 228.6 10.58 25.51 6678 100.0 85.1 192.8 9.02 21.62
2 0.0 0.0 0.0 0.00 0.00 21 0.3 0.3 0.5 0.03 0.05 24 0.3 0.3 0.5 0.02 0.06 22 0.3 0.3 0.5 0.03 0.06 3 0.0 0.0 0.1 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 5 0.1 0.1 0.1 0.01 0.01 1 0.0 0.0 0.0 0.00 0.00 2 0.0 0.0 0.1 0.00 0.01
36 0.4 0.4 0.8 0.03 0.08 647 7.7 7.7 14.5 0.75 1.51 41 0.5 0.5 1.0 0.06 0.13
340 4.1 4.1 7.8 0.39 0.79 163 1.9 1.9 3.9 0.21 0.46 44 0.5 0.5 1.1 0.05 0.15
228 2.7 2.7 5.3 0.24 0.58 231 2.8 2.8 5.3 0.23 0.57 155 1.8 1.9 3.6 0.13 0.42 15 0.2 0.2 0.3 0.02 0.03 6 0.1 0.1 0.2 0.01 0.02
259 3.1 3.1 5.9 0.32 0.61 13 0.2 0.2 0.3 0.01 0.03 55 0.7 0.7 1.4 0.09 0.12
162 1.9 1.9 3.7 0.20 0.40 1387 16.6 31.2 1.42 3.32
7 0.1 0.1 0.2 0.01 0.02 4 0.0 0.0 0.1 0.01 0.01
100 1.2 1.2 2.3 0.15 0.22 1560 18.6 18.6 38.5 2.86 4.46 28 0.3 0.3 0.6 0.03 0.07 17 0.2 0.2 0.4 0.04 0.04
745 8.9 8.9 17.6 1.19 1.95 208 2.5 2.5 5.4 0.37 0.67 63 0.8 0.8 1.3 0.06 0.10
295 3.5 3.5 7.2 0.50 0.79 2 0.0 0.0 0.1 0.00 0.01
13 0.2 0.2 0.3 0.02 0.02
116 1.4 1.4 3.0 0.19 0.35 2 0.0 0.0 0.0 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
97 1.2 1.2 2.2 0.11 0.24 0 0.0 0.0 0.0 0.00 0.00
36 0.4 0.4 0.9 0.04 0.07 179 2.1 2.1 4.4 0.30 0.41
1322 15.8 15.8 30.9 2.51 3.09 5 0.1 0.1 0.1 0.01 0.02 1 0.0 0.0 0.0 0.00 0.00
46 0.5 0.5 1.1 0.07 0.11 471 5.6 5.6 11.2 0.65 1.28 8 0.1 0.1 0.2 0.01 0.01
77 0.9 0.9 1.9 0.11 0.23 132 1.6 1.6 3.4 0.17 0.25 113 1.3 1.4 2.6 0.13 0.21 20 0.2 0.2 0.5 0.02 0.04 9 0.1 0.1 0.2 0.02 0.02 6 0.1 0.1 0.1 0.00 0.02
229 2.7 2.7 5.4 0.30 0.57 9773 116.8 230.1 14.15 24.70 8386 100.0 100.2 198.9 12.73 21.38
§Includes 25 cases of unknown age §Includes 27 cases of unknown age
† See note following population pyramid
Ecuador, Quito (2008–2012)
196
Central and South America
France, MartiniqueCONTRIBUTORSClarisse JoachimJonathan MacniAudrey PomierStephen Ulric-GervaiseMarie-José DorivalJacqueline Véronique-BaudinRoger SalamonPatrick Escarmant
France, Martinique (2008−2012)Average annual person−years by sex and age group
11 839 0- 11 564
13 174 5- 13 116
14 040 10- 13 574
14 348 15- 14 306
11 039 20- 11 176
8 479 25- 10 507
8 698 30- 11 860
11 624 35- 15 505
13 817 40- 17 475
14 649 45- 17 735
13 352 50- 15 346
11 433 55- 13 551
9 827 60- 11 453
7 777 65- 9 117
6 724 70- 8 224
5 048 75- 6 688
3 359 80- 5 123
2 697 85+ 5 524
Total181 924 211 844Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*No DCO registrations.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 165.5Colon 19.4Stomach 12.2Trachea, bronchus, and lung 9.5Rectum 8.7Pancreas 7.8Multiple myeloma 6.8Non-Hodgkin lymphoma 5.9Lymphoid leukaemia 5.8Other and unspecified 4.5Myeloid leukaemia 4.2Oesophagus 4.1Brain and nervous system 3.7Kidney 3.7Bladder 3.6Liver 3.5Larynx 3.1Gallbladder etc. 2.8Thyroid 2.5Melanoma of skin 2.5
All sites 304.7
Breast 62.5Colon 15.0Thyroid 9.7Corpus uteri 8.3Stomach 7.2Cervix uteri 7.1Trachea, bronchus, and lung 7.1Multiple myeloma 5.5Rectum 5.0Pancreas 4.7Ovary 4.7Non-Hodgkin lymphoma 4.0Lymphoid leukaemia 3.8Other and unspecified 3.1Myeloid leukaemia 3.1Brain and nervous system 2.1Melanoma of skin 2.1Kidney 2.0Gallbladder etc. 1.7Myelodysplastic syndromes 1.6
All sites 175.1
France, Martinique (2008−2012)Average annual person−years by sex and age group
11 839 0- 11 564
13 174 5- 13 116
14 040 10- 13 574
14 348 15- 14 306
11 039 20- 11 176
8 479 25- 10 507
8 698 30- 11 860
11 624 35- 15 505
13 817 40- 17 475
14 649 45- 17 735
13 352 50- 15 346
11 433 55- 13 551
9 827 60- 11 453
7 777 65- 9 117
6 724 70- 8 224
5 048 75- 6 688
3 359 80- 5 123
2 697 85+ 5 524
Total181 924 211 844Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data*No DCO registrations.�
20 major cancers, ASR (World) per 100 000Male FemaleProstate 165.5Colon 19.4Stomach 12.2Trachea, bronchus, and lung 9.5Rectum 8.7Pancreas 7.8Multiple myeloma 6.8Non-Hodgkin lymphoma 5.9Lymphoid leukaemia 5.8Other and unspecified 4.5Myeloid leukaemia 4.2Oesophagus 4.1Brain and nervous system 3.7Kidney 3.7Bladder 3.6Liver 3.5Larynx 3.1Gallbladder etc. 2.8Thyroid 2.5Melanoma of skin 2.5
All sites 304.7
Breast 62.5Colon 15.0Thyroid 9.7Corpus uteri 8.3Stomach 7.2Cervix uteri 7.1Trachea, bronchus, and lung 7.1Multiple myeloma 5.5Rectum 5.0Pancreas 4.7Ovary 4.7Non-Hodgkin lymphoma 4.0Lymphoid leukaemia 3.8Other and unspecified 3.1Myeloid leukaemia 3.1Brain and nervous system 2.1Melanoma of skin 2.1Kidney 2.0Gallbladder etc. 1.7Myelodysplastic syndromes 1.6
All sites 175.1
France, Martinique (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONData obtained from continuous censuses conducted by the National Institute of Statistics and Economic Studies (INSEE) during the period 2008–2012 (https://www.insee.fr/fr/statistiques).
NOTES ON THE DATA*No DCO registrations.
197
Central and South America
*France, Martinique (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreterBladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
3 0.1 0.2 0.2 0.03 0.03 25 0.5 1.4 1.7 0.12 0.21 29 0.6 1.6 2.0 0.17 0.24 3 0.1 0.2 0.2 0.02 0.02
27 0.6 1.5 1.8 0.14 0.23 27 0.6 1.5 1.8 0.11 0.22 10 0.2 0.5 0.7 0.05 0.07 19 0.4 1.0 1.2 0.07 0.17 6 0.1 0.3 0.4 0.02 0.07
66 1.4 3.6 4.1 0.25 0.48 210 4.4 11.5 12.2 0.50 1.38 16 0.3 0.9 1.1 0.08 0.15
307 6.5 16.9 19.4 1.06 2.40 142 3.0 7.8 8.7 0.46 1.03 3 0.1 0.2 0.2 0.01 0.02
56 1.2 3.1 3.5 0.21 0.38 45 1.0 2.5 2.8 0.16 0.30
129 2.7 7.1 7.8 0.37 0.97 6 0.1 0.3 0.5 0.04 0.05
45 1.0 2.5 3.1 0.27 0.31 147 3.1 8.1 9.5 0.54 1.13 4 0.1 0.2 0.3 0.02 0.02 7 0.1 0.4 0.8 0.05 0.05
38 0.8 2.1 2.5 0.17 0.28 7 0.4 0.5 0.04 0.07 4 0.1 0.2 0.3 0.03 0.03 2 0.0 0.1 0.1 0.00 0.01
15 0.3 0.8 1.4 0.07 0.11 18 0.4 1.0 1.1 0.06 0.14
16 0.3 0.9 0.9 0.03 0.10 2611 55.3 143.5 165.5 8.54 22.71 12 0.3 0.7 1.2 0.09 0.10 0 0.0 0.0 0.0 0.00 0.00
48 1.0 2.6 3.7 0.26 0.42 1 0.0 0.1 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
68 1.4 3.7 3.6 0.16 0.32 3 0.1 0.2 0.2 0.01 0.04 2 0.0 0.1 0.4 0.02 0.02
46 1.0 2.5 3.7 0.25 0.42 32 0.7 1.8 2.5 0.18 0.25 2 0.0 0.1 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00
14 0.3 0.8 1.4 0.10 0.10 75 1.6 4.1 5.9 0.38 0.64 6 0.1 0.3 0.4 0.02 0.05
114 2.4 6.3 6.8 0.35 0.82 81 1.7 4.5 5.8 0.33 0.61 59 1.2 3.2 4.2 0.27 0.39 1 0.0 0.1 0.1 0.01 0.01
26 0.6 1.4 2.0 0.14 0.21 24 0.5 1.3 1.2 0.04 0.15
71 1.5 3.9 4.5 0.31 0.51 4728 259.9 304.7 16.63 38.49 4721 100.0 259.5 304.1 16.59 38.42
0 0.0 0.0 0.0 0.00 0.00 7 0.2 0.3 0.4 0.03 0.04 5 0.2 0.2 0.2 0.01 0.02
14 0.4 0.7 0.9 0.06 0.09 6 0.2 0.3 0.3 0.01 0.04 1 0.0 0.0 0.1 0.01 0.01 3 0.1 0.1 0.2 0.02 0.02 1 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
11 0.3 0.5 0.4 0.01 0.05 174 5.4 8.2 7.2 0.30 0.81 19 0.6 0.9 1.2 0.09 0.15
318 9.9 15.0 15.0 0.87 1.72 100 3.1 4.7 5.0 0.29 0.64 22 0.7 1.0 1.2 0.10 0.13 33 1.0 1.6 1.5 0.08 0.18 39 1.2 1.8 1.7 0.07 0.21
115 3.6 5.4 4.7 0.20 0.54 6 0.2 0.3 0.3 0.03 0.03 6 0.2 0.3 0.3 0.02 0.04
142 4.4 6.7 7.1 0.42 0.86 4 0.1 0.2 0.3 0.02 0.03 8 0.2 0.4 0.7 0.03 0.06
36 1.1 1.7 2.1 0.17 0.20 8 0.4 0.6 0.04 0.05 1 0.0 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
23 0.7 1.1 1.4 0.09 0.16 1037 32.4 49.0 62.5 4.95 6.89
2 0.1 0.1 0.0 0.00 0.00 1 0.0 0.0 0.0 0.00 0.00
129 4.0 6.1 7.1 0.48 0.69 153 4.8 7.2 8.3 0.51 1.10 7 0.2 0.3 0.3 0.03 0.04
70 2.2 3.3 4.7 0.29 0.53 5 0.2 0.2 0.3 0.03 0.03 1 0.0 0.0 0.1 0.01 0.01
36 1.1 1.7 2.0 0.09 0.20 2 0.1 0.1 0.1 0.00 0.01 0 0.0 0.0 0.0 0.00 0.00
33 1.0 1.6 1.3 0.04 0.14 1 0.0 0.0 0.0 0.00 0.01 1 0.0 0.0 0.2 0.01 0.01
32 1.0 1.5 2.1 0.17 0.24 134 4.2 6.3 9.7 0.77 0.95 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
13 0.4 0.6 1.2 0.08 0.10 74 2.3 3.5 4.0 0.27 0.44 3 0.1 0.1 0.2 0.01 0.01
126 3.9 5.9 5.5 0.26 0.65 67 2.1 3.2 3.8 0.15 0.34 53 1.7 2.5 3.1 0.17 0.33 2 0.1 0.1 0.1 0.00 0.00
21 0.7 1.0 1.0 0.09 0.09 35 1.1 1.7 1.6 0.07 0.17
69 2.2 3.3 3.1 0.17 0.31 3209 151.5 175.1 11.62 19.37 3201 100.0 151.1 174.5 11.58 19.31
*See note following population pyramid
*France, Martinique (2008–2012)
198
Central and South America
French GuianaCONTRIBUTORSF. QuetM. AdamiS. BelliardoE. FleygnacN. GandolfoJ. PlenetS. Labbe
French Guiana (2008−2012)Average annual person−years by sex and age group
14 406 0- 13 920
13 891 5- 13 571
12 591 10- 11 789
10 417 15- 10 484
7 768 20- 8 557
8 177 25- 9 357
7 837 30- 8 758
8 157 35- 8 622
7 420 40- 7 510
6 373 45- 6 405
5 415 50- 5 219
4 118 55- 3 950
2 820 60- 2 655
1 834 65- 1 748
1 057 70- 1 324
710 75- 889
455 80- 600
287 85+ 624
Total113 733 115 982Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Fluctuation in rates from year to year.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 118.5Trachea, bronchus, and lung 24.1Stomach 17.1Colon 16.9Non-melanoma skin cancer 12.7Liver 11.2Non-Hodgkin lymphoma 11.2Bladder 9.4Pancreas 8.7Lymphoid leukaemia 6.7Multiple myeloma 6.5Rectum 6.3Kidney 5.8Oesophagus 5.6Myeloid leukaemia 5.4Brain and nervous system 4.9Larynx 4.8Mouth 4.4Melanoma of skin 3.9Other and unspecified 3.8
All sites 325.1
Breast 52.3Cervix uteri 20.7Colon 13.0Trachea, bronchus, and lung 10.4Ovary 9.8Multiple myeloma 8.8Stomach 8.5Non-melanoma skin cancer 7.3Thyroid 7.2Pancreas 6.7Corpus uteri 6.7Non-Hodgkin lymphoma 6.5Other and unspecified 5.1Bladder 5.0Melanoma of skin 4.1Brain and nervous system 3.7Lymphoid leukaemia 3.3Kidney 3.2Rectum 3.2Liver 2.9
All sites 216.6
French Guiana (2008−2012)Average annual person−years by sex and age group
14 406 0- 13 920
13 891 5- 13 571
12 591 10- 11 789
10 417 15- 10 484
7 768 20- 8 557
8 177 25- 9 357
7 837 30- 8 758
8 157 35- 8 622
7 420 40- 7 510
6 373 45- 6 405
5 415 50- 5 219
4 118 55- 3 950
2 820 60- 2 655
1 834 65- 1 748
1 057 70- 1 324
710 75- 889
455 80- 600
287 85+ 624
Total113 733 115 982Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*Fluctuation in rates from year to year.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 118.5Trachea, bronchus, and lung 24.1Stomach 17.1Colon 16.9Non-melanoma skin cancer 12.7Liver 11.2Non-Hodgkin lymphoma 11.2Bladder 9.4Pancreas 8.7Lymphoid leukaemia 6.7Multiple myeloma 6.5Rectum 6.3Kidney 5.8Oesophagus 5.6Myeloid leukaemia 5.4Brain and nervous system 4.9Larynx 4.8Mouth 4.4Melanoma of skin 3.9Other and unspecified 3.8
All sites 325.1
Breast 52.3Cervix uteri 20.7Colon 13.0Trachea, bronchus, and lung 10.4Ovary 9.8Multiple myeloma 8.8Stomach 8.5Non-melanoma skin cancer 7.3Thyroid 7.2Pancreas 6.7Corpus uteri 6.7Non-Hodgkin lymphoma 6.5Other and unspecified 5.1Bladder 5.0Melanoma of skin 4.1Brain and nervous system 3.7Lymphoid leukaemia 3.3Kidney 3.2Rectum 3.2Liver 2.9
All sites 216.6
French Guiana (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONData obtained from continuous censuses conducted by the National Institute of Statistics and Economic Studies (INSEE) during the period 2008–2012 (https://www.insee.fr/fr/statistiques).
NOTES ON THE DATA*Fluctuation in rates from year to year. †C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
199
Central and South America
*French Guiana (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
1 0.1 0.1 0.3 0.00 0.05 10 0.8 0.9 2.2 0.17 0.28 18 1.5 1.6 4.4 0.25 0.41 4 0.3 0.4 0.9 0.05 0.11
11 0.9 1.0 2.4 0.13 0.28 6 0.5 0.5 1.6 0.08 0.23
10 0.8 0.9 2.0 0.14 0.23 5 0.4 0.4 1.2 0.06 0.11 3 0.2 0.3 0.8 0.06 0.06
20 1.6 1.8 5.6 0.29 0.75 70 5.7 6.2 17.1 0.87 1.51 11 0.9 1.0 2.5 0.22 0.27 61 5.0 5.4 16.9 0.80 2.48 26 2.1 2.3 6.3 0.41 0.57 3 0.2 0.3 0.6 0.05 0.05
44 3.6 3.9 11.2 0.54 1.30 7 0.6 0.6 2.1 0.03 0.24
32 2.6 2.8 8.7 0.32 1.20 7 0.6 0.6 1.7 0.07 0.22
20 1.6 1.8 4.8 0.26 0.53 91 7.5 8.0 24.1 1.21 3.10 4 0.3 0.4 1.0 0.03 0.14 5 0.4 0.4 1.3 0.02 0.13
16 1.3 1.4 3.9 0.24 0.50 50 4.4 12.7 0.60 1.59 1 0.1 0.1 0.2 0.01 0.01 4 0.3 0.4 0.6 0.06 0.06 8 0.7 0.7 1.5 0.09 0.09 3 0.2 0.3 0.6 0.02 0.02
9 0.7 0.8 2.4 0.11 0.31 421 34.5 37.0 118.5 5.19 15.76 10 0.8 0.9 1.8 0.11 0.11 1 0.1 0.1 0.2 0.02 0.02
26 2.1 2.3 5.8 0.47 0.58 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
36 3.0 3.2 9.4 0.53 1.18 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.2 0.00 0.00
26 2.1 2.3 4.9 0.43 0.49 8 0.7 0.7 1.5 0.12 0.12 5 0.4 0.4 0.9 0.06 0.06 1 0.1 0.1 0.2 0.02 0.02 5 0.4 0.4 1.0 0.06 0.11
47 3.9 4.1 11.2 0.59 1.30 6 0.5 0.5 1.3 0.09 0.15
26 2.1 2.3 6.5 0.39 0.79 31 2.5 2.7 6.7 0.31 0.53 25 2.0 2.2 5.4 0.28 0.71 6 0.5 0.5 1.3 0.08 0.14 5 0.4 0.4 1.0 0.11 0.11 8 0.7 0.7 2.0 0.06 0.15
16 1.3 1.4 3.8 0.22 0.27 1270 111.7 325.1 16.33 39.44 1220 100.0 107.3 312.4 15.72 37.85
1 0.1 0.1 0.2 0.02 0.02 2 0.2 0.2 0.5 0.05 0.05 2 0.2 0.2 0.4 0.05 0.05 2 0.2 0.2 0.4 0.04 0.04 2 0.2 0.2 0.4 0.04 0.04 0 0.0 0.0 0.0 0.00 0.00 3 0.3 0.3 0.5 0.04 0.04 0 0.0 0.0 0.0 0.00 0.00 1 0.1 0.1 0.2 0.02 0.02 4 0.4 0.3 1.0 0.09 0.09
38 3.9 3.3 8.5 0.39 0.92 6 0.6 0.5 1.1 0.03 0.03
60 6.2 5.2 13.0 0.79 1.36 12 1.2 1.0 3.2 0.10 0.38 9 0.9 0.8 1.9 0.09 0.22
13 1.3 1.1 2.9 0.16 0.35 7 0.7 0.6 1.6 0.10 0.21
27 2.8 2.3 6.7 0.26 0.85 4 0.4 0.3 0.8 0.08 0.08 6 0.6 0.5 1.4 0.15 0.15
41 4.2 3.5 10.4 0.54 1.36 3 0.3 0.3 0.5 0.05 0.05 8 0.8 0.7 1.5 0.08 0.14
19 1.9 1.6 4.1 0.27 0.54 35 3.0 7.3 0.54 0.69 0 0.0 0.0 0.0 0.00 0.00 2 0.2 0.2 0.3 0.03 0.03 9 0.9 0.8 1.8 0.07 0.22
252 25.8 21.7 52.3 3.96 5.97 1 0.1 0.1 0.1 0.01 0.01 3 0.3 0.3 0.7 0.01 0.07
104 10.7 9.0 20.7 1.43 2.24 31 3.2 2.7 6.7 0.37 0.69 8 0.8 0.7 1.8 0.09 0.22
41 4.2 3.5 9.8 0.56 1.17 2 0.2 0.2 0.4 0.04 0.04 4 0.4 0.3 0.7 0.04 0.04
14 1.4 1.2 3.2 0.19 0.40 0 0.0 0.0 0.0 0.00 0.00 2 0.2 0.2 0.5 0.05 0.05
19 1.9 1.6 5.0 0.33 0.63 1 0.1 0.1 0.2 0.02 0.02 3 0.3 0.3 0.5 0.05 0.05
20 2.1 1.7 3.7 0.22 0.35 37 3.8 3.2 7.2 0.61 0.74 3 0.3 0.3 0.5 0.04 0.04 5 0.5 0.4 0.8 0.04 0.04 5 0.5 0.4 1.0 0.11 0.11
32 3.3 2.8 6.5 0.40 0.74 5 0.5 0.4 1.2 0.03 0.15
36 3.7 3.1 8.8 0.33 1.11 14 1.4 1.2 3.3 0.15 0.49 12 1.2 1.0 2.2 0.16 0.16 3 0.3 0.3 0.7 0.03 0.08 6 0.6 0.5 1.1 0.07 0.07 6 0.6 0.5 0.9 0.06 0.06
25 2.6 2.2 5.1 0.31 0.54 1010 87.1 216.6 13.82 24.26 975 100.0 84.1 209.2 13.28 23.57
†*See note following population pyramid
*French Guiana (2008–2012)
200
Central and South America
Jamaica, Kingston and St AndrewCONTRIBUTORSBarrie HanchardTracey N. GibsonDawn P. McNaughtonNadeen Waugh
Jamaica, Kingston and St Andrew (2008−2011)Average annual person−years by sex and age group
22 676 0- 21 880
23 706 5- 23 336
31 694 10- 30 666
32 783 15- 32 412
32 607 20- 34 176
29 049 25- 31 266
22 995 30- 25 369
21 240 35- 24 496
22 586 40- 24 160
19 671 45- 26 972
15 675 50- 17 640
12 202 55- 12 232
10 385 60- 10 615
7 174 65- 7 563
5 309 70- 5 926
4 081 75- 5 147
2 713 80- 4 137
2 001 85+ 4 516
Total318 547 342 509Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*No official mortality data.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 72.7Trachea, bronchus, and lung 18.9Other and unspecified 11.6Colon 10.7Stomach 7.8Non-melanoma skin cancer 6.9Rectum 5.9Non-Hodgkin lymphoma 5.6Bladder 5.1Multiple myeloma 3.2Lymphoid leukaemia 2.7Larynx 2.4Pancreas 2.2Kidney 2.0Oesophagus 2.0Mouth 1.6Brain and nervous system 1.5Myeloid leukaemia 1.3Penis 1.1Connective and soft tissue 0.8
All sites 177.0
Breast 45.7Cervix uteri 15.7Corpus uteri 14.8Colon 10.5Other and unspecified 7.1Non-melanoma skin cancer 5.3Non-Hodgkin lymphoma 4.8Rectum 4.6Thyroid 4.3Ovary 3.9Trachea, bronchus, and lung 3.8Stomach 3.7Lymphoid leukaemia 2.8Multiple myeloma 2.6Pancreas 2.0Brain and nervous system 1.9Bladder 1.6Gallbladder etc. 1.6Kidney 1.3Myeloid leukaemia 1.3
All sites 149.4
Jamaica, Kingston and St Andrew (2008−2011)Average annual person−years by sex and age group
22 676 0- 21 880
23 706 5- 23 336
31 694 10- 30 666
32 783 15- 32 412
32 607 20- 34 176
29 049 25- 31 266
22 995 30- 25 369
21 240 35- 24 496
22 586 40- 24 160
19 671 45- 26 972
15 675 50- 17 640
12 202 55- 12 232
10 385 60- 10 615
7 174 65- 7 563
5 309 70- 5 926
4 081 75- 5 147
2 713 80- 4 137
2 001 85+ 4 516
Total318 547 342 509Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*No official mortality data.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 72.7Trachea, bronchus, and lung 18.9Other and unspecified 11.6Colon 10.7Stomach 7.8Non-melanoma skin cancer 6.9Rectum 5.9Non-Hodgkin lymphoma 5.6Bladder 5.1Multiple myeloma 3.2Lymphoid leukaemia 2.7Larynx 2.4Pancreas 2.2Kidney 2.0Oesophagus 2.0Mouth 1.6Brain and nervous system 1.5Myeloid leukaemia 1.3Penis 1.1Connective and soft tissue 0.8
All sites 177.0
Breast 45.7Cervix uteri 15.7Corpus uteri 14.8Colon 10.5Other and unspecified 7.1Non-melanoma skin cancer 5.3Non-Hodgkin lymphoma 4.8Rectum 4.6Thyroid 4.3Ovary 3.9Trachea, bronchus, and lung 3.8Stomach 3.7Lymphoid leukaemia 2.8Multiple myeloma 2.6Pancreas 2.0Brain and nervous system 1.9Bladder 1.6Gallbladder etc. 1.6Kidney 1.3Myeloid leukaemia 1.3
All sites 149.4
Jamaica, Kingston and St Andrew (2008–2011)Average annual person–years by sex and age group
SOURCE OF POPULATIONProvided by the Statistical Institute of Jamaica.
NOTES ON THE DATA*No official mortality data. †C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
201
Central and South America
*Jamaica, Kingston and St Andrew (2008−2011)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
0 0.0 0.0 0.0 0.00 0.00 9 0.4 0.4 0.8 0.04 0.09
19 0.9 0.7 1.6 0.09 0.23 7 0.3 0.3 0.5 0.04 0.06 4 0.2 0.2 0.3 0.03 0.03 4 0.2 0.2 0.3 0.02 0.05
10 0.5 0.4 0.8 0.07 0.07 6 0.3 0.2 0.5 0.02 0.06 0 0.0 0.0 0.0 0.00 0.00
23 1.1 0.9 2.0 0.10 0.27 101 4.9 4.0 7.8 0.38 0.86 8 0.4 0.3 0.7 0.04 0.08
134 6.5 5.3 10.7 0.61 1.28 72 3.5 2.8 5.9 0.24 0.76 9 0.4 0.4 0.8 0.04 0.13
10 0.5 0.4 0.8 0.04 0.09 9 0.4 0.4 0.6 0.03 0.04
29 1.4 1.1 2.2 0.12 0.22 1 0.0 0.0 0.1 0.01 0.01
30 1.4 1.2 2.4 0.15 0.23 223 10.8 8.8 18.9 1.14 2.42 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.2 0.3 0.02 0.04 8 0.4 0.3 0.6 0.04 0.05
81 3.2 6.9 0.46 0.90 1 0.0 0.0 0.1 0.00 0.02 0 0.0 0.0 0.0 0.00 0.00
10 0.5 0.4 0.8 0.06 0.06 9 0.4 0.4 0.7 0.03 0.07
13 0.6 0.5 1.1 0.09 0.13 880 42.5 34.5 72.7 3.07 9.37 5 0.2 0.2 0.4 0.03 0.03 3 0.1 0.1 0.3 0.02 0.04
23 1.1 0.9 2.0 0.12 0.26 1 0.0 0.0 0.1 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00
65 3.1 2.6 5.1 0.28 0.58 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.2 0.3 0.02 0.02
18 0.9 0.7 1.5 0.10 0.14 9 0.4 0.4 0.8 0.06 0.11 3 0.1 0.1 0.4 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 8 0.4 0.3 0.5 0.04 0.04
71 3.4 2.8 5.6 0.41 0.61 1 0.0 0.0 0.1 0.00 0.02
36 1.7 1.4 3.2 0.17 0.50 33 1.6 1.3 2.7 0.13 0.22 17 0.8 0.7 1.3 0.07 0.14 3 0.1 0.1 0.2 0.01 0.01 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
136 6.6 5.3 11.6 0.56 1.60 2150 84.4 177.0 9.03 21.96 2069 100.0 81.2 170.2 8.57 21.06
1 0.0 0.0 0.1 0.00 0.02 4 0.2 0.1 0.2 0.01 0.01 9 0.4 0.3 0.7 0.00 0.12 7 0.3 0.3 0.5 0.04 0.06 1 0.0 0.0 0.1 0.00 0.02 1 0.0 0.0 0.1 0.00 0.02 3 0.1 0.1 0.2 0.01 0.01 6 0.3 0.2 0.5 0.04 0.06 0 0.0 0.0 0.0 0.00 0.00
13 0.6 0.5 0.9 0.04 0.12 55 2.6 2.0 3.7 0.15 0.48 6 0.3 0.2 0.4 0.04 0.04
157 7.6 5.7 10.5 0.65 1.23 72 3.5 2.6 4.6 0.30 0.50 9 0.4 0.3 0.5 0.03 0.05 7 0.3 0.3 0.6 0.05 0.07
23 1.1 0.8 1.6 0.06 0.19 28 1.3 1.0 2.0 0.10 0.29 9 0.4 0.3 0.5 0.02 0.05 3 0.1 0.1 0.2 0.01 0.01
54 2.6 2.0 3.8 0.23 0.46 0 0.0 0.0 0.0 0.00 0.00 3 0.1 0.1 0.2 0.01 0.01 5 0.2 0.2 0.4 0.04 0.06
81 3.0 5.3 0.32 0.64 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00 4 0.2 0.1 0.3 0.03 0.03
670 32.2 24.5 45.7 3.42 5.13 16 0.8 0.6 1.1 0.10 0.12 7 0.3 0.3 0.5 0.03 0.05
233 11.2 8.5 15.7 1.23 1.70 194 9.3 7.1 14.8 0.86 2.05 1 0.0 0.0 0.1 0.00 0.02
54 2.6 2.0 3.9 0.24 0.47 1 0.0 0.0 0.1 0.00 0.02 3 0.1 0.1 0.2 0.01 0.01
16 0.8 0.6 1.3 0.07 0.14 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
28 1.3 1.0 1.6 0.03 0.17 0 0.0 0.0 0.0 0.00 0.00 6 0.3 0.2 0.5 0.03 0.03
23 1.1 0.8 1.9 0.10 0.14 61 2.9 2.2 4.3 0.32 0.47 3 0.1 0.1 0.3 0.02 0.02 0 0.0 0.0 0.0 0.00 0.00 7 0.3 0.3 0.5 0.04 0.04
70 3.4 2.6 4.8 0.33 0.46 3 0.1 0.1 0.2 0.02 0.02
35 1.7 1.3 2.6 0.13 0.39 40 1.9 1.5 2.8 0.19 0.29 21 1.0 0.8 1.3 0.09 0.09 5 0.2 0.2 0.4 0.02 0.04 0 0.0 0.0 0.0 0.00 0.00 0 0.0 0.0 0.0 0.00 0.00
101 4.9 3.7 7.1 0.41 0.86 2159 78.8 149.4 9.87 17.28 2078 100.0 75.8 144.1 9.55 16.64
§Includes 5 cases of unknown age §Includes 6 cases of unknown age
†*See note following population pyramid
*Jamaica, Kingston and St Andrew (2008–2011)
202
Central and South America
Peru, LimaCONTRIBUTORSEduardo PayetPatricia PerezEbert PoquiomaEdgar DiazSaria Villanueva
Peru, Lima (2010−2012)Average annual person−years by sex and age group
400 834 0- 383 780
399 170 5- 381 205
398 256 10- 385 304
436 067 15- 444 146
417 550 20- 434 356
399 962 25- 426 657
386 983 30- 416 547
331 118 35- 354 649
297 989 40- 316 016
268 523 45- 286 844
216 078 50- 239 703
172 904 55- 196 464
134 429 60- 153 464
102 017 65- 118 951
76 580 70- 92 961
52 796 75- 68 993
25 734 80- 35 609
19 522 85+ 32 757
Total4 536 512 4 768 406Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*High DCO%.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 48.6Non-melanoma skin cancer 28.7Stomach 21.2Trachea, bronchus, and lung 13.3Non-Hodgkin lymphoma 11.2Colon 11.1Kidney 7.6Other and unspecified 6.9Bladder 6.0Liver 5.4Brain and nervous system 4.8Pancreas 4.7Rectum 3.9Gallbladder etc. 3.7Testis 3.3Connective and soft tissue 3.2Lymphoid leukaemia 3.0Melanoma of skin 3.0Thyroid 2.6Multiple myeloma 2.6
All sites 217.0
Breast 40.8Non-melanoma skin cancer 23.4Cervix uteri 21.1Stomach 13.7Thyroid 10.9Colon 10.3Trachea, bronchus, and lung 9.5Non-Hodgkin lymphoma 8.5Ovary 7.7Other and unspecified 6.9Corpus uteri 5.8Gallbladder etc. 5.5Pancreas 4.2Brain and nervous system 4.0Liver 4.0Rectum 3.6Kidney 3.4Lymphoid leukaemia 2.6Melanoma of skin 2.3Connective and soft tissue 2.1
All sites 211.0
Peru, Lima (2010−2012)Average annual person−years by sex and age group
400 834 0- 383 780
399 170 5- 381 205
398 256 10- 385 304
436 067 15- 444 146
417 550 20- 434 356
399 962 25- 426 657
386 983 30- 416 547
331 118 35- 354 649
297 989 40- 316 016
268 523 45- 286 844
216 078 50- 239 703
172 904 55- 196 464
134 429 60- 153 464
102 017 65- 118 951
76 580 70- 92 961
52 796 75- 68 993
25 734 80- 35 609
19 522 85+ 32 757
Total4 536 512 4 768 406Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Notes on the data*High DCO%.�
†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 48.6Non-melanoma skin cancer 28.7Stomach 21.2Trachea, bronchus, and lung 13.3Non-Hodgkin lymphoma 11.2Colon 11.1Kidney 7.6Other and unspecified 6.9Bladder 6.0Liver 5.4Brain and nervous system 4.8Pancreas 4.7Rectum 3.9Gallbladder etc. 3.7Testis 3.3Connective and soft tissue 3.2Lymphoid leukaemia 3.0Melanoma of skin 3.0Thyroid 2.6Multiple myeloma 2.6
All sites 217.0
Breast 40.8Non-melanoma skin cancer 23.4Cervix uteri 21.1Stomach 13.7Thyroid 10.9Colon 10.3Trachea, bronchus, and lung 9.5Non-Hodgkin lymphoma 8.5Ovary 7.7Other and unspecified 6.9Corpus uteri 5.8Gallbladder etc. 5.5Pancreas 4.2Brain and nervous system 4.0Liver 4.0Rectum 3.6Kidney 3.4Lymphoid leukaemia 2.6Melanoma of skin 2.3Connective and soft tissue 2.1
All sites 211.0
Peru, Lima (2010–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation projections based on the 2007 national population census. National Institute of Statistics and Informatics (INEI).
NOTES ON THE DATA*High DCO%. †C67 (bladder cancer) includes neo-plasms of uncertain or unknown behaviour together with invasive cancers.
203
Central and South America
*Peru, Lima (2010−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
12 0.1 0.0 0.1 0.00 0.01 99 0.4 0.4 0.8 0.04 0.10
141 0.6 0.5 1.1 0.05 0.12 64 0.3 0.2 0.5 0.03 0.05 33 0.1 0.1 0.3 0.02 0.03 25 0.1 0.1 0.2 0.01 0.02 35 0.1 0.1 0.3 0.02 0.03 33 0.1 0.1 0.3 0.01 0.02 7 0.0 0.0 0.1 0.00 0.00
224 0.9 0.8 1.8 0.05 0.18 2665 11.3 9.8 21.2 0.84 2.20 128 0.5 0.5 1.0 0.05 0.10
1393 5.9 5.1 11.1 0.45 1.14 494 2.1 1.8 3.9 0.19 0.44 44 0.2 0.2 0.4 0.02 0.04
689 2.9 2.5 5.4 0.24 0.53 452 1.9 1.7 3.7 0.16 0.42 568 2.4 2.1 4.7 0.21 0.54 72 0.3 0.3 0.6 0.03 0.06
261 1.1 1.0 2.1 0.08 0.25 1656 7.0 6.1 13.3 0.51 1.49 80 0.3 0.3 0.6 0.03 0.06
158 0.7 0.6 1.1 0.07 0.09 377 1.6 1.4 3.0 0.13 0.31
3626 13.3 28.7 0.97 2.79 70 0.3 0.3 0.6 0.03 0.07
215 0.9 0.8 1.5 0.09 0.14 416 1.8 1.5 3.2 0.16 0.31 21 0.1 0.1 0.2 0.01 0.02
147 0.6 0.5 1.1 0.05 0.11 5939 25.1 21.8 48.6 1.30 5.57 505 2.1 1.9 3.3 0.23 0.24 15 0.1 0.1 0.1 0.00 0.01
934 3.9 3.4 7.6 0.42 0.90 37 0.2 0.1 0.3 0.02 0.03 8 0.0 0.0 0.1 0.00 0.00
747 3.2 2.7 6.0 0.19 0.56 12 0.1 0.0 0.1 0.00 0.00 85 0.4 0.3 0.7 0.03 0.06
642 2.7 2.4 4.8 0.30 0.46 336 1.4 1.2 2.6 0.18 0.29 9 0.0 0.0 0.1 0.01 0.01 9 0.0 0.0 0.1 0.00 0.00
145 0.6 0.5 1.1 0.06 0.11 1432 6.0 5.3 11.2 0.57 1.17 25 0.1 0.1 0.2 0.01 0.03
318 1.3 1.2 2.6 0.12 0.32 377 1.6 1.4 3.0 0.15 0.19 328 1.4 1.2 2.5 0.14 0.25 145 0.6 0.5 1.1 0.05 0.10 50 0.2 0.2 0.4 0.02 0.03
120 0.5 0.4 0.9 0.03 0.08
886 3.7 3.3 6.9 0.34 0.71 27309 100.3 217.0 8.73 22.81 23683 100.0 87.0 188.3 7.76 20.02
8 0.0 0.0 0.0 0.00 0.00 155 0.5 0.5 1.0 0.05 0.11 149 0.5 0.5 1.0 0.06 0.10 77 0.3 0.3 0.5 0.03 0.05 18 0.1 0.1 0.1 0.01 0.01 17 0.1 0.1 0.1 0.01 0.01 11 0.0 0.0 0.1 0.01 0.01 30 0.1 0.1 0.2 0.02 0.02 8 0.0 0.0 0.0 0.00 0.00
91 0.3 0.3 0.6 0.03 0.06 2140 7.6 7.5 13.7 0.63 1.42 134 0.5 0.5 0.9 0.05 0.10
1603 5.7 5.6 10.3 0.45 1.07 551 2.0 1.9 3.6 0.19 0.39 180 0.6 0.6 1.2 0.07 0.15 626 2.2 2.2 4.0 0.16 0.41 836 3.0 2.9 5.5 0.29 0.61 646 2.3 2.3 4.2 0.18 0.48 52 0.2 0.2 0.3 0.02 0.03 45 0.2 0.2 0.3 0.02 0.03
1450 5.1 5.1 9.5 0.46 1.07 69 0.2 0.2 0.4 0.02 0.05
103 0.4 0.4 0.7 0.04 0.07 357 1.3 1.2 2.3 0.12 0.25
3710 13.0 23.4 1.00 2.34 39 0.1 0.1 0.3 0.01 0.03 38 0.1 0.1 0.2 0.01 0.01
315 1.1 1.1 2.1 0.14 0.21 6021 21.3 21.0 40.8 2.99 4.51 146 0.5 0.5 0.9 0.03 0.09 43 0.2 0.2 0.3 0.01 0.03
3161 11.2 11.0 21.1 1.61 2.23 834 3.0 2.9 5.8 0.43 0.68 231 0.8 0.8 1.5 0.08 0.15
1140 4.0 4.0 7.7 0.53 0.85 17 0.1 0.1 0.1 0.01 0.01 68 0.2 0.2 0.4 0.03 0.03
492 1.7 1.7 3.4 0.19 0.35 26 0.1 0.1 0.2 0.00 0.01 8 0.0 0.0 0.0 0.00 0.00
290 1.0 1.0 1.8 0.07 0.18 12 0.0 0.0 0.1 0.00 0.01 73 0.3 0.3 0.6 0.03 0.04
588 2.1 2.1 4.0 0.25 0.39 1652 5.8 5.8 10.9 0.83 1.12 15 0.1 0.1 0.1 0.01 0.01 9 0.0 0.0 0.1 0.00 0.01
89 0.3 0.3 0.6 0.04 0.04 1285 4.5 4.5 8.5 0.47 0.92 53 0.2 0.2 0.4 0.02 0.05
251 0.9 0.9 1.7 0.09 0.20 338 1.2 1.2 2.6 0.15 0.18 277 1.0 1.0 1.9 0.11 0.18 134 0.5 0.5 0.9 0.04 0.08 61 0.2 0.2 0.4 0.03 0.04
119 0.4 0.4 0.8 0.03 0.07
1070 3.8 3.7 6.9 0.37 0.70 31961 111.7 211.0 12.52 22.27 28251 100.0 98.7 187.6 11.52 19.94
§Includes 26 cases of unknown age §Includes 51 cases of unknown age
†*See note following population pyramid
*Peru, Lima (2010–2012)
204
Central and South America
USA, Puerto RicoCONTRIBUTORSDiego E. Zavala ZegarraCarlos Torres CintronMariela Alvarado OrtizYadira Roman RuizNivia E. Vazquez CubanoGladys Ojeda ReyesJulio Arce CortesOmar Centeno RodriguezKaren Ortiz OrtizGuillermo Tortolero Luna
USA, Puerto Rico (2008−2012)Average annual person−years by sex and age group
114 937 0- 109 902
125 507 5- 119 523
140 576 10- 133 806
145 666 15- 139 989
135 167 20- 133 939
125 441 25- 130 135
123 717 30- 132 408
119 783 35- 128 482
118 672 40- 130 500
117 880 45- 134 662
111 862 50- 130 636
103 496 55- 123 432
98 593 60- 117 687
81 234 65- 97 890
62 539 70- 76 497
44 458 75- 58 315
28 750 80- 41 439
24 796 85+ 41 786
Total1 823 074 1 981 028Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 100.8Colon 21.6Trachea, bronchus, and lung 14.7Rectum 10.2Bladder 9.4Non-Hodgkin lymphoma 9.3Liver 8.3Kidney 6.7Stomach 6.1Thyroid 5.9Other and unspecified 5.3Pancreas 4.9Larynx 4.3Brain and nervous system 4.2Oesophagus 4.0Multiple myeloma 3.3Testis 3.2Lymphoid leukaemia 3.2Myeloid leukaemia 2.7Hodgkin lymphoma 2.6
All sites 259.0
Breast 58.7Thyroid 25.5Colon 15.5Corpus uteri 15.4Cervix uteri 9.3Non-Hodgkin lymphoma 7.2Trachea, bronchus, and lung 6.9Rectum 5.5Ovary 5.1Other and unspecified 3.7Stomach 3.5Pancreas 3.4Kidney 3.3Brain and nervous system 3.1Bladder 2.7Myeloid leukaemia 2.4Multiple myeloma 2.4Liver 2.3Hodgkin lymphoma 2.0Lymphoid leukaemia 1.9
All sites 198.4
USA, Puerto Rico (2008−2012)Average annual person−years by sex and age group
114 937 0- 109 902
125 507 5- 119 523
140 576 10- 133 806
145 666 15- 139 989
135 167 20- 133 939
125 441 25- 130 135
123 717 30- 132 408
119 783 35- 128 482
118 672 40- 130 500
117 880 45- 134 662
111 862 50- 130 636
103 496 55- 123 432
98 593 60- 117 687
81 234 65- 97 890
62 539 70- 76 497
44 458 75- 58 315
28 750 80- 41 439
24 796 85+ 41 786
Total1 823 074 1 981 028Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 100.8Colon 21.6Trachea, bronchus, and lung 14.7Rectum 10.2Bladder 9.4Non-Hodgkin lymphoma 9.3Liver 8.3Kidney 6.7Stomach 6.1Thyroid 5.9Other and unspecified 5.3Pancreas 4.9Larynx 4.3Brain and nervous system 4.2Oesophagus 4.0Multiple myeloma 3.3Testis 3.2Lymphoid leukaemia 3.2Myeloid leukaemia 2.7Hodgkin lymphoma 2.6
All sites 259.0
Breast 58.7Thyroid 25.5Colon 15.5Corpus uteri 15.4Cervix uteri 9.3Non-Hodgkin lymphoma 7.2Trachea, bronchus, and lung 6.9Rectum 5.5Ovary 5.1Other and unspecified 3.7Stomach 3.5Pancreas 3.4Kidney 3.3Brain and nervous system 3.1Bladder 2.7Myeloid leukaemia 2.4Multiple myeloma 2.4Liver 2.3Hodgkin lymphoma 2.0Lymphoid leukaemia 1.9
All sites 198.4
USA, Puerto Rico (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONUnited States Census Bureau.
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
205
Central and South America
USA, Puerto Rico (2008−2012)
S I T E ICD-10
Male
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
§No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
44 0.1 0.2 0.3 0.02 0.03 357 0.9 2.0 2.6 0.18 0.31 318 0.8 1.7 2.2 0.14 0.27 142 0.4 0.8 1.0 0.06 0.11 194 0.5 1.1 1.4 0.11 0.17 97 0.3 0.5 0.7 0.05 0.09 75 0.2 0.4 0.6 0.04 0.08
148 0.4 0.8 1.0 0.05 0.12 118 0.3 0.6 0.8 0.06 0.11 594 1.6 3.3 4.0 0.22 0.49 977 2.6 5.4 6.1 0.28 0.69 167 0.4 0.9 1.2 0.07 0.14
3287 8.7 18.0 21.6 1.09 2.57 1448 3.8 7.9 10.2 0.62 1.25 116 0.3 0.6 0.9 0.06 0.11
1215 3.2 6.7 8.3 0.51 1.00 204 0.5 1.1 1.3 0.07 0.14 754 2.0 4.1 4.9 0.24 0.59 67 0.2 0.4 0.5 0.03 0.06
624 1.7 3.4 4.3 0.25 0.52 2353 6.2 12.9 14.7 0.64 1.79 33 0.1 0.2 0.3 0.02 0.02 92 0.2 0.5 0.9 0.05 0.07
330 0.9 1.8 2.4 0.14 0.25 90 0.5 0.7 0.05 0.07 23 0.1 0.1 0.1 0.00 0.01
109 0.3 0.6 0.9 0.06 0.09 213 0.6 1.2 1.7 0.10 0.17 83 0.2 0.5 0.6 0.03 0.07
221 0.6 1.2 1.5 0.09 0.19 15101 40.1 82.8 100.8 5.03 13.51 299 0.8 1.6 3.2 0.24 0.24 15 0.0 0.1 0.1 0.01 0.01
912 2.4 5.0 6.7 0.42 0.79 30 0.1 0.2 0.2 0.01 0.02 23 0.1 0.1 0.1 0.00 0.01
1554 4.1 8.5 9.4 0.37 1.04 55 0.1 0.3 0.3 0.02 0.03 83 0.2 0.5 0.7 0.04 0.06
466 1.2 2.6 4.2 0.26 0.41 686 1.8 3.8 5.9 0.44 0.62 18 0.0 0.1 0.2 0.01 0.02 14 0.0 0.1 0.2 0.01 0.01
270 0.7 1.5 2.6 0.17 0.22 1238 3.3 6.8 9.3 0.59 0.99 79 0.2 0.4 0.5 0.03 0.06
506 1.3 2.8 3.3 0.17 0.39 366 1.0 2.0 3.2 0.16 0.27 346 0.9 1.9 2.7 0.15 0.27 159 0.4 0.9 1.1 0.04 0.10 110 0.3 0.6 0.8 0.04 0.09 141 0.4 0.8 0.9 0.03 0.08
808 2.1 4.4 5.3 0.27 0.57 37772 207.2 259.0 13.84 31.41 37682 100.0 206.7 258.3 13.79 31.34
24 0.1 0.1 0.1 0.01 0.01 147 0.5 0.7 0.8 0.05 0.08 143 0.4 0.7 0.8 0.04 0.08 99 0.3 0.5 0.6 0.04 0.06 44 0.1 0.2 0.3 0.02 0.04 14 0.0 0.1 0.1 0.00 0.01 15 0.0 0.1 0.1 0.01 0.01 17 0.1 0.1 0.1 0.00 0.01 24 0.1 0.1 0.1 0.00 0.01
159 0.5 0.8 0.7 0.03 0.07 710 2.2 3.6 3.5 0.17 0.39 129 0.4 0.7 0.7 0.04 0.09
2962 9.3 15.0 15.5 0.86 1.76 954 3.0 4.8 5.5 0.34 0.66 198 0.6 1.0 1.1 0.07 0.12 490 1.5 2.5 2.3 0.08 0.27 279 0.9 1.4 1.4 0.06 0.18 720 2.3 3.6 3.4 0.15 0.38 44 0.1 0.2 0.3 0.02 0.03 70 0.2 0.4 0.4 0.03 0.05
1357 4.3 6.8 6.9 0.34 0.81 20 0.1 0.1 0.2 0.01 0.01 76 0.2 0.4 0.7 0.04 0.05
223 0.7 1.1 1.4 0.09 0.14 104 0.5 0.7 0.05 0.06 7 0.0 0.0 0.0 0.00 0.00
15 0.0 0.1 0.1 0.01 0.01 194 0.6 1.0 1.5 0.09 0.13
9205 29.0 46.5 58.7 4.20 6.79 192 0.6 1.0 1.0 0.06 0.11 122 0.4 0.6 0.7 0.04 0.08
1203 3.8 6.1 9.3 0.73 0.88 2339 7.4 11.8 15.4 1.16 1.86 135 0.4 0.7 0.8 0.06 0.09 829 2.6 4.2 5.1 0.33 0.56 42 0.1 0.2 0.3 0.02 0.03 6 0.0 0.0 0.1 0.00 0.00
514 1.6 2.6 3.3 0.21 0.37 31 0.1 0.2 0.1 0.00 0.01 23 0.1 0.1 0.1 0.00 0.01
570 1.8 2.9 2.7 0.11 0.29 27 0.1 0.1 0.1 0.01 0.01 38 0.1 0.2 0.3 0.02 0.02
412 1.3 2.1 3.1 0.19 0.31 3249 10.2 16.4 25.5 2.00 2.55 19 0.1 0.1 0.2 0.01 0.02 10 0.0 0.1 0.1 0.01 0.01
231 0.7 1.2 2.0 0.13 0.16 1184 3.7 6.0 7.2 0.45 0.80 93 0.3 0.5 0.6 0.04 0.07
449 1.4 2.3 2.4 0.12 0.29 225 0.7 1.1 1.9 0.09 0.15 339 1.1 1.7 2.4 0.15 0.22 153 0.5 0.8 0.8 0.04 0.08 138 0.4 0.7 0.8 0.05 0.09 115 0.4 0.6 0.5 0.02 0.05
759 2.4 3.8 3.7 0.18 0.38 31890 161.0 198.4 13.09 21.81 31786 100.0 160.5 197.7 13.04 21.75
§Includes 20 cases of unknown age §Includes 7 cases of unknown age
† See note following population pyramid
USA, Puerto Rico (2008–2012)
206
Central and South America
UruguayCONTRIBUTORSEnrique BarriosRafael AlonsoMariela GarauCarina Musetti
Uruguay (2008−2012)Average annual person−years by sex and age group
121 672 0- 116 231
129 700 5- 124 192
137 423 10- 132 158
134 151 15- 130 079
126 481 20- 123 952
120 192 25- 120 074
120 665 30- 122 944
112 169 35- 115 378
102 369 40- 107 776
101 445 45- 107 928
95 402 50- 102 752
82 462 55- 91 164
70 361 60- 81 151
59 515 65- 72 778
48 134 70- 65 108
37 651 75- 58 106
24 494 80- 44 057
16 118 85+ 39 153
Total1 640 404 1 754 981Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 59.3Non-melanoma skin cancer 47.4Trachea, bronchus, and lung 46.4Colon 24.0Bladder 16.1Kidney 14.0Stomach 13.2Other and unspecified 12.5Rectum 12.0Non-Hodgkin lymphoma 10.1Pancreas 9.4Oesophagus 7.2Testis 6.1Brain and nervous system 6.0Larynx 6.0Melanoma of skin 5.1Gallbladder etc. 3.2Myeloid leukaemia 3.2Liver 3.1Lymphoid leukaemia 2.9
All sites 337.0
Breast 65.8Non-melanoma skin cancer 32.4Colon 19.2Cervix uteri 14.6Trachea, bronchus, and lung 10.8Thyroid 9.9Other and unspecified 8.5Corpus uteri 8.0Ovary 7.4Pancreas 7.1Non-Hodgkin lymphoma 6.7Rectum 6.7Kidney 6.1Stomach 5.7Brain and nervous system 4.0Gallbladder etc. 3.8Melanoma of skin 3.6Bladder 3.2Myeloid leukaemia 2.3Multiple myeloma 2.2
All sites 248.7
Uruguay (2008−2012)Average annual person−years by sex and age group
121 672 0- 116 231
129 700 5- 124 192
137 423 10- 132 158
134 151 15- 130 079
126 481 20- 123 952
120 192 25- 120 074
120 665 30- 122 944
112 169 35- 115 378
102 369 40- 107 776
101 445 45- 107 928
95 402 50- 102 752
82 462 55- 91 164
70 361 60- 81 151
59 515 65- 72 778
48 134 70- 65 108
37 651 75- 58 106
24 494 80- 44 057
16 118 85+ 39 153
Total1 640 404 1 754 981Male (%) Female (%)
0 2 4 6 810 0 2 4 6 8 10
Note on the data†C67 includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
20 major cancers, ASR (World) per 100 000Male FemaleProstate 59.3Non-melanoma skin cancer 47.4Trachea, bronchus, and lung 46.4Colon 24.0Bladder 16.1Kidney 14.0Stomach 13.2Other and unspecified 12.5Rectum 12.0Non-Hodgkin lymphoma 10.1Pancreas 9.4Oesophagus 7.2Testis 6.1Brain and nervous system 6.0Larynx 6.0Melanoma of skin 5.1Gallbladder etc. 3.2Myeloid leukaemia 3.2Liver 3.1Lymphoid leukaemia 2.9
All sites 337.0
Breast 65.8Non-melanoma skin cancer 32.4Colon 19.2Cervix uteri 14.6Trachea, bronchus, and lung 10.8Thyroid 9.9Other and unspecified 8.5Corpus uteri 8.0Ovary 7.4Pancreas 7.1Non-Hodgkin lymphoma 6.7Rectum 6.7Kidney 6.1Stomach 5.7Brain and nervous system 4.0Gallbladder etc. 3.8Melanoma of skin 3.6Bladder 3.2Myeloid leukaemia 2.3Multiple myeloma 2.2
All sites 248.7
Uruguay (2008–2012)Average annual person–years by sex and age group
SOURCE OF POPULATIONPopulation projections published by the National Institute of Statistics (INE; http://www.ine.gub.uy) based on censuses (last national census in 2011).
NOTES ON THE DATA†C67 (bladder cancer) includes neoplasms of uncertain or unknown behaviour together with invasive cancers.
207
Central and South America
Uruguay (2008−2012)
S I T E ICD-10
Male
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
Female
No. cases Freq. (%)
Crude rate(per 100 000)
ASRworld
Cum. rates 0-64 (%)
0-74
C00C01-02C03-06C07-08C09C10C11C12-13C14C15C16C17C18C19-20C21C22C23-24C25C30-31C32C33-34C37-38C40-41C43C44C45C46C47+C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-72C73C74C75C81C82-86,C96C88C90C91C92-94C95MPDMDSO&UC00-96C00-96 exc. C44
LipTongueMouthSalivary glandsTonsilOther oropharynxNasopharynxHypopharynxPharynx unspecifiedOesophagusStomachSmall intestineColonRectumAnusLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea, bronchus, and lungOther thoracic organsBoneMelanoma of skinOther skinMesotheliomaKaposi sarcomaConnective and soft tissueBreastVulvaVaginaCervix uteriCorpus uteriUterus unspecifiedOvaryOther female genital organsPlacentaPenisProstateTestisOther male genital organsKidneyRenal pelvisUreter
†BladderOther urinary organsEyeBrain and nervous systemThyroidAdrenal glandOther endocrineHodgkin lymphomaNon-Hodgkin lymphomaImmunoproliferative diseasesMultiple myelomaLymphoid leukaemiaMyeloid leukaemiaLeukaemia unspecifiedMyeloproliferative disordersMyelodysplastic syndromes
Other and unspecifiedAll sitesAll sites except C44
33 0.1 0.2 0.3 0.01 0.03 275 0.8 1.7 2.6 0.18 0.32 189 0.6 1.2 1.7 0.11 0.22 82 0.2 0.5 0.7 0.04 0.08
144 0.4 0.9 1.4 0.11 0.18 49 0.1 0.3 0.4 0.03 0.06 68 0.2 0.4 0.7 0.05 0.08
129 0.4 0.8 1.1 0.08 0.14 66 0.2 0.4 0.6 0.04 0.07
872 2.6 5.3 7.2 0.36 0.85 1590 4.7 9.7 13.2 0.68 1.57 91 0.3 0.6 0.7 0.03 0.08
2951 8.7 18.0 24.0 1.09 2.87 1437 4.2 8.8 12.0 0.61 1.48 97 0.3 0.6 0.9 0.05 0.12
364 1.1 2.2 3.1 0.15 0.40 398 1.2 2.4 3.2 0.12 0.39
1146 3.4 7.0 9.4 0.46 1.12 55 0.2 0.3 0.5 0.03 0.06
680 2.0 4.1 6.0 0.34 0.77 5380 15.9 32.8 46.4 2.49 5.93 56 0.2 0.3 0.5 0.03 0.06
105 0.3 0.6 1.2 0.07 0.09 575 1.7 3.5 5.1 0.31 0.57
5954 36.3 47.4 2.09 5.26 38 0.1 0.2 0.3 0.02 0.04 61 0.2 0.4 0.7 0.05 0.06
194 0.6 1.2 1.8 0.09 0.19 96 0.3 0.6 0.8 0.05 0.09
141 0.4 0.9 1.2 0.07 0.13 7294 21.5 44.5 59.3 2.27 7.81 529 1.6 3.2 6.1 0.45 0.46 14 0.0 0.1 0.1 0.01 0.01
1549 4.6 9.4 14.0 0.91 1.69 44 0.1 0.3 0.4 0.03 0.06 21 0.1 0.1 0.2 0.01 0.03
2010 5.9 12.3 16.1 0.68 1.92 20 0.1 0.1 0.2 0.01 0.02 50 0.1 0.3 0.6 0.03 0.04
598 1.8 3.6 6.0 0.37 0.60 198 0.6 1.2 2.0 0.14 0.21 27 0.1 0.2 0.3 0.02 0.03 8 0.0 0.0 0.1 0.01 0.01
174 0.5 1.1 2.0 0.14 0.17 1087 3.2 6.6 10.1 0.59 1.09 23 0.1 0.1 0.2 0.01 0.02
324 1.0 2.0 2.8 0.14 0.33 285 0.8 1.7 2.9 0.13 0.24 326 1.0 2.0 3.2 0.19 0.32 70 0.2 0.4 0.5 0.02 0.05 69 0.2 0.4 0.6 0.04 0.07
212 0.6 1.3 1.7 0.06 0.16
1574 4.6 9.6 12.5 0.56 1.34 39822 242.8 337.0 16.66 39.98 33868 100.0 206.5 289.6 14.57 34.72
25 0.1 0.1 0.2 0.01 0.02 100 0.3 0.6 0.6 0.04 0.07 102 0.3 0.6 0.6 0.03 0.07 75 0.2 0.4 0.5 0.03 0.06 31 0.1 0.2 0.2 0.02 0.03 9 0.0 0.1 0.1 0.00 0.01
27 0.1 0.2 0.2 0.02 0.02 19 0.1 0.1 0.1 0.01 0.02 20 0.1 0.1 0.2 0.01 0.02
405 1.3 2.3 2.1 0.10 0.22 954 3.1 5.4 5.7 0.31 0.62 96 0.3 0.5 0.6 0.04 0.07
3369 10.9 19.2 19.2 0.93 2.16 1081 3.5 6.2 6.7 0.39 0.76 148 0.5 0.8 1.0 0.07 0.13 150 0.5 0.9 1.0 0.04 0.09 643 2.1 3.7 3.8 0.21 0.44
1333 4.3 7.6 7.1 0.30 0.81 33 0.1 0.2 0.2 0.01 0.02 94 0.3 0.5 0.7 0.04 0.08
1505 4.9 8.6 10.8 0.72 1.33 34 0.1 0.2 0.3 0.02 0.02 63 0.2 0.4 0.6 0.04 0.05
480 1.6 2.7 3.6 0.24 0.40 5218 29.7 32.4 1.82 3.62 18 0.1 0.1 0.1 0.01 0.01 9 0.0 0.1 0.1 0.01 0.01
205 0.7 1.2 1.7 0.12 0.16 8613 27.9 49.1 65.8 4.64 7.43 170 0.6 1.0 1.0 0.05 0.11 62 0.2 0.4 0.4 0.02 0.05
1603 5.2 9.1 14.6 1.17 1.46 1132 3.7 6.5 8.0 0.53 0.99 179 0.6 1.0 1.0 0.05 0.10
1001 3.2 5.7 7.4 0.52 0.84 61 0.2 0.3 0.4 0.02 0.04 13 0.0 0.1 0.2 0.01 0.01
840 2.7 4.8 6.1 0.38 0.72 33 0.1 0.2 0.2 0.01 0.02 12 0.0 0.1 0.1 0.01 0.01
568 1.8 3.2 3.2 0.15 0.36 10 0.0 0.1 0.0 0.00 0.00 27 0.1 0.2 0.3 0.01 0.02
484 1.6 2.8 4.0 0.23 0.40 1004 3.3 5.7 9.9 0.79 0.93 18 0.1 0.1 0.3 0.01 0.02 8 0.0 0.0 0.1 0.01 0.01
150 0.5 0.9 1.7 0.11 0.13 939 3.0 5.4 6.7 0.40 0.75 21 0.1 0.1 0.1 0.01 0.01
358 1.2 2.0 2.2 0.12 0.26 205 0.7 1.2 1.8 0.08 0.13 295 1.0 1.7 2.3 0.14 0.22 75 0.2 0.4 0.4 0.02 0.04 85 0.3 0.5 0.5 0.02 0.05
229 0.7 1.3 1.3 0.07 0.14
1642 5.3 9.4 8.5 0.37 0.88 36083 205.6 248.7 15.54 27.45 30865 100.0 175.9 216.3 13.73 23.83
† See note following population pyramid
Uruguay (2008–2012)